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Circadian and seasonal rhythmicity in life on earth
Our	 natural	 environment	 is	 filled	with	 cyclical	 patterns	whose	 ultimate	 origins	 lie	 in	 the	
configuration	of	our	 solar	 system.	Due	 to	 the	daily	 rotation	of	 the	earth	around	 its	 axis,	







to	 survive.	Diurnal	 animals	 reap	 the	benefits	 of	 a	 higher	 daytime	 temperature	 and	 light	
exposure,	 allowing	 a	 lower	 metabolic	 cost	 and	 higher	 visibility	 for	 finding	 food.	 Being	
nocturnal	provides	the	advantage	of	being	harder	to	detect	and	avoids	competition	with	
diurnal	animals.	In	addition,	animals	should	reproduce	in	a	time	of	year	when	there	is	enough	
food	 to	 feed	 the	 offspring,	while	 they	 should	 conserve	 energy	 in	 times	 of	 food	 scarcity.	
It	 is	 therefore	 evolutionary	 beneficial	 to	 have	 ones	 metabolism	 optimalized	 for	 active	
behavior	at	certain	times	and	rest	at	other	times.	Rhythms	of	about	24	hours,	otherwise	
termed	“circadian rhythms”	(circa =	around,	dies	=	a	day),1	and	seasonal	rhythms	are	deeply	













Circadian rhythms are endogeneously generated and can be entrained
Circadian	and	 seasonal	 rhythms	 in	 these	bodily	 processes	 are	not	 just	 a	direct	 response	
to	 environmental	 fluctuations,	 but	 they	 are	 endogenously	 generated.	 The	 first	 evidence	












































opening	 and	 closing	 of	 the	 leaves	 continued	 in	 constant	 darkness,	 thus	 in	 the	 absence	
of	 environmental	 light	 input.	 Since	 then,	many	other	experiments	have	been	performed	
confirming	the	existence	of	endogenous	circadian	rhythmicity	under	constant	conditions.	
The	Frenchman	Michel	Siffre	confined	himself	underground	in	a	cave	for	63	days	and	was	
the	 first	 to	 prove	 that	 circadian	 rhythms	 sustained	 in	 humans	 over	 a	 prolonged	 period	
without	environmental	cues.17 Interestingly,	Siffre’s	time	of	waking	became	later	each	day,	
indicating	that	his	internal	rhythm	was	longer	than	24	hrs.	In	all	organisms,	rhythms	start	






is	 called	“entrainment”	and	external	cues	used	 for	entrainment	are	 termed	“Zeitgebers”. 
This	 term	was	first	used	 in	1955	by	 Jürgen	Aschoff,18	 one	of	 the	 founders	of	 the	field	of	
chronobiology.	The	most	important	Zeitgeber	is	light,	and	other	examples	are	temperature,	
exercise,	social	interactions,	and	temporal	food	patterns.	In	1960,	DeCoursey	was	the	first	
to	demonstrate	 that	 rodents	displayed	clear	 circadian	 rhythms	 in	behavior	when	kept	 in	





night	will	have	an	opposite	effect,	 speeding	up	 the	clock	 to	a	“phase advance”	and	thus	
the	animal	will	 start	active	behavior	earlier	on	 the	 following	day.	Light	pulses	during	 the	






























































Molecular basis for circadian rhythms
Virtually	 all	 cells	 display	 circadian	 rhythmicity	 that	 is	 powered	 by	 a	 transcriptional	 /	
translational	feedback	loop	that	is	hardwired	by	circadian	“clock genes”	and	their	protein	
products.	The	first	clock	gene	was	 identified	 in	Drosophila	and	called	“Period”.47	 In	1994,	




and	 accumulate	 until	 their	 levels	 are	 sufficient	 to	 inhibit	 the	 activity	 of	 BMAL1/CLOCK	





contains	 a	 ROR	 element,	 that	 activates Bmal1	 expression	 when	 bound	 by	 RORα,	 while	
REV-ERBα	surpresses	Bmal1.	Several	clock	gene	mutant	animals	have	been	generated,	all	
displaying	abnormalities	in	their	circadian	rhythmicity.	
The master oscillator in the suprachiasmatic nuclei (SCN) 
The	anatomical	 location	of	the	central	clock	was	discovered	relatively	 late	 in	comparison	
to	 accumulating	 evidence	 of	 general	 properties	 of	 circadian	 rhythms.	 As	 light	 is	 the	
most	 important	 Zeitgeber	 for	 circadian	 rhythms,	 the	 central	 clock	 was	 hypothesized	
to	 lay	 in	 the	 vincity	 of	 the	 optic	 tract.	 In	 1972,	 a	 small	 pair	 of	 structures	 located	 in	 the	
anterior	 hypothalamus	was	 identified	 that	when	 lesioned	 resulted	 in	 a	 complete	 loss	 of	
circadian	 rhythms.53,54	 The	 hypothalamus	 is	 an	 evolutionarily	 ancient	 part	 of	 the	 brain	
that	 is	 responsible	 for	 regulating	 key	 physiological	 processes	 such	 as	metabolism,	 body	
temperature,	 hunger,	 thirst,	 reproduction,	 thereby	 maximizing	 survival	 and	 fitness.	 The	
brain	structures	responsible	for	circadian	rhythms	were	located	just	above	the	optic	chiasm,	
















































Inputs of the SCN
Light	reaches	photoreceptive	rods	and	cones	in	the	retina,	which	contain	rhodopsins	and	








transmitted	 through	 the	 retino-hypothalamic	 tract	 (RHT)	 to	 the	 SCN,	 the	 intergeniculate	
leaflet	(IGL)	and	the	olivary	pretectal	nucleus	(OPN).	Neurons	composing	this	tract	release	
pituitary	adenylate	cyclase-activating	peptide	(PACAP)	and	glutamate	upon	light	exposure,	
increasing	 the	 firing	 rate	 of	 SCN	 neurons	 and	 increasing	 Ca2+	 concentrations	 through	




The	 terminals	 of	 the	 brainstem	 raphe	 nucleus	 release	 5-HT	 in	 the	 SCN	 whenever	
animals	are	active.63,64	5-HT	modulates	light-induced	glutamate	release	from	the	RHT	and	
alters	 the	 postsynaptic	 sensitivity	 to	 glutamate,	 hereby	 changing	 the	 sensitivity	 of	 SCN	
neurons	to	 light.33,35	The	 IGL	terminals	also	release	NPY	 in	response	to	behavior	and	NPY	
release	is	enhanced	by	5-HT.65	Through	this	pathway,	behavior	affects	the	SCN.	Behavioral	
activity	during	the	day	leads	to	a	suppressed	firing	rate	of	SCN	neurons	in vivo.46,66 In vitro 
















































Neuronal activity of the SCN – united we stand, divided we fall 
In	 1979,	 the	 multiunit	 neuronal	 activity	 of	 the	 SCN	 was	 first	 recorded	 in vivo	 in	 rats.76 




pacemaker.	SCN	neuronal	actitivy	was	also	measured	 in vitro	 in	rat	brain	slices	that	were	
articificially	kept	alive,	also	showing	high	multiunit	activity	(MUA)	during	the	day	and	low	














a	 robust	 rhythm.	Even	 in	 clock	gene	mutant	mice	 that	display	 rhythm	abnormalities	 the	
SCN	displays	a	robust	multi	unit	rhythm,	showing	that	the	network	can	rescue	defects	 in	
individual	cells.	Communication	of	the	SCN	cells	through	synapses	and	gap	junctions	allows	




only	 spike	 for	 some	hrs	per	day,	 the	MUA	rhythm	of	 the	SCN	 is	high	 troughout	 the	day.	
Interestingly,	when	days	are	 longer,	the	MUA	activity	remains	high	throughout	the	phase	
















































stored	and	used	by	 the	SCN. 83	 In	 this	manner,	 the	SCN	provides	 the	body	with	seasonal	
cues.86,87	The	neurotransmitter	vasoactive	intestinal	peptide	(VIP)	has	been	proposed	as	a	
major	substance	involved	in	this	process	(Chapter 4).	















When	 the	 core	and	 shell	 regions	are	 surgically	 separated	 in vitro	 after	exposure	 to	a	
phase	 shift,	 the	 shell	 region	will	 not	 entrain	 to	 the	 new	 rhythm,	 implying	 the	 need	 for	
communication	between	 the	 two	 regions	 for	mutual	 synchronization.	GABA	and	VIP	 are	
major	players	 in	this	process	and	blocking	GABA-A	receptors	after	a	phase	shift	will	have	




Output pathways of the SCN
The	 SCN	 produces	 both	 neuronal	 and	 humoral	 output	 and	 there	 is	 evidence	 that	 both	



































































The	pineal	 gland	produces	melatonin	 in	 the	absence	of	 light	exposure	and	 transfers	 this	












and	 injection	 into	 the	SCN	or	 third	ventricle	 influences	behavioral	activity.	However,	also	
clear	evidence	was	provided	that	if	neuro-endocrine	rhythms	were	to	be	sustained	point-to-
point	neuronal	connections	are	necessary.118,119 
Partially	 independent	 circadian	oscillations	are	also	present	outside	 the	SCN	 in	many	
organs	 and	 cells	 throughout	 the	 body,	 and	 are	 referred	 to	 as	 “peripheral clocks”.120 A 
transgenic	mouse	line	was	developed	with	the	enzyme	luciferase	bound	to	the	promotor	
region	of	clock	gene	Per1.	This	coupling	leads	to	light	emission	upon	transcription	of	Per1. 





















































A	 normal	 night	 of	 sleep	 consists	 of	 series	 of	 sleep	 stages	 in	which	 different	 brain	wave	








Although	 sleep	 and	 circadian	 rhythms	 are	tightly	 linked	 in	 everyday	 life,	 sleep	 is	 not	









The	 first	 postulations	 of	 the	 localisation	 of	 the	 sleep-wake	 regulatory	 system	 were	
made	by	von	Economo	in	1930.126	He	observed	that	patients	with	encephalitis	lethargica,	
a	 viral	 disease	 causing	 lesions	 in	 the	posterior	 hypothalamus	 and	 rostral	midbrain,	 slept	
for	20	or	more	hrs	a	day	for	many	weeks.	A	subset	of	patients,	namely	those	with	lesions	
involving	the	basal	ganglia	and	anterior	hypothalamus,	could	not	sleep	longer	than	a	few	























































neuropeptide	 orexin,	 produced	 in	 the	 lateral	 hypothalamus	 and	 mainly	 present	 in	 the	
ascending	arousal	system,	may	provide	additional	stability	for	the	on	or	off	switch.
Adenosine	 acting	 in	 the	 basal	 forebrain	 is	 a	 key	 regulator	 of	 sleep	 homeostasis.131,132 
Glucose	is	stored	as	glycogen.	During	the	breakdown	of	glycogen	and	subsequent	oxidation	
of	glucose	(glycolysis),	adenosine	triphosphate	(ATP)	is	formed.	Adenosine	is	a	breakdown	
product	of	ATP.	During	wakefulness,	ATP	 is	used	as	energy	supplier,	causing	 the	 levels	of	




Feedback of sleep on the SCN
SCN	activity	 is	 influenced	by	 sleep	 stages	 and	by	 components	of	 the	 sleep	 system.	REM	
sleep	associates	with	high	SCN	activity	and	NREM	with	low	SCN	activity.138	Stimulation	of	the	
PPT/LDT	of	the	ascending	arousal	pathway	influences	neurotransmitter	levels	in	the	SCN.139 








expression	 in	 the	 SCN.143,144	 Infusion	 of	 adenosine	 receptor	 agonists	 produces	 a	 similar	











































Disrupted rhythms and sleep in society
Many	individuals	in	the	modern	world	are	subject	to	disruption	of	their	sleep-wake	cycle.	
Artificial	 lighting	 as	 well	 as	 economic	 demands	 have	 contributed	 to	 a	 24-hour	 society	
in	 current	 times,	 further	 supported	 by	 technological	 profileration	 and	 globalisation	 of	
economy.	Recent	 satellite	data	 revealed	 that	75%	of	 the	US	and	European	population	 is	
exposed	to	light	at	night.148 Additionally,	medical	environments	such	as	intensive	care	units	
and	nursing	homes	exhibit	 little	diurnal	variability	 in	 light	 levels.149,150	Animals	exposed	to	




About	one	 third	of	 individuals	 in	 the	US	 reported	 sleeping	 less	 than	6	hrs	 per	night,	

















Health effects of insufficient sleep and disrupted rhythms
Insufficient	sleep	has	been	related	to	a	spectrum	of	cardiovascular	and	metabolic	diseases	
by	altering	multiple	pathways	 (Chapter 1, Chapter 2).	 In	 addition,	 insufficient	 sleep	may	





















































Short	 term	 experimentally-induced	 discrepancy	 between	 external	 and	 internal	
circadian	rhythms	may	already	negatively	affect	cardiometabolic	health.	A	10-day	circadian	
misalignment	protocol	(28-hr	days)	which	caused	participants	to	eat	and	sleep	out	of	phase	
from	 their	 habitual	 times	 resulted	 in	 increased	 blood	 pressure	 and	 decreased	 glucose	
tolerance.180	 Forced	 circadian	 disruption	 also	 leads	 to	 changes	 in	 glucose	metabolism,	 a	
larger	body	mass181	and	increased	risk	for	cardiometabolic	disease.182




































































Chronotype	 is	 a	 stable	 trait	 that	 is	 independent	 of	 socio-economic	 status,	 gender	
and	etnicity.206	Chronotype	does	vary	with	age:	in	the	early	adult	years	a	peak	in	evening	
preference	 is	 reached,	 then	 chronotype	 progressively	 moves	 towards	 morningness.205	A 
heritability	of	43-57%	has	been	reported	by	means	of	twin	studies.207-209	Polymorphisms	in	
circadian	clock	genes	have	been	associated	with	diurnal	preference.210-213 














core	 temperature	 rhythms	 and	usual	wake	up	time	was	 earlier	 in	morning	 types.217	 The	
temporal	 difference	 between	 phase	 of	 bodily	 rhythms	 and	wake	 up	 time	was	 longer	 in	












contribute	 to	other	 sleep	timing	 in	 chronotypes.	 It	has	also	been	 reported	 that	morning	
and	evening	types	express	different	personality	traits,	with	evening	types	displaying	more	
















































Outline of this thesis
The	first	Chapters	of	this	thesis	contain	two	reviews	describing	the	interplay	between	sleep	
deprivation	and	metabolic	disturbances	(Chapters 2 and 3).	The	experimental	part	of	this	
thesis	is	divided	into	three	parts,	beginning	with	basic	clock	mechanisms	and	then	becoming	
progressively	clinical.	Part	of	the	experiments	described	in	this	thesis	have	been	performed	
in	mice	(Chapter 4 to 8),	whereas	another	part	of	the	experiments	hase	been	performed	in	
a	human	study	population	comprised	of	either	obese	short	sleeping	US	citizens	(Chapters 
9 and 10)	 or	Dutch	 individuals	 (Chapter 11).	 Furthermore,	most	experiments	have	been	
performed	in	the	Leiden	University	Medical	Center	(LUMC)	in	the	Netherlands	(Chapter 4 to 
8 and Chapter 11)	and	two	projects	were	executed	at	the	National	Institutes	of	Health	(NIH)	
in	the	United	States	(Chapters 9 and 10).
PART I - The basic functioning of the circadian pacemaker
In	Chapter 4,	we	 investigated	 the	 role	of	 the	neurotransmitter	VIP	 in	 synchronization	of	




and	 control	 mice	 in	 a	 light-dark	 environment,	 and	 also	 in	 constant	 darkness	 conditions	
so	 that	 the	 endogenous	 rhythm	 of	 the	 SCN	 without	 environmental	 input	 becomes	
visible.	Then,	we	repeated	these	analysis	in	animals	that	were	exposed	to	short	and	long	







the	 phase	 shifting	 capacity	 of	 the	 SCN	 in	 response	 to	 light.143,144	Adenosine	 agonists	 and	
antagonists	reduced	and	enhanced	light-induced	phase	shifting,	respectively.145-147	Caffeine	

















































circadian	 activity),	 and	 in	 constant	 light	 (to	 observe	 endogenous	 circadian	 activity	 in	
combination	with	 constant	 light	 input).	 These	mice	were	 given	 caffeine	 in	 their	 drinking	
water,	and	we	determined	the	effects	of	caffeine	on	amount	of	total	behavioral	activity	and	
on	the	period	of	their	free	running	activity.	
The	 experiments	 described	 in	 Chapter 6	 investigate	 the	 relationship	 of	 behavioral	
activity	and	SCN	functioning.	Timing	of	behavioral	activity	 is	 in	 large	part	dictated	by	the	







PART II - Health outcomes of altered circadian rhythms
In	Chapter 7,	we	present	studies	that	examined	the	role	of	disturbed	function	of	the	SCN	
in	 obesity	 and	 type	 2	 diabetes.	 A	 link	 between	 circadian	 rhythms	 and	 metabolism	 has	
been	suggested	from	clock	gene	mutant	mice.	For	example,	Clock gene	mutant	mice	are	
hyperphagic,	 obese,	 and	 hyperglycemic,232 indicating	 a	 link	 between	 circadian	 rhythms	
and	metabolism.	However,	by	the	use	of	these	models	it	is	not	possible	to	distuinguish	the	
contribution	of	 the	 SCN	 to	 the	metabolic	 effects,	 because	 clock	 gene	mutations	 are	not	
specific	to	the	SCN.	SCN	rhythmicity	is	altered	in	aging233	and	neurogenerative	disorders.61,234	
By	performing	bilateral	SCN	lesions	in	mice,	we	examined	the	effect	of	dysfunction	of	the	
central	 clock	 on	 metabolic	 parameters,	 including	 body	 mass	 and	 composition,	 indirect	
calorimetry	measuring	oxygen	consumption,	 food	 intake	and	activity	 in	metabolic	 cages,	
and	 hyperinsulinemic-euglycemic	 clamp	 studies	 in	 order	 to	 assess	 insulin	 sensitivity.	
Additionally,	 some	 lesions	 induced	 collateral	 damage	 to	 areas	 surrounding	 the	 SCN	 that	
regulate	energy	homeostasis,	such	as	the	PVN	and	the	VMH,	so	that	the	combined	effects	of	
loss	of	the	central	clock	and	damage	to	these	areas	could	be	assessed	separately.
Another,	 less	 invasive	 method	 that	 we	 used	 was	 exposure	 of	 mice	 to	 constant	
light	 and	 is	 presented	 in	Chapter 8.	 Hereby,	we	mimick	 the	 overuse	 of	 artificial	 light	 in	











































attenuation	 of	 circadian	 rhythmicity.157	 Light	 exposure	 at	 unnatural	 phases	 decreases	
photosynthesis,	 growth	 and	 survival	 in	 plants,235	 demonstrating	 the	 detrimental	 health	
effects	of	a	desynchrony	between	environmental	and	internal	rhythmicity.	Human	studies	
show	 an	 association	 between	 shift	work	 and	 loss	 of	 health,174-179	 but	 cannot	 distinguish	
cause	and	effect	and	 the	selective	contribution	of	 light	exposure	at	night.	Therefore,	we	
examined	the	long	term	health	effects	of	light	at	night	in	a	large	multidisciplinary	and	strictly	
controlled	 study	 in	mice.	 In	addition,	we	assessed	 the	 reversibility	of	 these	effects	upon	
restoration	of	 the	normal	 light-dark	regime.	Well	 functioning	muscles,	strong	bones,	and	
adequate	immune	system	responses	are	main	contributers	to	health	and	fitness.	Therefore,	
we	 assessed	muscle	 function,	 bone	microstructure,	 immune	 response	 and	 homeostasis	
at	 several	timepoints	of	 circadian	disruption	 (2,	8,	16	and	24	wks)	and	after	 subsequent	
restoration	of	regular	12	hr	light;	12	hr	dark	cycles.
Beside	 deliberate	 pertubations	 of	 circadian	 rhythms,	 differences	 in	 health	 outcomes	
may	also	arise	from	individual	variations	in	circadian	systems.	In	contrast	to	experimental	
mouse	 studies	 described	 above,	 studies	 in	 Chapter 9 describe	 cross-sectional	 analyses	
in	 a	 human	 study	 that	 compares	metabolism	 in	morning	 and	evening	 types.	 The	 cohort	
consisted	 of	 obese,	 short	 sleeping	US	 individuals	 and	was	 orginally	 set	 up	 for	 the	Sleep 
Extension Study.236	 While	 it	 is	 known	 that	 morning	 and	 evening	 types	 differ	 in	 certain	
health	parametes,	 like	BMI	and	risk	 for	type	2	diabetes	and	hypertension,227-229 the	effect	
of	 chronotype	on	metabolic	 parameters	 in	 obese	 and	 short	 sleeping	 individuals	 has	 not	
been	described.	Demographic,	anthropometric,	sleep	and	food	intake	characteristics	were	
compared	 between	 chronotypes.	 Furthermore,	 we	 examined	 differences	 in	 endocrine	
features	 (plasma	 adrenocorticotropic	 hormone	 (ACTH)	 levels,	 plasma	 cortisol	 levels	 and	
urinary	 norepinephrine	 and	 epinephrine	 levels)	 and	metabolic	 features	 (plasma	 insulin,	
glucose	and	lipid	levels)	between	morning	and	evening	types.	Multivariate	statistical	models	
were	constructed	to	assess	the	independent	importance	of	parameters	in	chronotype.




mainly	 affects	 attention	 and	 memory	 functions,	 while	 obesity	 predominantly	 interferes	
















































coaching.	 To	 accomplish	 this,	 neurocognitive	 functions,	 sleep	 and	hormonal	 parameters,	
were	reassessed	averagely	1.5	yrs	later	and	compared	to	values	at	baseline.	Furthermore,	
mixed	 models	 were	 constructed	 to	 assess	 which	 parameter	 influenced	 neurocognitive	
performance	most	strongly.	
Sleep	 characteristics	 have	 also	 been	 associated	 with	 musculoskeletal	 health,	 but	
studies	are	scarce	and	inconsistent.243-246	Osteopenia	(low	bone	mineral	density,	BMD)	and	
sarcopenia	(low	muscle	mass)	are	common	problems	in	the	elderly	that	induce	a	state	of	
vulnerability,245-246	so	 risk	 factors	 need	 to	 be	 identified.	 In	Chapter 11,	 we	 evaluated	 the	
associations	between	sleep	parameters	and	osteopenia/sarcopenia	in	the	study	population	
of	 the	Netherlands Epidemiology for Obesity (NEO) study247 (45-65	 yrs	 old,	 56%	women,	
BMI	26	±	5kg/m2)	in	further	detail.	As	a	lack	of	sleep	is	known	to	affect	certain	mediators	
that	 are	 potentially	 harmful	 to	 bones	 and	muscles	 such	 as	 cortisol	 and	 catecholamines,	
we	 hypothesized	 that	 insufficient	 sleep	would	 associate	with	 osteopenia/sarcopenia.	 As	
the	“restorative”	effect	of	sleep	is	dependent	on	sleep	duration,	but	also	on	sleep	quality	
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decreased	 energy	 expenditure,	 increased	 appetite,	 and	 immunological	 changes.	 On	 the	
other	 hand,	 psychological,	 endocrine,	 and	 anatomical	 abnormalities	 in	 individuals	 with	
obesity	and/or	diabetes	can	interfere	with	sleep	duration	and	quality,	thus	creating	a	vicious	
cycle.	In	this	review,	we	address	mechanisms	linking	sleep	with	metabolism,	highlight	the	



















































rise	 in	the	prevalence	of	obesity.	These	figures	are	reflected	 in	 important	obesity-related	
complications,	 such	 as	 hypertension,	 hyperlipidemia,	 and	 type	 2	 diabetes,	 all	 leading	
causes	of	cardiovascular	disease.2	Type	2	diabetes	affects	8.3%	of	the	U.S	population	(27%	
of	U.S.	residents	aged	65	yrs	and	older),	whereas	35%	of	U.S.	adults	have	fasting	glucose	
and	glycosylated	hemoglobin	(HbA1c)	 levels	 in	the	prediabetic	range.3	Thus,	 it	 is	of	great	
importance	to	characterize	contributing	etiological	factors	in	order	to	effectively	counteract	
the	 obesity	 and	 diabetes	 epidemics.	 The	 exact	 mechanisms	 explaining	 the	 relationship	
between	short	sleep,	obesity,	and	diabetes	remain	unclear.	
Accumulating	evidence	has	pointed	 to	an	association	between	sleep	curtailment	and	








































































This	 ideal	 approach	 may	 not	 be	 practical	 in	 this	 case:	 studies	 of	 sleep	 extension	 or	
curtailment	cannot	be	blinded,	and	participants	may	not	behave	according	to	the	allocation	







15	kg	 in	16	yrs,	respectively.18,19	Thus,	there	 is	a	 large	variability	among	studies	 in	weight	
gain	associated	with	 short	 sleep	 for	unknown	reasons:	 the	magnitude	of	 this	effect	may	
be	gender	dependent	or	depend	on	other	yet-to-be	identified	genetic	and	environmental	
factors.	 For	 example,	 short	 sleep	 may	 affect	 metabolism	 differently	 in	 natural	 “short	
sleepers”	vs.	chronically	sleep-deprived	individuals.	A	large	study	including	35,247	subjects	
found	that	lean	men,	but	not	lean	women,	who	slept	fewer	than	five	hrs	had	increased	odds	
of	 becoming	overweight	within	one	 year	 (OR	1.91;	 1.36–2.67).25	 In	 contrast,	 in	 a	 cohort	







Many	mechanisms	may	be	 responsible	 for	 the	 frequently	observed	 insulin	 resistance	
in	obese	individuals,	including	increased	release	of	free	fatty	acids,	leptin,	and	TNF-α	from	
adipose	tissue.26	We	suggest	that	short	sleep	(fewer	than	five	to	six	hours)	may	now	qualify	

























































evidence	 for	 an	 interconnection	 between	 sleep	 duration	 (too	 short	 or	 too	 long),	 insulin	
resistance,	and	obesity. 
Physiological changes of metabolism during normal sleep
Sleep	 architecture,	 the	 structure	 and	 pattern	 of	 sleep,	 is	 best	 described	 by	 a	 combined	





of	 “core	 clock”	 genes,	 including	 the	 CLOCK	 gene.40,41	 Timekeeping	 signals	 are	 passed	 on	
from	the	suprachiasmatic	nucleus	 to	oscillators	 in	peripheral	tissues	also	containing	core	
clock	genes.	Endogenous	rhythms,	in	turn,	are	synchronized	to	the	outside	world	by	various	



































































at	 sleep	onset	during	 SWS	 (Fig. 2).49	GH	 levels	were	 lower	 in	 SWS-deprived	 individuals50 
and	 higher	 in	 individuals	 with	 pharmacologically	 induced	 SWS.51	 In	 addition,	 REM	 sleep	




Cortisol	 concentrations	 reach	 their	 zenith	 in	 the	 morning,	 experience	 a	 gradual	 fall	
during	 the	day,	which	 is	briefly	 interrupted	by	meals,	 and	have	 their	nadir	 around	3	am	
(Fig. 2).48	Cortisol	 impairs	 insulin	sensitivity	with	a	 latency	of	 four	 to	six	hrs.56,58,59	Plasma	
insulin	levels	also	display	a	modest	diurnal	variation	with	a	10%	excursion,	a	nadir	between	









(adapted	 from	 Ref.	 39).	 Sleep	 can	 be	
divided	into	rapid	eye	movement	(REM)	
and	 nonrapid	 eye	 movement	 (NREM)	
sleep.	On	average,	adults	spend	75–80%	













































SWS,	and	REM	sleep;48 n =14	for	insulin,	glucose,	total	and	acetylated	ghrelin;76 n	=	8	for	catecholamines73);	in	23	
lean	women	for	leptin	and	adiponectin;69	and	in	25	individuals	(13	females,	12	males)	for	IL-6	and	TNF-α.83	Ghrelin	
levels	are	 indicated	as	a	percent	of	mean	24	hrs.	values	(1027	pg/mL	for	total	ghrelin;	80	pg/mL	for	acetylated	












































Individuals	 with	 type	 2	 diabetes	 typically	 have	 low	 adiponectin	 levels,	 even	 when	




and	 TNF-α	 production.	 Finally,	 adiponectin	 displays	 some	 diurnal	 variability,	 with	 lower	
levels	at	night	(Fig. 2).68,69 
During	 sleep,	 vagal	 tone	 increases.70	 Sympathovagal	 balance	 is	 lowest	 during	 REM	
sleep,	when	the	locus	coeruleus,	the	main	brain	source	of	catecholamine	biosynthesis,	 is	
silent.71	Plasma	norepinephrine	(NE)	and	epinephrine	(EPI)	are	produced	by	the	sympathetic	
system:	 EPI	 is	 secreted	 exclusively	 from	 the	 adrenal	 medulla,	 whereas	 NE	 can	 also	 be	




Several	hormones	 involved	 in	 appetite	 regulation	display	 circadian	 rhythms.	 Leptin	 is	
secreted	by	the	white	adipose	tissue	in	a	highly	pulsatile	fashion.74	Leptin	reflects	fat	stores:	
its	 levels	 increase	 after	 meals	 and	 during	 the	 night	 and	 are	 associated	 with	 decreased	





proopiomelanocortin/cocaine-	 and	 amphetamine-regulated	 transcript	 (POMC/CART)	 and	
orexigenic	 neuropeptide	 Y/agouti-related	 protein	 (NPY/AgRP)	 neurons.	 Leptin	 activates	
























































a	second	peak	around	5	am	(Fig. 2).82,83	 IL-1β	decreases	during	 the	night	and	reaches	 its	
nadir	at	8	am	 in	the	morning.82 TNF-	α	also	displays	a	circadian	rhythm,	peaking	close	to	
the	awakening	(6	am)	and	reaching	a	nadir	around	3	pm	(Fig. 2).	IL-6	and	TNF-α	stimulate	
secretion	 of	 cortisol	 and,	 in	 turn,	 cortisol	 inhibits	 their	 secretion.84 Reports	 on	 diurnal	
variability	 of	 CRP	 are	 few	 and	 inconsistent:	 some	 report	 no	 diurnal	 variance,85	 whereas	
others	 find	 increased	morning	 levels.86	 In	 10	 healthy,	 lean	men,	white	 blood	 cell	 counts	
peaked	around	11	pm,	decreased	throughout	the	night	and	reached	a	nadir	at	8	am.82 
The	 relationships	 here	 described	 between	 hormone	 secretion	 and	 sleep	 stages	 are	
necessarily	 descriptive.	 In	 theory,	 as	 new	 pharmacological	 tools	 aimed	 at	 manipulating	




different	metabolic	needs	during	 the	 sleep	and	wake	 states.	 In	 the	next	 section,	we	will	
report	the	effect	of	sleep	deprivation	on	these	metabolic	parameters.	
Effects of sleep restriction on metabolic parameters
The	 relationship	 between	 sleep	 and	metabolism	has	 been	extensively	 studied	 in	 human	
subjects	 under	 varying	 conditions,	 such	 as	 total	 sleep	 deprivation,87–100	 partial	 sleep	
deprivation,101–122	and	sleep	 fragmentation (Table 1).123–125	Partial	 sleep	deprivation	affects	
SWS	 less	 than	other	sleep	stages.	Most	of	 the	experiments	on	the	effects	of	acute	sleep	
deprivation	were	conducted	 in	healthy,	 lean	volunteers.	Food	 intake	and	physical	activity	
were	 often,	 but	 not	 always,	 strictly	 controlled	 (Table 1).	 It	 is	 important	 to	 note	 that	
experimentally	 induced	sleep	alterations	may	not	be	representative	of	changes	occurring	
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VAS:	visual	analogue	scale;	RMR:	resting	metabolic	 rate;	 IL-6:	 interleukin	6;	 IL-1β:	 interleukin	1β;	TNF-α:	 tumor	
necrosis	 factor-α;	 EE:	 energy	 expenditure;	 ivGTT:	 intravenous	 glucose	 tolerance	 test;	 RQ:	 respiratory	 quotient;	
OGTT:	oral	glucose	tolerance	test;	REM:	rapid-eye	movement;	GH:	growth	hormone;	ACTH:	adrenocorticotropic	
hormone;	FDG:	fludeoxyglucose;	PET:	position	emission	tomography.	
Effects on glucose metabolism
In	the	course	of	the	night,	glucose	supply	to	the	brain	must	remain	adequate	in	the	setting	
of	 slightly	 declining	 plasma	 glucose	 levels.	 Infusion	 of	 [3H3]-labeled	 glucose	 in	 healthy,	
lean	subjects	revealed	decreased	glucose	usage	during	the	night,	whereas	in	subjects	kept	
awake	glucose	usage	was	increased	(Table 1).44	Total	and	partial	sleep	deprivation	reduced	
glucose	 tolerance	 in	 lean	 individuals.	 This	 has	been	documented	by	 intravenous	 glucose	
tolerance	 tests	 (ivGTT),101,109,114,123,124	 oral	 glucose	 tolerance	 tests	 (OGTT),87,89,109 insulin 
suppression	tests	with	octreotide,90	as	well	as	hypoglycemic	and	euglycemic	hypoinsulinemic	
























































whereas	 the	 following	 day,	 resting	 and	 postprandial	 EE	 were	 reduced	 by	 5%	 and	 20%,	













Fig. 3.	 A	 simplified	 schematic	 representation	of	putative	pathways	of	 sleep	 curtailment	 leading	 to	obesity	 and	
diabetes,	via	endocrine	mechanisms	that	stimulate	appetite,	decrease	energy	expenditure,	and	 increase	 insulin	
resistance.	The	direction	of	change	(an	increase	or	decrease)	of	each	mechanism	due	to	sleep	loss	is	displayed;	
increased	 sympathovagal	 balance	 could	 stimulate	 EE,	 depicted	 by	 +,	 while	 a	 decreased	 EE	 would	 contribute	
to	obesity.	 For	 readability,	 the	 relationships	between	decreases	 in	 leptin	 levels	 associated	with	 IL-6	and	TNF-α	
production	are	not	displayed.	Cortisol	and	proinflammatory	cytokines	display	a	positive	bidirectional	relationship.	












































Additional endocrine mechanisms linking sleep, glucose metabolism, and energy 
expenditure
As	mentioned	above,	 thyroid	hormones,	GH,	cortisol,	adipokines	 (e.g.,	adiponectin),	and	
sympathovagal	 balance	 modulate	 glucose	 metabolism	 and	 energy	 homeostasis	 (Fig. 3).	
Acute	 total	 sleep	 deprivation	 increased	 TSH	 and	 free	 T4	 levels,88	 whereas	 partial	 sleep	
deprivation	of	5.5	hrs	nights	 for	 two	wks	or	six	4-hr	nights	decreased	TSH	and	T4	 levels,	
suggesting	 a	 dose-related	 effect (Table 1).104,116	 Decreased	 peripheral	 thyroid	 hormone	























sleep	deprivation.95,102,109	 In	 a	 sleep-deprived	 state,	 cortisol	 levels	decreased	more	 slowly	
after	 reaching	 their	 acrophase,	 possibly	 indicating	 decreased	 sensitivity	 to	 the	 negative	
feedback	effects	on	the	hypothalamic–pituitary–adrenal	axis.	Mean	24-hr	levels	of	plasma	
cortisol	 often	 remain	 unchanged	 by	 sleep	 deprivation,43,95,96,99,106,109,123	 but	 the	 circadian	
cortisol-pattern	changes,	as	described	above.	
Adiponectin	 levels	 were	 similar	 after	 partial	 and	 total	 sleep	 deprivation	 and	 sleep	















































Sympathovagal	balance,	defined	as	 the	 ratio	between	 the	activity	of	 the	sympathetic	
and	the	parasympathic	nervous	system,	can	be	indirectly	assessed	with	heart	rate	variability	
analysis.	 Since	 the	 activity	 of	 this	 system	 is	 very	 diverse,	 on	 the	 basis	 of	 the	 different	
anatomic	 branches,	 it	 is	 unclear	 to	 which	 extent	 perturbations	 in	 heart-rate	 variability	
may	be	predictive	of	changes	in	basal	metabolic	rate	and	insulin	sensitivity.	Furthermore,	
heart	rate,	EPI	and	NE	levels	are	markers	of	sympathetic	activity.	Acute	sleep	deprivation	
is	 associated	 with	 increased	 sympathetic	 activity,	 decreased	 parasympathetic	 tone	 and	
therefore,	 with	 increased	 sympathovagal	 balance (Table 1).101,109,123,124	 Total	 EE	 is	 usually	
decreased	in	acute	sleep	deprivation;	thus,	other	mechanisms,	such	as	decreased	thyroid	
hormones	or	adiponectin	levels,	must	prevail	over	increased	sympathovagal	tone	(Fig. 3).	









It	 is	not	clear	 to	what	extent	obesity	 in	 subjects	with	 short	 sleep	 is	 caused	by	 increased	
energy	intake	vs.	decreased	EE	(Fig. 3 and Table 1).133	If	food	is	provided	ad	libitum,	partial	
or	 total	 sleep	 deprivation	 may	 not	 change	 hunger	 ratings,	 while	 likely	 increasing	 food	
intake.99,117,120	On	the	other	hand,	when	food	intake	is	controlled,	sleep	deprivation	usually	
increases	appetite.	Self-reported	sleep	quality	was	inversely	related	to	appetite	in	53	first	





deprivation.113	 In	 addition,	 the	 amount	 of	 sleep	 deprivation	 needed	 to	 increase	 hunger	
ratings	may	be	variable.	One	night	of	total,	but	not	partial,	sleep	deprivation,	significantly	
increased	hunger	 ratings	 in	normal	weight	males.98,113	No	differences	 in	 total	 food	 intake	















































Chronotype,	 the	 individual	 attribute	 determining	 morning	 or	 evening	 preference,	












morning	 values	 of	 leptin.5	 Some	 studies	 found	 no	 association	 between	 short	 sleep	 and	
leptin	levels.94,98,100,119,136	On	the	contrary,	morning	leptin	levels	were	found	to	be	increased	
after	five	nights	of	four	hours,120	after	one	night	of	three	hours117	and	after	one	night	of	total	
sleep	 deprivation.99	 Short	 sleep	 duration,	 as	 assessed	 by	 one	 night	 of	 polysomnography	
in	561	subjects,	also	related	to	higher	morning	leptin	levels.137	 It	is	difficult	to	explain	the	
inconsistent	results	of	these	different	studies.	Of	note,	studies	that	found	decreased	leptin	
after	 short	 sleep	 controlled	 food	 intake,	 whereas	 when	 sleep-deprived	 subjects	 were	
allowed	to	eat	ad	libitum,	leptin	levels	were	unchanged	or	even	increased.	









were	higher	 after	 two	nights	 of	 4-hr	 sleep.105	CLOCK	3111TC/CC	 carriers,	who	display	 an	
evening	preference	and	 sleep	20	min	 shorter,	also	had	 increased	morning	ghrelin	 levels.	
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The	 effect	 of	 sleep	 deprivation	 on	 the	 orexin	 system	 in	 normal	 subjects	 is	 not	 well	
studied.	However,	it	is	known	that	patients	with	narcolepsy	have	abnormally	low	orexin-A	
CSF	 levels,	 which	 correlate	 both	 with	 body	 weight	 and	 sleep	 abnormality.139 Total	 sleep	





food	 intake	 during	 sleep	 deprivation.	 In	 summary,	 appetite	 and	 food	 intake	 are	 often	
increased	following	sleep	curtailment,	possibly	via	decreased	leptin,	increased	ghrelin	and	a	
hyperactive	orexin	system	(Fig. 3).	






partial,106,112	 and	 total	 sleep	 deprivation,96	 but	 one	 study	 did	 not	 find	 any	 changes	 after	
total	 sleep	 deprivation	 (Table 1).82	 TNF-α	 levels	 are	most	 often,82,93,112	 but	 not	 always,107 
unchanged	after	partial	sleep	restriction.	One	study	only	found	increases	in	men,	but	not	
in	women,	after	partial	sleep	deprivation	(Table 1).106	Another	study	reported	higher	levels	








The other side of the coin: metabolic dysfunction influencing sleep
Most	of	the	studies	of	sleep	deprivation	have	been	performed	in	healthy,	lean	subjects	and	
therefore	could	not	address	 the	effect	of	 sleep	deprivation	on	subjects	with	obesity	and	
diabetes.	Obesity	 and	diabetes	 are	 often	 associated	with	 increased	 stress	 or	 differences	
in	 life	 style	 that	 could	 negatively	 influence	 sleep	 (Fig. 3).146	 Depression	 and	obesity	may	













































also	 been	 observed	 in	 youth.	 Decreased	 total	 sleep	 time	 and	 less	 sleep	 efficiency	were	
observed	in	severely	obese	adolescents,	of	which	74%	displayed	sleep	apnea	(16.5	yrs;	BMI	
60.3	±	2.1	kg/m2).149	Changes	in	sleep	architecture	in	obesity	have	been	reported:	severely	









Of	 note,	 augmented	 amplitude	 of	 the	 peripheral	 and	 central	 circadian	 rhythms	 favors	
wakefulness	during	the	day	and	sleep	at	night,	whereas	an	attenuated	circadian	amplitude	
disrupts	 the	 sleep–wake	 cycle.153	 Likewise,	 studies	 in	 rodents	 demonstrate	 that	 physical	
activity	 at	 the	 congruent	 time	 (i.e.	 nocturnal	 for	 mice)	 increases	 the	 central	 circadian	
amplitude,	 suggesting	 that	 active	behavior	 during	 the	day	 and	 sleep	at	 night	 in	 humans	
may	be	beneficial	for	high-amplitude	circadian	rhythms.154	Thus,	sleep	and	circadian	rhythm	




In	 summary,	metabolic	 dysfunction,	 altered	 hormone	 levels,	 and	 sleep	 abnormalities	






Possible therapeutic role of melatonin
In	 nonequatorial	 areas,	 the	 duration,	 intensity,	 and	 spectral	 quality	 of	 natural	 light	 vary	
across	 seasons.158	For	 example,	 during	 a	 summer	 in	 England,	 there	 was	 relatively	 more	
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than	 200	 lux	 completely	 suppressed	 nocturnal	 plasma	melatonin	 production,	 dim	 room	
light	 (106	 lux)	 reduced	melatonin	by	88%	and	 light	 intensities	 lower	 than	80	 lux	did	not	
affect	melatonin	levels.159	As	the	night	progresses,	the	intensity	of	continuous	artificial	light	
needed	to	suppress	circulating	melatonin	increases.160	Of	note,	light	of	shorter	wavelength,	
such	 as	 the	 light	 that	 is	 typically	 emitted	 by	 electronic	 devices	 such	 as	 televisions	 and	
computers,	induces	relatively	more	melatonin	suppression	and	likely	leads	to	greater	sleep	
disruption.160	







Recent	 studies	 suggest	 that	 melatonin	 may	 have	 a	 physiological	 role	 in	 modulating	
metabolism.	 For	 example,	 removal	 of	 the	 pineal	 gland	 decreased	 the	 responsiveness	
of	 several	 insulin-dependent	 hepatic	 kinases	 during	 the	 dark	 phase	 in	 rats.162 This	 effect	
was	 reversed	 by	 nocturnal	 supplementation	 of	melatonin	 in	 the	 drinking	water.	 Chronic	
melatonin	 supplementation	 in	 drinking	water	 also	 reduced	 body	weight	 in	 rodents.163,164 
Patients	with	metabolic	syndrome	have	disturbances	in	melatonin	production,	characterized	
by	 an	 alteration	 of	 the	 night	 melatonin-insulin	 ratio	 of	 unclear	 clinical	 significance.165 
In	 a	 large	 genome-wide	 association	 studies	 conducted	 in	 individuals	 of	 European	origin,	
certain	genetic	variants	of	 the	melatonin	 receptor	1B	were	associated	with	an	 increased	
risk	of	type	2	diabetes.166–168	However,	the	most	common	receptor	variant	did	not	influence	
the	 relationship	 between	 sleep	 abnormalities	 and	 type	 2	 diabetes.166	 Interestingly,	 the	
melatonin	 receptor	 1B	 is	 present	 on	 pancreatic	 β-cells,	 and	melatonin	 has	 an	 inhibitory	

















































improved	HbA1c	 levels	were	 in	part	due	 to	other	 factors	 than	melatonin	administration,	











age	plays	a	 clear	 role	as	 the	 relationship	between	 short	 sleep	and	obesity	 is	 stronger	 in	
children.	Sleep	duration	and	sleep	architecture	change	with	age	in	healthy	individuals,	with	













objective	 sleep	 duration	measurements	 are	warranted	 in	 different	 subgroups	 to	 further	
explore	this	relationship.	
In	 addition,	 the	 causality	 of	 the	 relationship	 between	 sleep	 and	metabolic	 disorders	
remains	unclear,	even	 in	prospective	studies.	Obese/diabetic	 individuals	may	be	sleeping	
less	 than	 lean	 subjects	because	of	differences	 in	 life	 style	or	 stress;	 their	 sleep	could	be	
interrupted	more	often	by	symptoms	of	disturbed	glucose	levels	or	sleep	apnea;	evidence	
arises	 that	 possibly	 circulating	 hormones	 affect	 the	 brain	 inducing	worsened	 sleep	 (Fig. 
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and	 significant	 challenges,	 including	 the	 fact	 that	 the	 biological	 need	 for	 optimal	 sleep	
duration	varies	and	cannot	be	estimated	at	an	individual	level.	Sleep	is	regulated	by	circadian	
and	 homeostatic	mechanisms.	 As	 far	 as	 homeostatic	mechanisms	 are	 concerned,	 it	 has	
been	the	matter	of	a	 long	scientific	debate	whether	during	wakefulness,	 single	or	 rather	
multiple	metabolites	accumulate,	progressively	increasing	the	pressure	to	sleep	during	the	
day.	Classic	experiments	of	parabiosis	 seem	to	support	 the	notion	of	endogenous	“sleep	
promoting”	 substances.	 Recently,	 the	 importance	 of	 adenosinergic	 neurotransmission	 in	
the	 regulation	of	 sleep,	 especially	non-REM	sleep,	has	been	underlined.177	Nevertheless,	
it	is	certain	that	there	is	a	large	individual	variability	in	sleep	needs.	Sensitive	and	specific	













decreases	 in	 EE,	 and	 influences	 on	 glucose	metabolism	 (Fig. 3).	 Endocrine	mechanisms	
influencing	these	pathways	are	complex	and	interconnected.	The	existing	studies	of	sleep	
deprivation	have	generated	variable	 results;	 small	 sample	 size,	differences	 in	 the	control	
of	food-intake	and	physical	activity	levels,	and	inherent	individual	differences	may	have	all	
contributed	to	this	variability.	In	addition,	these	studies	only	addressed	the	effects	of	acute	
sleep	deprivation	and	were	not	performed	 in	 real-life	 situations.	We	suggest	 that	 future	
studies	 should	 focus	 on	 the	 effects	 of	 sleep	 deprivation	 in	 specific	 patient	 populations,	
including	 obese/insulin-resistant	 individuals	 and	 chronic	 insomniacs	 vs.	 natural	 short	
sleepers,	and	should	mimic	real-life	conditions.	
Most	 studies	find	worsened	glucose	 tolerance	after	 sleep	 curtailment,	which	may	be	
beneficial	from	a	teleological	perspective,	at	 least	 in	the	short	term.	When	our	ancestors	
remained	 awake	 during	 the	 night,	 they	 were	 probably	 experiencing	 a	 threat	 (e.g.,	
absence	of	 food,	presence	of	predators),	so	 inducing	a	state	 in	which	glucose	availability	


















































from	melatonin	administration	as	well,	as	 it	 improved	 lipid	profiles.171,172	Thus,	melatonin	
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Obesity,	 exposure	 to	 stress	 and	 inadequate	 sleep	 are	 prevalent	 phenomena	 in	 modern	





HPA-axis	 alterations	which,	 in	 turn,	may	negatively	 affect	 sleep.	 These	findings	 implicate	
that	 obesity,	 stress	 and	 sleep	 loss	 are	 all	 related	 in	 a	 vicious	 circle.	 Finally,	 we	 discuss	



















































society	 has	 become	 increasingly	 fast-paced,	 presenting	 us	 with	 numerous	 stressors	
including	lack	of	restorative	sleep.	In	addition,	self-reported	sleep	duration	has	declined	by	
1.5	to	2	hrs	during	the	last	50	yrs	in	America.2	Epidemiological	and	experimental	research	







was	 further	 demonstrated	 in	 a	 meta-analysis	 of	 45	 cross-sectional	 studies,	 including	









The HPA-axis and obesity 
Physiology and assessment of the HPA-axis 
Exposure	to	stress	elicits	a	highly	orchestrated	series	of	physical	reactions,	mainly	operated	




load.8	The	parvocellular	cells	 in	 the	paraventricular	nucleus	of	 the	hypothalamus	secrete	
corticotrophin-releasing	 hormone	 (CRH)	 in	 response	 to	 stressors,	 including	 physiological	










































turn,	 stimulates	 the	 anterior	 pituitary	 gland	 to	 secrete	 adrenocorticotrophic	 hormone	
(ACTH),	which	 induces	 the	 synthesis	 and	 secretion	of	 glucocorticoids,	mineralocorticoids	
and	androgenic	steroids	by	the	adrenal	cortex.	Cortisol,	the	main	glucocorticoid	in	humans,	
suppresses	the	immune	system	and	induces	glycogenolysis,	as	well	as	insulin	resistance.10 
CRH	 and	 ACTH	 synthesis	 and	 release	 are	 inhibited	 by	 peripheral	 negative	 feedbacks	
mediated	by	cortisol	 (Fig. 1).	 In	addition,	CRH	activates	the	sympathetic	 locus	coeruleus-












CBG	 are	 eliminated.	 Saliva	 specimens	 are	 easier	 to	 collect	 than	 plasma	 and,	 because	 of	
the	 non-invasive	 collection,	 they	 are	 stress-free.	 Although	 urinary	 free	 cortisol	 refers	 to	





Two	 NAPD(H)-dependent	 isoenzymes	 11β-hydroxysteroid	 dehydrogenase	 (11β-HSD1	
and	11β-HSD2)	 intracellularly	convert	the	 inactive	cortisone	to	hormonally	active	cortisol	




and	 5β-THF),	while	 cortisone	 is	metabolized	 to	 cortolone	 and	 tetrahydrocortisone	 (THE)	





















































Inadequate	sleep	 is	more	common	 in	obese	subjects.	Circulating	cortisol	 levels,	both	 in	 free	 form	or	bound	 to	




abundantly	 expressed	 in	 the	 kidney	and	 colon.	Hepatic	 cortisol	 levels	 are	decreased	 in	obese	 subjects,	 due	 to	
decreased	11β-HSD1	levels.	In	contrast,	cortisol	levels	in	adipose	tissue	are	increased	due	to	increased	levels	of	
11β-HSD1.	Cortisol	and	cortisone	are	metabolized	by	reductases	to	the	inactive	tetrahydrometabolites	(THM)	of	











































Association of the HPA-axis and obesity 
Morning	 levels	 of	 cortisol	 in	 saliva	 and	 plasma	 either	 show	 no	 correlation,	 or	 correlate	




among	 individuals.	 Furthermore,	 cortisol	measurements	 can	 be	 confounded	 by	 daytime	









Variations	 in	 tissue-specific	 cortisol	 concentrations	 can	 exist	 without	 any	 changes	 in	
plasma	cortisol	levels	through	varying	local	11β-HSD	activity.	In	obese	subjects,	11β-HSD1	
activity	has	been	reported	either	as	normal18,19	or	 impaired,14	as	 indicated	by	 the	urinary	
cortisol/cortisone	ratio	–	a	rather	crude	and	non-specific	reflection,	since	this	ratio	can	be	




in	animal	models	 (reviewed	 in	Ref	20):	mice	overexpressing	11β-	HSD1	 in	white	adipose	
tissue	 have	 unaltered	 plasma,	 but	 elevated	 corticosterone	 levels	 in	 the	 adipose	 tissue,	
and	 develop	 truncal	 obesity,	 whereas	mice	with	 liver-specific	 upregulation	 of	 11β-HSD1	
do	 not	 exhibit	 increases	 in	 adipose	 mass.	 Correspondingly,	 mice	 with	 11β-HSD1	 gene	




with	 a	 heterozygous	 (GTTT)n repeat	 in	 intron	 1	 of	 the	 CBG	 gene	were	more	 sensitive	 to	
0.25	 mg	 dexamethasone	 suppression.23	 Since	 CBG	 is	 expressed	 locally	 in	 the	 adipose	
tissue,	decreased	local	CBG	levels	could	enhance	free	cortisol	exposure	without	changes	in	
circulating	cortisol	concentrations.21 
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HPA-axis alterations in obese subjects: cause and effect?
The	dramatic	effects	of	altered	circulating	cortisol	levels	on	body	weight	are	exemplified	by	






HPA-axis	 hyperactivation	 may	 lead	 to	 adiposity	 through	 increases	 in	 food	 intake,	 as	




chronic	 stress	may	also	 lead	 to	weight	 loss	 in	 a	 subset	of	 individuals,	 possibly	mediated	
by	hyperactivation	of	β-adrenergic	lipolytic	pathways	or	differences	in	dietary	restraint	or	
coping	mechanisms.3 
In	 order	 to	 determine	 the	 relationship	 between	 stress	 and	 body	 weight	 regulation,	
the	HPA-axis	has	been	examined	 in	obese	 subjects	before	and	after	weight	 loss.	 Sixteen	
wks	 of	 very	 low	 caloric	 diet	 induced	 a	 29	 kg	 weight	 loss	 which	 was	 associated	 with	 a	














































hypercortisolism.33	 Subclinical	 inflammation	 in	 obesity	 may	 contribute	 to	 alterations	 of	





Inadequate	 sleep	has	been	associated	with	 increased	BMI	 (Fig. 1).4,6	Obese	adults	 (BMI:	
41	±	 1	 kg/m2)	without	 sleep	apnea	 slept	 88	min	 less	 than	 lean	 subjects,	 as	 assessed	by	
polysomnography.35	 In	 prospective	 studies,	 there	 was	 a	 distinct	 but	modest	 weight	 gain	








can	 therefore	 serve	 as	 an	 objective	 measurement	 to	 indirectly	 assess	 appetite.	 Short	
habitual	 sleep	 duration,	 was	 correlated	 with	 lower	 levels	 of	 morning	 leptin	 and	 higher	
levels	of	 ghrelin,	which	would	presumably	 lead	 to	 increases	 in	 appetite	 via	 activation	of	









The HPA-axis and sleep


























































hyposecretion.16	On	 the	other	 hand,	 hypoxia	 can	 stimulate	ACTH	and	 cortisol	 levels	 and	
treating	the	sleep	apnea	with	continuous	positive	airway	pressure	resulted	in	normalization	
of	circulating	cortisol.16 









Salivary	 and	 plasma	 cortisol	 were	 elevated	 in	 the	 afternoon	 and	 evening	 following	
experimental	 partial	 and	 total	 sleep	 deprivation,	 while	 morning	 levels	 were	 unchanged	
or	 even	 decreased.4 Mean	 24	 hrs	 plasma	 cortisol	 levels	 measured	 every	 30	 min	 were	
unchanged.4	Some	studies	also	report	a	decreased	cortisol	peak	following	sleep	deprivation	
and	a	slower	decline	of	cortisol	levels	after	its	acrophase.4	In	addition,	sleep	may	interfere	
with	 the	 dynamics	 of	 the	 HPA-axis:	 subjects	 indicating	 poor	 sleep	 had	 an	 exaggerated	
response	to	a	combined	dexamethasone/CRH	challenge.40	
Acute	 sleep	 deprivation	 is	 a	 stressor	 known	 to	 activate	 sympathetic	 activity,	 while	











































Consequences of HPA alterations on sleep
Patients	with	Cushing’s	syndrome	often	have	obstructive	sleep	apnea,	which	in	turn	affects	
sleep	 quality.16,41	 In	 addition,	 even	 patients	 with	 ACTH-dependent	 Cushing’s	 syndrome	
without	 sleep	 apnea	have	 an	18%	decrease	 in	 sleep	efficiency	 (ratio	of	time	asleep	 and	
time	 spent	 in	 bed),	 patients	woke	up	 twice	 as	 often	 (6	vs.	 3	 times)	 and	 a	 12%	 increase	
in	stage	1	sleep	compared	to	normal	controls.41	This	demonstrates	the	direct	deleterious	
effects	 on	 sleep	 of	 abnormally	 elevated	 levels	 of	 circulating	 glucocorticoids.	 Sleep	 in	








Battling HPA-axis alterations and sleep loss: novel therapies for obesity? 
As	 both	 the	 HPA-axis	 and	 sleep	 alterations	 appear	 to	 influence	 body	 weight	 regulation	









alterations	 of	 cortisol	 concentrations,	without	 affecting	 circulating	 levels.	 Carbenoxolone	
is	a	non-selective	 inhibitor	of	11β-HSD1	and	11β-HSD2.	Some	studies	using	this	 inhibitor	
report	 lower	 11β-HSD1	 expression	 in	 adipose	 tissue	 while	 some	 do	 not.19,20	 One	 study	





been	 examined	 in	 randomized	 controlled	 trails.	 In	 patients	 with	 type	 2	 diabetes	 with	 a	




























































increased	 their	 BMI	 by	 2.1	 points.49	 This	 study	was	 not	 randomized	 and	 assessed	 sleep	
duration	only	at	two	time-points	and	with	a	questionnaire,	a	subjective	measurement.	We	















As	 sleep	 loss	 and	 the	HPA-axis	 appear	 to	be	 involved	 in	 the	pathogenesis	of	obesity,	











































selected	 tissues	 without	 affecting	 circulating	 cortisol	 levels,	 therefore	 having	 limited	
unwanted	 side	 effects.	 The	 appeal	 of	 a	 new	 class	 of	 drugs	 based	 on	 the	 mechanism	
summarized	 above	 is	 reflected	 by	 the	 magnitude	 of	 ongoing	 research.	 Clinical	 studies	
focusing	 at	 reducing	 overall	 stress	 levels	 or	 improving	 sleep	 hygiene	 by	 increasing	 sleep	
duration	are	currently	being	conducted.	
In	conclusion,	obesity,	sleep,	and	the	HPA-axis	appear	to	be	related	in	a	deleterious	cycle	
with	many	 complex	 interactions,	 including	 the	 immune	 system	 and	 appetite-regulation.	




Program:	National	 Institute	 of	 Diabetes	 and	Digestive	 and	 Kidney	 Diseases	 (NIDDK).	We	
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Role of vasoactive intestinal peptide 





















































The neuropeptide vasoactive intestinal peptide (VIP) is critical for the proper functioning of 
the neural circuit that generates circadian rhythms. Mice lacking VIP show profound deficits 
in the ability to generate many behavioral and physiological rhythms. To explore how the 
loss of VIP impacts on the intact circadian system, we carried out in vivo multiunit neural 
activity (MUA) recordings from the suprachiasmatic nucleus of freely moving VIP knockout 
(KO) mice. The MUA rhythms were largely unaltered in the VIP KO mice, with no significant 
differences being seen in the amplitude or phase of the rhythms in light–dark conditions. 
Robust differences between the genotypes were revealed when the mice were transferred 
from light–dark to constant darkness conditions. In addition, the ability of the VIP KO mice 
to encode changes in photoperiod was examined. Strikingly, the behavioral and physiological 
rhythms of VIP KO mice showed no adaptation to short or long photoperiods. The data 
indicate that the intact circadian system can compensate for some of the consequences of 













































Circadian rhythms are present in almost all organisms, and have evolved as an adaptation 
to the rotation of the earth around its axis. In mammals, these rhythms are generated in 
the suprachiasmatic nucleus (SCN) of the hypothalamus. The SCN consists of approximately 
20,000 neurons that produce an endogenous circadian rhythm in multiunit neuronal activity 
(MUA), reaching its peak during the day and its trough at night.
In order to function adaptively, the SCN neural activity rhythms need to be synchronized 
to the environment, and a variety of evidence indicates that the light–dark (LD) cycle is 
the main environmental signal responsible. In addition to its role in the generation of daily 
rhythms, the SCN is critical for the body’s response to seasonal changes. In particular, the 
neural activity patterns in the SCN change as a function of day-length.1-4 These photoperiod-
induced changes in the patterns of SCN neural activity are thought to underlie seasonal 
changes in mammals’ physiology and behavioral activity patterns.4-6 Thus, the SCN is critically 
involved in both circadian and seasonal changes in physiology and behavior. In order to 
generate a coherent output signal, it is important for individual neurons within the SCN to be 
mutually synchronized. A major candidate implicated in interneuronal SCN synchronization 
is vasoactive intestinal peptide (VIP). Anatomically, VIP is expressed in neurons in the ventral, 
core SCN region that receive light input through the retinohypothalamic tract (RHT). These 
VIP-expressing cells send projections to the dorsal, shell SCN, as well as leaving the SCN and 
innervating SCN targets such as the subparaventricular zone.7-9 Application of VIP alters the 
firing rate of SCN neurons,10 induces Per1 expression,11 and causes phase shifts of the SCN 
circadian rhythm.12-14 The loss of VIP or its receptor (VIP receptor 2, VIPR2) disrupts neural 
activity rhythms of the SCN measured in vitro,15-16 at least partly because of loss of synchrony 
of the SCN cell population.17-18 Behaviorally, all VIP-deficient and VIP2R-deficient mice exhibit 
disruptions in their ability to express a coherent circadian rhythm in constant darkness (DD) 
as well as alterations in their ability to synchronize to the LD cycle.17-20 
Synchronization of neurons within the SCN is also important for seasonal encoding 
mechanisms of the SCN.1,3,4 In short days, the SCN ensemble rhythm is compressed and 
shows a narrow peak, whereas in long days, it is decompressed and shows a broad peak. The 
changes in the waveform pattern of the electrical SCN rhythm arise from changes in phase 
relationships among activity patterns of single neurons. In short days, subpopulations of 
SCN neurons are synchronized, whereas in long days, these subpopulations show a broader 
distribution.1 An important attribute of the seasonal encoding system is its ‘memory’ for 
photoperiod. Even when animals are transferred from the photoperiod into DD, the phase 
relationships are preserved, and animals continue to show the characteristic behavioral 
patterns for days–weeks. It is not yet understood how the seasonal information is stored 











































In the present study, we first carried out in vivo MUA recordings from the SCN of freely 
moving VIP knockout (KO) mice and littermate wild-type (WT) controls. We then exposed the 
VIP KO mice to long (LD16:8) and short (LD8:16) photoperiods and measured the behavioral 
and physiological responses. 
Materials and methods
Animals and housing
The VIP⁄PHI-/- mouse model was originally generated in the Department of Psychiatry and 
Biobehavioral Sciences at the University of California in Los Angeles. Mouse genotype was 
confirmed with a triple-primer PCR assay (see Colwell et al., 2003 for more information). 
Littermate VIP+/+ mice were used as WT control animals in this experiment. The Animal 
Experiments Ethical Committee of Leiden University Medical Center approved all of the 
experiments. 
Electrode implantation
Male mice were housed under LD12:12, LD18:6 (long day) or LD6:18 (short day) cycles. 
At a minimum age of 12 wks, the mice were anesthetized with Hypnorm ⁄ Dormicum and 
implanted with tripolar stainless steel electrodes (0.125 mm; Plastics One, Roanake, VA, USA) 
with a stereotaxic instrument. Two electrodes (polyimideinsulated) were used for differential 
recordings of the MUA, and one was placed in the gray matter for reference. Aiming for 
the SCN under a 5° angle in the coronal plane, the following stereotaxic coordinates were 
used: 0.4 mm anterior of bregma, 0.48 mm lateral to the midline, and 5.44 mm ventral to 
the surface of the cortex.21 At the end of the experiment, the position of the electrode was 
histologically confirmed by passing a small electric current through the electrode, enabling 
the resulting iron deposition from the tip to be stained with potassium ferrocyanide. 
In vivo MUA recordings
All mice had a recovery period after surgery of at least 1 week before placement in the 
recording cage with a Plexiglas front, and were connected to the recording system with 
a counterbalanced swivel system that allowed the mice to move freely. After appropriate 
amplification and filtering (0.5–5 kHz) of the signal, the action potentials were detected 
with window discriminators and counted in 10-s epochs. MUA data were smoothed with a 
penalized least-squares algorithm22 to describe the waveform of the rhythm, and to determine 
peak and trough time, and peak width. Behavioral activity was measured simultaneously with 
passive infrared sensors. Mice were initially held for 5 days under an LD12:12 cycle followed 
by DD. The peak width was determined per mouse in the smoothed curve at half-maximum 
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The time of the peak and trough were determined with zeitgeber time (ZT) 12 defined 
as lights-off. The MUA data were smoothed, and the mean period of MUA was calculated by 
determining peak-to-peak time in DD per mouse. The mean amplitude was calculated per 
cycle, per mouse, by subtraction of trough height from peak height. The mean amplitude 
decrease after transfer to DD was calculated by dividing the mean amplitude levels in DD 
by the mean amplitude levels in the LD cycle. Phase advances in MUA were calculated by 
comparing the time of the 50% level of the final downward slope in the LD cycle and the 
half-maximum level of the first downward slope in DD, and were corrected for endogenous 
period. 
Mice were entrained to short and long photoperiods for 25 days before recordings, as 
shorter entrainment periods did not lead to consistent waveform changes in the MUA rhythm 
in WT mice.1 Mice exposed to long and short days were recorded for at least 5 days in the LD 
cycle and for approximately 5 days in DD. The peak width and phase of MUA were calculated. 
For mice that were exposed to long photoperiods, the quality of the rhythm decreased, and 
not all peaks could be used for the analysis. We only used peaks that had an amplitude of at 
least 30% of the amplitude in the LD cycle. 
Behavioral data collection and analysis
We used passive infrared sensors to register behavioral activity during the MUA recording (Fig. 
1, Fig. 2, Fig. 4, Suppl. Fig. 2). We made activity profiles by adding behavioral activity in 10-min 
bins per 24 hrs, and we made MUA profiles by adding smoothed MUA data per 24 hrs (Suppl. 
Fig. 2). For all other behavioral analyses, behavioral activity was monitored by the wheel-
running activity of individually housed mice, recorded in 1-min bins (Clocklab; Actimetrics, 
Wilmette, IL, USA). VIP KO mice and their WT littermates were recorded for 30 days in either 
short or long days, and the recordings were continued for at least 14 days after release into 
DD. The duration of the active phase of the activity rhythm (alpha) was determined manually 
in individual mice by estimation of the activity onsets and offsets on each day. Amplitudes of 
behavioral rhythms were determined in individual mice by F periodogram analysis over the 
first 10 days of wheel running activity in DD. The phase advance in behavioral activity after 
release into DD was determined by fitting a straight line through all activity onsets, and was 
corrected for endogenous period. 
Statistical analysis
Independent samples two-sided t-tests were performed in SPSS, and differences were 
considered to be significant if P < 0.05. To assess the normality of the data obtained from the in 
vivo MUA recordings, Shapiro–Wilk tests were performed. All data were normally distributed, 
except for the phase advance after lights off in WT mice (P = 0.01), so we performed a Mann–










































behavioral activity patterns, calculations of differences in alpha, in total behavioral activity 













Wheel-running activity was measured under LD12:12 and DD conditions to confirm the 
VIP-deficient phenotype observed in previous studies (see Suppl. Fig. 1 for examples). All 
of the VIP KO (n = 8) and WT littermate (n = 7) mice showed clear rhythms of locomotor 
activity in LD conditions. When transferred to DD, VIP KO mice, in contrast to WT mice, began 
behavioral activity 5.59 ± 0.78 hrs earlier than what would be expected on the basis of their 
previous activity rhythm under LD conditions. All VIP KO mice remained rhythmic during the 
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shorter (23.31 ± 0.38 hrs) than that of WT mice (23.73 ± 0.06 hrs), but this difference was not 
significant (P = 0.33). 





Long-term MUA rhythms were recorded from the SCN of VIP KO (n = 5) and WT littermate 
(n = 6) mice (Fig. 1A and B). Recordings were performed for five cycles in LD12:12, and then 
for five cycles in DD. All of the VIP KO and WT mice showed diurnal rhythms in MUA when 
exposed to the LD cycle, with a peak in MUA in the middle of the day, and a trough in the 
middle of the night. The mean times to peak after lights-on (ZT 0) were 8.34 ± 1.05 hrs in 
WT mice and 8.22 ± 1.17 hrs in VIP KO mice (P = 0.94, t-test). MUA reached its trough at 
ZT 17.42 ± 0.76 hrs and ZT 17.21 ± 0.94 hrs in WT and VIP KO mice, respectively (P = 0.79, 
t-test). Under these conditions, the durations of the width of the peak in MUA measured at 
half maximum levels were 11.81 ± 0.32 hrs in WT mice and 12.17 ± 0.41 hrs in VIP KO mice (P 
= 0.50, t-test). Thus, in LD conditions, VIP KO mice were able to maintain a robust rhythm in 
electrical activity with characteristics and phasing comparable to WT rhythms. 
All of the VIP KO (n = 5) and WT (n = 6) mice showed circadian rhythms in MUA when the 
mice were held in DD. In DD, VIP KO mice tended to have a shorter free-running period of 
the MUA rhythm (VIP KO, 21.92 ± 0.86 hrs; WT, 23.45 ± 0.41 hrs), but this difference was not 
significant (P = 0.16, t-test). The mean free-running periods of MUA rhythms were similar 
to the periods in wheel-running activity in VIP KO mice (P = 0.11) and in WT mice (P = 0.55). 
The width of the peak in MUA was almost identical between WT mice (11.14 ± 0.34 hrs) and 
VIP KO mice (11.31 ± 0.41 hrs; P = 0.76). There were two robust differences between the 
genotypes when they were transferred from LD conditions to DD. First, the amplitude of the 
MUA rhythm decreased more in VIP KO mice (48% ± 8%) than in WT mice (22 ± 4%, P < 0.01, 
t-test). Second, the MUA activity rhythm was dramatically phase advanced (Fig. 2B). The 
half-maximum level of the downward slope in MUA, which is strongly correlated with activity 











































WT mice (P < 0.01, Mann–Whitney test). The start of behavioral activity of the same VIP KO 
mice was earlier than expected on the basis of endogenous period when lights were switched 
off (Fig. 2A). Average waveforms in MUA under LD conditions did not differ between the 
groups (Fig. 2C). We observed that the downward slope of MUA was strongly correlated with 
activity onset in both strains of mice (Fig. 2D). We made activity profiles of total behavioral 
activity per 24 hrs and 24 hrs. profiles of concurrently measured MUA of both genotypes 
(Suppl. Fig. 2). We calculated the level of MUA at which half of the total behavioral activity 
had occurred. On average, this occurred at the same level of MUA in WT mice (1 ± 0%) and in 
VIP KO mice (7 ± 4%, P = 0.28, t-test). 
Fig. 2.	Phase	advance	in	behavior	and	MUA	after	release	in	DD.	Bar	graphs	compare	the	phase	advance	in	behavior	
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Behavioral and MUA rhythms measured in long and short photoperiods
The wheel-running activity of VIP KO and WT mice was measured in short (LD8:16; KO, n = 
16; WT, n = 17) and long (LD16:8; KO, n = 11; WT, n = 16) photoperiods, respectively. Mice 
were held in the LD cycle for 30 days, and were then released into DD (Fig. 3; Table 1). All 
of the mice showed a robust daily rhythm in LD conditions, with activity increasing sharply 
after lights-off. The amplitude of the daily rhythm in locomotor activity was reduced (P < 
0.01) in VIP KO mice as compared with WT controls, with the mutant mice in the long days 
exhibiting the lowest amplitude (Table 1). Total behavioral activity was significantly lower 
in the VIP KO mice (P < 0.01) than in controls, but did not differ between long and short 
photoperiod exposure in either genotype. Following entrainment to long days and release 
into DD, VIP KO mice showed a phase advance of behavioral activity of 12.74 ± 0.61 hrs as 
compared with the time of expected behavioral onset based on endogenous period. After 
short day exposure and release into DD, VIP KO mice started activity 3.85 ± 0.28 hrs earlier 
than expected. The behavioral phase advance in DD was significantly (P < 0.05) altered by 
exposure to the different photoperiods (Fig. 3). In DD, VIP KO mice showed lower amplitude 
rhythms than WT controls (Table 1). 
Suppl. Fig. 2. Correlation	between	behavior	
and	MUA	in	WT	and	VIP	KO	mice	in	LD12:12.	
Correlation	 between	 behavior	 and	 MUA	
in	 WT	 and	 VIP-deficient	 mice	 in	 LD12:12.	
Typical	 examples	 of	 activity	 profiles	 of	 a	
WT	mouse	 (A)	 and	of	 two	VIP	KO	mice	 (B).	
Behavioral	 activity	 as	 measured	 by	 passive	
infrared	 sensors	 is	 depicted	 in	 grey	 in	
10-minute	bins	 as	 a	percentage	of	maximal	
activity	per	bin	 size.	 The	black	 curve	 shows	
normalized	mean	multiunit	electrical	activity	
(MUA).	Light	is	depicted	at	the	top	of	the	plot	
with	 grey	 indicating	 darkness.	 The	 point	 in	
time	and	 relative	 to	MUA	value	where	50%	




















































Short day Long day
VIP KO WT VIP KO WT
Alpha in LD (hrs)*,† 12.8	±	0.3 12.9	±	0.3 6.4	±	0.2 7.7	±	0.1
Alpha in DD (hrs)*,‡,§ 9.3	±	0.5 12.6	±	0.3 11.2	±	0.6 9.0	±	0.3
Period in DD (hrs) 23.9	±	0.2 23.8	±	0.2 23.8	±	0.4 23.9	±	0.2
Amplitude in DD (hrs)†,‡,§ 0.6	±0.1 0.9	±	0.0 0.4	±	0.2 0.9	±	0.0
Phase advance (hrs)†,‡,§ 3.9	±	0.3 0.2	±	0.1 12.7	±	0.6 0.0	±	0.1
*P <	0.05	between	short	and	long	days	in	WT	mice;	†P <	0.05	between	short	and	long	days	in	VIP	KO	mice;	‡P <	0.05	
between	genotypes	in	short	days;	§P <	0.05	between	genotypes	in	long	days.	
One of the important changes in circadian behavior observed in mice held in different 
photoperiods is an adaptive alteration in the duration of the night activity interval (alpha) 
(Fig. 3). WT mice showed a significantly (P < 0.05) longer alpha when held in short days 
(12.9 ± 0.3 hrs) than when held in long days (7.7 ± 0.0 hrs). Similar differences in alpha (P < 
0.05) were observed in VIP KO mice held in short days (12.8 ± 0.3 hrs) or long days (6.4 ± 0.2 
hrs). As expected, when WT animals were released into DD, alpha remained significantly (P < 
0.05) longer after short days (12.6 ± 0.3 hrs) than after long days (9.0 ± 0.3 hrs). This history-
dependent change in alpha (after-effects) was lost in the mutant mice. When VIP KO mice 
held in short days were released into DD, the alpha of the activity rhythm was only 9.3 ± 0.5 
hrs, and those that were in long days showed an alpha of 11.4 ± 0.5 hrs. 
Finally, long-term MUA rhythms were recorded from the SCN of VIP KO mice held in long 
days (n = 6) or short days (n = 6; Fig. 4). Recordings were performed for five cycles in the 
LD condition, followed by five cycles in DD. All of the VIP KO mice showed diurnal rhythms 
in MUA, whether exposed to a short or a long photoperiod. The average width of the MUA 
peak measured at halfmaximum levels was significantly (P < 0.001, t-test) decreased when 
the mice were held in short day (9.82 ± 0.38 hrs) as compared with long day (14.40 ± 0.45 hrs) 
conditions. In three mice, MUA was measured in more than one photoperiod consecutively 
(Suppl. Table 1). The peak width of MUA lengthened with longer photoperiod exposure. When 
mice were transferred to DD, all of the VIP KO mice (6 ⁄ 6) continued to show clear circadian 
rhythms in MUA after short day exposure. In contrast, after exposure to long photoperiods, 
some of the VIP KO mice (2 of 6) lost the circadian rhythmicity in MUA, and the remaining 
mice showed weak rhythms. Therefore, we could only reliably determine period and phase 
advance in MUA after short day exposure: 22.96 ± 0.13 and 1.97 ± 0.81 hrs. Importantly, after 
exposure to DD, the prior photoperiod had no significant impact on the MUA peak width (Fig. 
4). The mean widths of the peak were 10.93 ± 0.83 and 12.16 ± 0.77 hrs after short and long 
day exposure (P = 0.37, t-test). Thus, for both the behavioral and MUA rhythms, the VIP KO 

















































Suppl. Table 1.	Width	of	 the	peaks	 in	MUA	in	a	subpopulation	of	VIP	KO	mice	that	were	measured	 in	multiple	
photoperiods.
Short day LD12:12 Long day
Animal	1	 9.04	hrs	 - 13.05	hrs
Animal	2	 9.54	hrs	 11.66	hrs	 15.51	hrs























































We implanted electrodes into the SCN of VIP KO mice and littermate WT controls, and 
continuously recorded MUA in freely moving mice. Under LD12:12 conditions, VIP KO mice 
showed strong daily rhythms in MUA that peaked during the second half of the day and 
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the rhythms could not be distinguished from those recorded from the SCN of WT mice. 
When VIP KO mice were transferred to DD, the MUA rhythm continued, but displayed a 
reduction in amplitude that was significantly larger than the amplitude drop observed in WT 
mice (Fig. 1). Also, upon release into DD, the MUA rhythm of VIP KO mice showed a phase 
advance of about 6 hrs (Fig. 2), consistent with behavioral findings in earlier reports.17,18,20 
We analysed the half-maximum levels of the downward slope of MUA, as this phase of the 
rhythm is closely correlated with behavioral onset.23 We found that the phase advance of the 
electrical activity rhythm was similar to the phase advance of the behavioral activity rhythm. 
We considered whether this shift reflects an unmasking of the rhythm in DD. As the electrical 
activity rhythm of the SCN peaked at the middle of the day under LD conditions, we have no 
evidence for masking of the SCN rhythm by the light. Our results indicate that, in both LD 
and DD conditions, the VIP KO mice show a stable phase relationship between the SCN and 
behavioral activity, and start their activity at the 50% level of the falling slope, as do WT mice. 
The impact of VIP deficiency varies with output
As a result of recent work, it is becoming clear that the impact of the loss of VIP or VIPR2 
varies with the output being measured. For example, in DD, the wheel-running activity in VIP 
KO mice is reduced in amplitude and coherence, and declines into arrhythmicity over the 
course of several weeks,20 whereas VIPR2 KO mice are apparently arrhythmic from the start of 
constant conditions.18 Rhythms in body temperature,24-26 feeding and metabolism27 are phase 
advanced but remain relatively intact. Rhythms in sleep (non-rapid eye movement and rapid 
eye movement) show reduced day–night amplitude and a phase advance in LD conditions.24, 
28 Rhythms in heart rate in both VIP and VIPR2 mutants are low-amplitude or arrhythmic in LD 
and DD conditions.24,26 Similarly, rhythms in the blood levels of adrenocorticotropic hormone 
and cortisol are all lost in VIP KO mice in both LD and DD conditions.29 With the present 
work, we see for the first time what is occurring at the level of the SCN in vivo, and find that 
the overall SCN neural activity rhythm is normal in LD conditions (Fig. 1). This suggests that 
we may need to look to the output pathways to explain the variability in the impact of the 
loss of VIP on SCN-driven behaviors. Presumably, the SCN projects to extra-SCN tissues and 
peripheral outputs via interneurons, particularly those that regulate autonomic outflow from 
the paraventricular nucleus or the brainstem, and ⁄ or those that drive the pituitary output 
and hence adrenal or other endocrine rhythms.30 Many of these interneurons are VIPergic, 
and VIP may therefore be required for communication between the SCN and peripheral 
tissues to drive rhythms in behavior and other biological processes.7,31-33 
Cellular consequences
The quality of the rhythm in MUA is remarkable, given the compelling evidence that VIP 
plays a critical role in coupling cells in the SCN circuit.34 Within the SCN, genetic loss of VIP 










































loss of VIP decreases the number of electrically rhythmic SCN neurons and weakens the 
synchrony among the rhythmic SCN neurons.17,18 Even at the molecular level, the temporal 
expression of Per1, Per2 and Bmal1 is disrupted in the SCN.35 SCN explants from VIP or VIPR2 
KO mice showed low-amplitude rhythms in PER2::LUC and PER1::LUC bioluminescence that 
were not altered in phase as compared with controls.35-37 Recent work by Maywood et al.38 
has demonstrated that paracrine signalling is sufficient to induce rhythmicity in VIP-deficient 
SCN slices, and that VIP plays a predominant role in mediating this coupling as measured by 
PER2::LUC bioluminescence. All of the analyses of the VIP and VIPR2 KO mice indicate that 
the coupling within the SCN network is greatly reduced by the loss of VIP ⁄ VIPR2 signalling, 
and that the VIP KO mice can be considered to have a ‘broken’ SCN network. 
System-level compensation
The present results raise the question of what is occurring in the intact system that enables 
the SCN to maintain strong rhythms in MUA in the presence of reduced cellular synchrony 
resulting from the loss of VIP. The most obvious explanation is that light directly stimulates 
SCN activity when animals are kept in an LD cycle.39,40 The decreased behavioral amplitude in 
DD is also explainable by an absence of entraining light signals. The melanopsin expressing 
retinal ganglion cells are both directly light-sensitive and receive information from rods 
and cones.41-43 These melanopsin-expressing retinal ganglion cells thus encode ambient 
lighting44 and generate action potentials that travel down the RHT and reach the SCN. The 
RHT terminals release glutamate8 and, under certain conditions, the neuropeptide pituitary 
adenylate cyclaseactivating peptide.45 The net result of RHT stimulation is an increase in the 
firing rate of SCN neurons. Prior work with VIP KO mice demonstrated that the direct effects 
of light in suppressing activity and of darkness in enhancing activity are completely unaltered 
by the loss of VIP.20 Therefore, in an LD cycle, the direct effects of light and dark on MUA are 
likely to play a major role in maintaining the rhythmicity in SCN physiology and behavior. 
Previous work has also provided evidence that SCN neural activity is influenced by activity 
in other brain regions,46,47 which may explain why, in VIP KO animals, the rhythms in DD are 
maintained in vivo, whereas the rhythms measured in vitro are severely decreased.16,17 Prior 
studies with the VIPR2 KO mice have also found behavioral48 and physiological24 evidence that 
activity is a strong regulator of rhythmicity in these mice. A variety of earlier studies have 
noted that locomotor activity itself can modify SCN activity.49-52 The direct regulation of SCN 
firing by lighting and activity levels would not be detected in the in vitro recording, and could 
be viewed as a systems-level compensation for the loss of coupling in the VIP KO mice. 
Role of VIP in seasonal encoding
The SCN serves as a seasonal clock through its ability to encode daylength.4,53,54 In line 
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compressed when WT mice were exposed to short and long days, respectively (Fig. 3). 
Interestingly, alpha in VIP KO mice was shorter under long than under short photoperiods. 
When mice were transferred to DD, alpha remained highly correlated with the previous 
length of photoperiod in WT mice. In VIP KO mice, however, the duration of alpha was not 
shorter after long day exposure following release into darkness. In fact, alpha was even 
longer after long days, and we cannot explain this phenomenon. We therefore conclude that 
seasonal encoding is greatly compromised in VIP KO mice. Similar to observations in LD12:12 
conditions, VIP KO mice exposed to different photoperiods showed a rapid and large phase 
advance with the transition to DD, but the amplitude of the phase advance was dependent on 
the previous photoperiods (Fig. 3). The phase advance was particularly large after exposure 
to long photoperiods, and was much smaller, and almost the same as, the behavior of WT 
mice following exposure to short photoperiods. The fact that the behavior of mice after short 
days resembled the behavior of WT mice may indicate that the short photoperiod has acted 
as a strong synchronizer, thereby normalizing the behavior of VIP KO mice. 
To test whether the impairment in seasonal encoding in VIP KO mice is based on 
deficiencies within the SCN clock, we investigated the impact of photoperiod on SCN MUA 
waveform (Fig. 4). The waveform of the SCN rhythm shows major differences in response 
to long and short photoperiods that are brought about by changes in synchrony among 
molecular and electrical activity rhythms of SCN neurons.1,3,56-59 A major question that follows 
from these results concerns the underlying mechanism of phase synchrony vs. desynchrony in 
seasonality. To investigate the putative role of VIP, we measured the electrical activity patterns 
from SCN neurons in VIP KO mice exposed to short and long days (Fig. 4). VIP KO mice showed 
a broadening of their MUA patterns when they were kept in long days, and a lengthening when 
kept in short days. The broadness of the peaks at half-maximum levels differed significantly 
between the photoperiods (14.6 vs. 9.8 hrs), which is similar to what is seen in WT animals.1 
Importantly, the MUA of three mice was recorded in multiple photoperiods. The results from 
these three recordings showed the same photoperiod-driven changes in peak width that we 
observed in the population (Suppl. Table 1). Interestingly, when VIP KO mice were transferred 
to DD, the width of the MUA profiles was indistinguishable between the groups from long 
and short photoperiods. It is well accepted that the ‘after-effects’ in DD indicate the storage 
of photoperiodic information in the SCN clock. In other words, to test the encoding capacity 
of the SCN for photoperiod information, the waveform of the rhythm should be evaluated 
after termination of the light cycle. In our results, the peak width in long days did not exceed 
the peak width in short days, and in fact it became narrower. The absence of any after-effect 
on the electrical activity rhythm therefore suggests a total absence of seasonal encoding 
capability of the SCN in the absence in VIP. 
Although photoperiod did not affect the width of the peak, it did affect the phase 










































phase advance was about 10 hrs after exposure to long days and about 2.5 hrs after exposure 
to short days. These findings were consistent with the magnitude of the behavioral advances 
that we observed in VIP KO mice. Finally, we note that the overall quality of the rhythm in 
both behavior and in MUA activity, as indicated by the amplitude, was better after exposure 
to short photoperiods than after exposure to long photoperiods. Possibly, the short days 
functioned as a strong synchronizer, resulting in an absence of a strong phase advancing 
response and a diminished attenuation of the rhythm in darkness. 
Conclusion
The robustness of the rhythm in electrical impulse frequency of the SCN in vivo, as compared 
with previous in vitro recordings,16,17 indicate that communication between neuronal 
networks can compensate for the absence of VIP-induced synchrony among SCN neurons. 
The SCN MUA is acutely increased by retinal input,40 and we speculate that the direct effect 
of light boosts the magnitude of the MUA rhythms. Possibly, light input maintains phase 
coherence via the RHT or through behavioral feedback effects, via the geniculohypothalamic 
input or the median raphe. Additional regulatory effects of behavioral activity and sleep from 
other brain regions on SCN activity are also likely, 46,49,50 and need to be further explored. 
Prior work has provided elegant evidence that SCN intercellular coupling provides robustness 
in the circadian system against genetic perturbations.60 Here, we show that the intact SCN 
circuit can overcome the dysfunction caused by the loss of intercellular coupling in the SCN. 
To put it another way, as important as VIP is for the coupling of SCN neurons, the intact 
system appears to be able to compensate for its loss, at least under some lighting conditions. 
However, our findings also indicate that there are some functions that require VIP-mediated 
intercellular coupling, for example the reorganization of the SCN circuit that is part of the 
adaptation to changes in photoperiod. Without VIP, both the behavior and the physiology of 
the SCN appear to be unable to adapt to seasonal changes, and the ‘memory’ for photoperiod 
is lost. This is an important finding in the search for mechanisms underlying the consolidation 
of phase synchrony within the SCN. 
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Caffeine increases light responsiveness 

























































of	 the	 suprachiasmatic	nucleus	 (SCN)	of	 the	hypothalamus,	where	 the	circadian	clock	of	
mammals	 resides.	 Previous	 studies	have	 shown	 that	 sleep	deprivation	 reduces	 circadian	
clock	phase-shifting	capacity	and	decreases	SCN	neuronal	activity.	In	addition,	application	
of	adenosine	agonists	and	antagonists	mimics	and	blocks,	respectively,	the	effect	of	sleep	
deprivation	on	 light-induced	phase	 shifts	 in	behavior,	 suggesting	a	 role	 for	adenosine.	 In	
the	present	study,	we	examined	the	role	of	sleep	deprivation	in	and	the	effect	of	caffeine	
on	light	responsiveness	of	the	SCN.	We	performed	 in vivo	electrical	activity	recordings	of	
the	SCN	 in	 freely	moving	mice,	 and	 showed	 that	 the	 sustained	 response	 to	 light	of	 SCN	
neuronal	activity	was	attenuated	after	6	hrs	of	 sleep	deprivation	prior	 to	 light	exposure.	
Subsequent	intraperitoneal	application	of	caffeine	was	able	to	restore	the	response	to	light.	
Finally,	we	performed	behavioral	 recordings	 in	 constant	conditions,	and	 found	enhanced	
period	 lengthening	 during	 chronic	 treatment	with	 caffeine	 in	 drinking	water	 in	 constant	
light	 conditions.	 The	 data	 suggest	 that	 increased	 homeostatic	 sleep	 pressure	 changes	














































Caffeine	 is	 the	psychoactive	 stimulant	 that	 is	most	 commonly	used	 to	 reduce	 sleepiness	
worldwide.	 It	 mainly	 acts	 as	 an	 adenosine	 receptor	 antagonist,	 and	 disrupts	 sleep	 and	
increases	 alertness	 in	many	mammals.1	 Adenosine	 is	 one	 of	 the	 substances	 thought	 to	








clock.	 Photic	 information	 reaches	 the	 SCN	 via	 the	 eyes	 through	 the	 retinohypothalamic	
tract.	Retinal	ganglion	cells	project	via	 this	monosynaptic	pathway	 to	 the	SCN.	Following	










caffeine	on	 the	 light	 responsiveness	of	 the	circadian	 system.	We	 recorded	SCN	electrical	
activity	in	freely	moving	mice,	and	examined	the	effect	of	sleep	deprivation	on	the	response	
of	 SCN	 neuronal	 activity	 to	 light	 pulses.	 To	modulate	 this	 activity	 pharmacologically,	we	
studied	the	effect	of	the	non-selective	adenosine	receptor	antagonist	caffeine	on	the	light-
induced	changes	in	SCN	neuronal	discharge	after	sleep	deprivation.	Finally,	we	determined	























































and	 is	 equivalent	 to	 the	 caffeine	 concentration	 in	 ordinary	 drip	 coffee.	 During	 in vivo 
electrophysiological	experiments,	caffeine	was	injected	at	a	concentration	of	15	mg/kg.	This	
concentration	was	shown	to	significantly	increase	waking	in	the	following	hours,23,24 and is 
equivalent	to	approximately	three	cups	of	coffee	in	humans.1 
Behavioral activity
Mice	 were	 individually	 housed	 in	 cages	 containing	 either	 a	 plexiglass	 running	 wheel	
(diameter,	 24	 cm)	 or	 a	 passive	 infrared	 (PIR)	 motion	 detector	 (Hugrosens	 Instruments,	
Löffingen,	Germany).	PIR	detectors	and	sensors	on	the	running	wheels	were	connected	to	
a	ClockLab	data	collection	system	(Actimetrics,	 IL,	USA).	The	numbers	of	wheel	 rotations	
were	measured	 and	 stored	on	 a	 computer	 in	 1-min	 bins.	 Animal	 care	 and	 experimental	
procedures	were	carried	out	under	dim	red	light	conditions.	
Sleep deprivation
Sleep	 deprivation	 was	 performed	 during	 behavioral	 experiment	 1	 and	 during	 the	












































































In vivo electrophysiology experiment 1
After	 connection	 to	 the	 recording	 chamber,	 the	mice	 (n	 =	 11)	were	 placed	 in	DD.	 Sleep	
deprivation	was	performed	during	the	in vivo	electrophysiological	recording	between	CT8	
and	CT14.5,	on	the	third	and	seventh	days	in	DD.	During	sleep	deprivation,	mice	were	kept	













































































Sleep deprivation and behavior

















































Sleep deprivation and SCN electrophysiology 










Fig. 1. (A-B)	 Two	 representative	 double-
plotted	actograms	of	mice	demonstrating	the	
phase-shifting	 response	 of	 running-wheel	
activity	to	a	15-min	light	pulse	applied	at	CT14	
on	 the	 second	 day	 in	 DD.	 Mice	 were	 either	
kept	 in	DD	 (A)	 or	 sleep-deprived	 in	DD	 for	 6	
hrs	(B)	prior	to	light	exposure.	The	light	regime	
is	 plotted	 as	 bars	 above	 the	 actograms.	 The	
striped	 area	 in	 B	 reflects	 the	 period	 of	 sleep	
deprivation	 (not	 double-plotted).	 (C)	 Mean	
phase	 shifts	 ±	 standard	 error	 of	 the	 mean	
of	 wheel-running	 activity	 of	 mice	 (n	 =	 6)	 in	
response	 to	a	 light	pulse	with	 (grey	bar)	 and	
without	(black	bar)	prior	sleep	deprivation;	the	
white	bar	shows	the	magnitude	of	the	phase	
shift	 in	 response	 to	 sleep	 deprivation	 alone,	
without	light	exposure.	*P <	0.05,	paired	t-test.	
Light	exposure	preceded	by	sleep	deprivation	






























































Fig. 2. (A)	 An	 example	 of	 a	 coronal	 slice	 of	 the	mouse	
brain	with	the	SCN	immediately	above	the	optic	chiasm	
at	 the	 base	 of	 the	 hypothalamus.	 The	 location	 of	 the	
electrode	could	be	verified	by	the	blue	spot,	which	was	
marked	with	an	electrolytic	current.	 (B-C)	Responses	of	
SCN	 electrical	 activity	 to	 light	 at	 CT15	 in	 freely	moving	
mice	in	the	control	condition	(B)	or	after	sleep	deprivation	
in	DD	 for	6	hrs	 (C).	Mice	were	repeatedly	exposed	 to	a	
5-min	 light	 pulse.	 The	 presence	 of	 light	 is	 indicated	 as	
a	white	 background.	 Time	 is	 plotted	 in	minutes	 on	 the	
x-axis,	 and	 the	 frequency	 of	 electrical	 activity	 of	 SCN	
neurons	is	plotted	on	the	y-axis.	Black	vertical	lines	at	the	
bottom	of	 each	 graph	 indicate	 PIR-recorded	 locomotor	
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neuronal	 activity	 after	 6	 hrs	 of	 sleep	 deprivation.	
Mice	 were	 exposed	 to	 5-min	 light	 pulses.	 In	





vertical	 lines	 at	 the	 bottom	 of	 each	 graph	 indicate	
PIR-recorded	locomotor	activity	in	the	cage.	(B)	Mean	
light-induced	 increases	 in	 SCN	 neuronal	 activity	 ±	
standard	 error	 of	 the	mean	 after	 sleep	 deprivation	
are	 summarized	 (n	 =	 6).	 Mice	 received	 either	 no	
injection	 or	 intraperitoneal	 injections	 of	 saline	 or	
caffeine	(15	mg/kg),	and	were	then	exposed	to	5-min	
light-pulses.	 **P <	 0.01,	 ratio	 paired	 t-tests	 (saline	
vs.	caffeine,	P =	0.004,	t	=	0.4125;	sleep	deprivation	
vs.	saline,	P =	0.697,	t	=	5.097).	Caffeine	significantly	























































Fig. 4.	 (A- B)	Double-plotted	actograms	of	
behavioral	 activity	 of	mice	 demonstrating	
the	 effect	 of	 caffeine	 on	 free	 running	
periods	 in	 constant	 darkness	 (A)	 and	
constant	 light	 (B).	 The	 light	 regime	 is	





caffeine	 (0.08%)	 via	 their	 drinking	 water.	
(C)	Mean	period	length	±	standard	error	of	
the	mean	 in	DD	 (n	 =	 8)	with	 and	without	
caffeine	and	in	LL	(n	=	9)	with	and	without	
caffeine.	*P <	 0.05	and	**P <	 0.01,	mixed	
model	 with	 factors	 light	 and	 caffeine,	
unpaired	 t-test.	Administration	of	 caffeine	





























































increased	 the	 sensitivity	 of	 the	 endogenous	 circadian	 clock	 to	 light,	 and	 in	 accordance	
lengthened	the	period	of	the	clock.	








previously	 that	 application	 of	 an	 adenosine	 agonist	 attenuates	 the	 light-induced	 phase	
delays	in	behavior,	which	are	restored	by	an	adenosine	receptor	antagonist.20,21	In	contrast,	
a	 recent	 study	 showed	 that	 caffeine	 administration	 blocks	 light-induced	 phase	 delays;	
however,	the	dose	applied	was	three	times	larger,	and	the	activity	of	the	animals	was	very	


























































for	 these	 receptors.	 In	 various	 brain	 regions,	 stimulation	 of	 the	 A1	 adenosine	 receptor	


















similar	 to	 the	phase	shifts	 induced	by	glutamate.	These	shifts	were	 fully	blocked	by	pre-
incubation	with	 RyR	 blockers,	which	 indicates	 a	 role	 for	 RyRs	 in	 regulating	 the	 light-like	
phase-shifting	effect	of	caffeine.57	However,	the	concentrations	needed	to	activate	the	RyRs	
in vivo	 are	most	 likely	not	 reached	with	peripheral	administration	of	caffeine.	Therefore,	
we	hypothesize	a	role	for	adenosine	receptors,	in	particular	A1	receptors,	in	mediating	the	
effects	reported	in	our	study.	
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Uitnodiging
CHAPTER 6 
Amplitude of the SCN clock enhanced 



























































type	 of	 behavioral	 activity.	 The	 suppression	was	moderate	 (32%	of	 circadian	 amplitude)	
for	low-intensity	behavior	and	considerable	(59%)	for	locomotor	activity.	Mild	manipulation	
of	 the	animals	had	reversed	effects	on	 the	SCN	 indicating	that	different	mechanisms	are	




















































of	 humoral	 signals,	 giving	 rise	 to	 circadian	 rhythms	 in	 physiology	 and	 overt	 behavior.2 
Synchronization	of	the	circadian	system	to	the	environmental	day	and	night	primarily	relies	
on	external	light	information,	transmitted	to	the	SCN	via	the	retinohypothalamic	tract.3
While	 light	 is	 the	most	 important	 cue	 for	 synchronization,	 the	 phase	 of	 the	 clock	 is	
also	affected	by	the	animal’s	behavioral	activity.	Arousal	or	increased	voluntary	behavioral	






































































activity.	 Instead,	 SCN	neuronal	 activity	 of	 4	 out	 of	 these	 5	mice	 showed	 responsiveness	
to	 light,	while	 lightinduced	 responses	were	not	observed	 in	 the	animals	with	behavioral	
suppressions.	 In	 the	 responsive	mice,	 episodes	 of	 spontaneous	 behavioral	 activity	were	
consistently	associated	with	a	decrease	in	SCN	electrical	activity	(Fig. 1).	
Fig. 1.	 SCN	 electrical	 activity	 is	 suppressed	 during	 brief	 episodes	 of	 spontaneous	 behavioral	 activity.	 (A)	


























































darkness	 (DD;	observations	 from	7	animals)	 and	 in	 constant	 light	 (LL;	 observations	 from	
2	 animals).	 The	magnitude	 of	 suppression	 reached	 values	 to	 up	 to	 89%	 of	 the	 rhythm	
amplitude.	The	time	course	of	recovery	after	an	episode	of	behavioral	activity	followed	an	
exponential	pattern,	and	the	time	required	to	return	to	baseline	levels	was	on	average	15	
±	4	min	 (range	 from	5	 to	21	min),	 irrespective	of	 the	duration	of	behavioral	activity	and	
circadian	time.	
Fig. 2.	Time	course	of	suppressions	of	SCN	electrical	
activity	 during	 spontaneous	 behavioral	 activity.	
The	start	of	behavioral	activity	 is	characterized	by	
an	acute	drop	of	SCN	firing	rate.	Decreased	 levels	
of	 SCN	 electrical	 activity	 are	 typically	 sustained	
throughout	 the	 duration	 of	 behavioral	 activity.	
Representative	 examples	 of	 different	 durations	
are	 shown.	 Behavioral	 activity	 and	 associated	
suppressed	levels	of	SCN	electrical	activity	 last	for	
approximately	 (A)	 10	 sec,	 (B)	 10	min,	 and	 (C)	 30	
min.	Behavioral	activity	as	detected	by	the	passive	
infrared	detector	is	plotted	in	the	lower	bar	(all-or-
nothing	modus).	Note	 that	 the	 PIR	 detector	 does	
not	 detect	 all	 behavioral	 activity	 which	 became	
apparent	 from	the	video	recordings.	Suppressions	
that	 lasted	<1	min	were	observed	 in	~20%	of	 the	
cases,	the	occurrence	of	suppressions	of	1–25	min	
was	~65%,	and	the	occurrence	of	long	suppressions	
of	 >25	 min	 was	 ~15%.	 In	 each	 figure,	 the	 x-axis	
represents	 time	 (scale	 unit	 is	 given	 by	 the	 bar	 in	
the	 figure).	 Suppressions	 of	 all	 shown	 examples	
occurred	between	Zeitgeber	Time	(ZT)	3	and	ZT10)	















































sub-populations.	 Action	 potential	 thresholds	 were	 set	 off-line	
in	 such	 a	 way	 that	 an	 average	 firing	 frequency	 of	 18	 Hz	 was	













the	accompanying	video	recordings	were	analyzed	(Fig. 4, Suppl. Video 1).	The	magnitude	

































































































































disturbance	of	 the	animal’s	 rest	during	 the	day.	
The	 disturbance	 was	 established	 by	 making	 a	
small	movement	 of	 the	 cage,	without	 touching	
the	animal.	The	timing	of	disturbance	is	indicated	
by	 the	 arrow.	 The	 increment	 of	 SCN	 discharge	
levels	is	acute,	and	returned	to	baseline	quickly.	
In	some	cases	the	increment	in	electrical	activity	
was	 followed	 by	 a	 suppression	 in	 electrical	
activity	 when	 behavioral	 activity	 continued	
(lower graph).	 It	 is	possible	 that	 in	 these	cases,	
induced	 activity	 had	 changed	 into	 motivated	
activity.	Behavioral	activity	as	recorded	by	passive	
infrared	 detector	 is	 depicted	 at	 the	 bottom	 of	
each	MUA	trace	in	a	graded	scale.
Influence on circadian amplitude
























































Fig. 6. Circadian profile of SCN electrical activity in the presence and absence of PIR-recorded behavioral activity. 
To visualize the effect of behavioral activity on SCN rhythm amplitude, the passive infrared activity data are 
integrated in the electrical activity data: whenever passive infrared movement was detected during a 10 sec 
recording bin, the number of SCN spikes counted in that bin is represented by a black dot. Grey dots show 
multiunit activity data points from bins when no movement was detected. Eye-fitted lines were drawn through 
grey dots (blue line) and black dots (red line) to illustrate the presence of a circadian rhythm in either profile. The 












SCN	 and	 show	 that	 behavioral	 activity	 itself	 acts	 as	 a	 potent	 stimulus	 that	 modulates	
SCN	pacemaker	activity.	 The	SCN	electrical	 activity	was	 strongly	affected	by	 the	animal’s	
spontaneous	 behavioral	 activity	 level	 in	 an	 intensity-	 and	 duration-dependent	 manner.	
Electrical	 discharges	 were	 abruptly	 decreased	 upon	 the	 start	 of	 activity,	 and	 remained	




of	 the	 SCN	 at	 high	 levels.	 Thus,	 a	 reciprocal	 interaction	 exists	 between	overt	 behavioral	
activity	and	the	rhythm	amplitude	of	the	central	circadian	pacemaker.	
Identification of effective behavioral activity
Video	recordings	allowed	for	the	identification	of	specific	types	of	behavior	that	were	able	
to	 induce	 suppression	 of	 SCN	 activity.	We	 established	 the	 dependence	 of	 SCN	neuronal	
suppression	 on	 the	 duration	 and	 intensity	 of	 activity.	 Surprisingly,	 ultra-short	 (<1	 min)	










































levels	 indistinguishable	 from	 those	 induced	 by	 longer	 activity	 periods.	 Furthermore,	 we	
found	that	non-intense	types	of	behavior	were	capable	of	inducing	substantial	suppression	
(~30%)	 of	 SCN	 electrical	 discharge	 levels.	Notwithstanding,	with	more	 vigorous	 types	 of	
behavioral	activity,	the	suppression	of	SCN	activity	became	larger.	The	strongest	modulation	
of	 SCN	 firing	 rates	was	 associated	with	 locomotor	 activity	 (~60%;	 Fig. 4).	When	 activity	
switched	from	one	type	to	another,	the	electrical	activity	remained	suppressed,	but	often	the	
level	of	suppression	changed,	depending	on	whether	the	activity	was	more	intense	(further	
suppression),	or	 less	 intense	 (Fig. 4A).	The	presence	of	behaviorally-induced	suppression	











SCN	 in vitro,	no	spontaneous	suppression	of	 the	SCN	neuronal	activity	 is	observed	while	
recording	techniques	are	comparable	(i.e.	stationary	MUA	recordings).26	This	indicates	that	













activity	 patterns,	 such	 as	 those	 induced	 by	 cage	 cleaning,	 lead	 to	 phase	 shifts,	 albeit	 of	
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Effects of induced versus spontaneous activity; response direction and kinetics
When	 behavioral	 activity	 was	 evoked	 by	 mild	 disturbance	 of	 the	 animal,	 the	 observed	
responses	of	 SCN	neuronal	 activity	were	 transient	 and	excitatory.	 These	 responses	were	
opposite	to	those	induced	by	spontaneous	behavior	observed	in	the	same	animals	(Suppl. 
Fig. 1).	SCN	neuronal	discharge	 levels	 immediately	 increased	 in	response	to	the	stimulus	
and	remained	elevated	for	a	maximum	of	200	sec	(Fig. 5).	The	kinetics	of	the	recovery	of	
the	 excitatory	 responses	was	 different	 as	 compared	 to	 the	 recovery	 from	 suppressions.	
Following	 suppression,	 the	 recovery	 took	 remarkably	 long	 (approximately	 15	 min)	 and	
resembled	an	exponential	function	in	accordance	with	previous	results.24	 In	contrast,	the	
recovery	 from	 the	 excitation	 was	 fast.	 These	 findings	 raise	 questions	 on	 the	 potential	
underlying	mechanisms.	
Suppl. Fig. 1.	 Illustration	of	SCN	suppression	and	SCN	excitation	in	the	same	animal.	Representative	example	of	
a	 trace	 showing	 suppression	 of	 SCN	 electrical	 activity	 in	 response	 to	 spontaneous	 behavioral	 activity	 (A).	 The	





































































Elevations	 in	 firing	 rate	may	 be	 due	 to	 excitatory	 stimulation	 of	 the	 SCN,	 as	well	 as	
to	 a	 transient	 inactivation	 of	 hyperpolarizing	 signals	 (disinhibition).	 Thus,	 the	 involved	
neurotransmitter	system	could	be	excitatory	or	 inhibitory.	The	analysis	of	subpopulations	
revealed	heterogeneity	within	the	recorded	population.	This	suggests	that	incoming	fibers	









rhythm	 and	 were	 found	 at	 all	 phases	 of	 the	 circadian	 cycle.	 As	 behavioral	 activity	 of	
nocturnal	animals	 is	concentrated	during	the	night,	suppression	of	SCN	electrical	activity	
is	 especially	present	during	 the	night.	As	a	 result,	 the	 trough	 in	 SCN	electrical	 activity	 is	
lowered.	This	finding	indicates	that	the	SCN	rhythm	amplitude	can	be	boosted	by	behavioral	
activity	during	the	animal’s	active	phase,	 i.e.	 the	phase	of	the	cycle	where	SCN	electrical	
activity	 is	 low	 (Fig. 7).	Accordingly,	 the	SCN	pacemaker	 itself	 can	be	 regarded	as	a	node	




















































Fig. 7. Consequence of night- vs. day-time activity on SCN rhythm amplitude. Blue line represents the SCN activity 
in the absence of behavioral activity; red line represents the SCN activity in the presence of behavioral activity. 
Both lines are based on results shown in Fig. 6. The black lines represent two extreme possibilities: (A) when 
behavioral activity is concentrated during the night and is absent during the day, the amplitude of the SCN 
electrical activity is maximal. (B) In contrast, when behavioral activity would occur during the day and rest occurs 
during the night, the SCN amplitude will be negatively affected and shows a reduced amplitude. Horizontal lines 
indicate peak and trough SCN activity levels. The LD12:12 light cycle is indicated above the record (white, lights 
on; black, lights off). 
 
 
Fig. 7.	 Consequence	 of	 night-	 vs.	 day-time	 activity	 on	
SCN	 rhythm	 amplitude.	 Blue	 line	 represents	 the	 SCN	
activity	 in	 the	 absence	 of	 behavioral	 activity;	 red	 line	
represents	the	SCN	activity	in	the	presence	of	behavioral	
activity.	 Both	 lines	 are	 based	 on	 results	 shown	 in	 Fig.	
6.	The	black	 lines	 represent	 two	extreme	possibilities:	
(A)	 when	 behavioral	 activity	 is	 concentrated	 during	
the	night	and	 is	absent	during	 the	day,	 the	amplitude	
of	the	SCN	electrical	activity	is	maximal.	(B)	In	contrast,	
when	 behavioral	 activity	 would	 occur	 during	 the	 day	
and	rest	occurs	during	the	night,	the	SCN	amplitude	will	
be	negatively	affected	and	shows	a	reduced	amplitude.	
Horizontal	 lines	 indicate	peak	and	 trough	 SCN	activity	

































































All	 experiments	 were	 performed	 under	 the	 approval	 of	 the	 Animal	 Experiments	 Ethical	














SCN electrical activity recordings
After	 a	 recovery	 period	 of	 at	 least	 one	 week,	 the	 animal	 was	 individually	 housed	 in	 a	
temperature	 controlled	 recording	 chamber	 (22˚C),	where	 food	and	water	were	available	
ad	 libitum	and	where	 the	mouse	 could	move	 freely.	 The	 electrical	 signal	was	 amplified,	

































































Data analysis – SCN electrical activity
Electrical	 activity	 data	 were	 smoothed	 in	 MATLAB	 (Mathworks	 Inc.).	 The	 smoothing	
parameter	was	 set	 to	 the	 lowest	 value	 yielding	 a	 single	 peak	 and	 through	per	 circadian	
cycle.	 Rhythm	amplitudes	were	 determined	by	measurement	 of	 the	 difference	between	
peaks	and	troughs.	The	magnitude	of	 the	behaviorallyinduced	neuronal	suppression	was	
defined	 as	 the	 difference	 between	 baseline	 electrical	 activity	 and	 the	 average	 electrical	































































By	 video-analysis,	 the	 following	 behavioral	 activities	were	 scored	 in	 1	 sec	 bins:	 digging,	
drinking,	eating,	grooming,	lying,	moving,	rearing,	sitting,	and	walking.	For	the	analysis,	we	








a	 potassium	 ferrocyanide	 containing	 fixative	 solution	which	 caused	 the	 iron	 deposits	 in	
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The suprachiasmatic nucleus controls 



































































glucose	 infusion	 rate	was	 significantly	 lower	 in	SCN	 lesioned	mice	compared	with	 sham-
operated	mice	(-63%).	Although	insulin	potently	inhibited	endogenous	glucose	production	
(-84%),	 this	 was	 greatly	 reduced	 in	 SCN	 lesioned	 mice	 (-7%),	 indicating	 severe	 hepatic	
insulin	resistance.	Our	data	show	that	SCN	malfunctioning	plays	an	 important	role	 in	the	


































































of	 SCN	 cellular	 organization	 in	 aging,15	 neurodegenerative	 disorders,	 and	 dementia,13,16 





such	as	 the	ventromedial	hypothalamus	 (VMH)	and	paraventricular	nucleus	 (PVN),	 great	
care	was	taken	to	distinguish	between	exclusively	SCN	lesioned	mice	and	mice	with	collateral	













































Research design and methods
Animals
All	 animal	 experiments	were	 approved	 by	 the	 Animal	 Ethic	 Committee	 from	 the	 Leiden	







Mice	were	 anesthetized	 using	 a	mixture	 of	 ketamine	 (100	mg/kg;	 Aescoket,	 Boxtel,	 the	
Netherlands),	xylazine	(10	mg/kg;	Bayer	AG,	Leverkusen,	Germany),	and	atropine	(0.1	mg/
kg;	Pharmachemie,	Haarlem,	The	Netherlands)	and	mounted	in	a	stereotactic	device	(Digital	
Just	 for	Mouse	 Stereotaxic	 Instrument;	 Stoelting,	Wood	 Dale,	 IL).	 After	 identification	 of	
bregma,	a	hole	was	drilled	through	which	the	lesion	electrode	was	inserted	into	the	brain.	
Lesion	needles	were	made	by	 isolating	a	0.3-mm	stainless	steel	 insect	pin	using	 isolating	
resin,	 except	 for	 0.2	mm	 at	 the	 tip.	 The	 electrode	 tip	was	 aimed	 at	 the	 SCN,	 0.46	mm	





After	 SCN	 lesioning,	 all	 mice	 were	 housed	 in	 constant	 dark	 for	 10	 consecutive	 days	 to	




was	 determined	 by	 F-periodogram	 analysis	 based	 on	 the	 algorithm	 of	 Dörrscheidt	 and	
Beck.18	Mice	were	included	in	the	lesion	group	when	no	significant	rhythm	was	present.
Positional check of the SCN lesion
The	 SCN	 lesions	 were	 checked	 as	 described	 previously.10	 To	 verify	 the	 position	 of	 the	
SCN	 lesions,	 brains	 were	 removed	 and	 fixed	 by	 immersion	 with	 4%	 paraformaldehyde	
















































biotinylated	 goat	 anti-rabbit	 IgG,	 and	 subsequently	 incubated	 for	 1	 hrs	 in	 avidin–	 biotin	
complex	 (Vector	 Laboratories,	 Burlingame,	 CA).	 The	 reaction	 product	 was	 visualized	 by	
incubation	 in	 1%	 diaminobenzidine	 with	 0.01%	 hydrogen	 peroxide	 for	 5–7	 min.	 Nickel	
ammonium	 sulfate	 (0.05%)	 was	 added	 to	 the	 diaminobenzidine	 solution	 to	 darken	 the	
reaction	product	(diaminobenzidine/	nickel).	All	sections	were	mounted	on	gelatin-coated	
glass	 slides,	dried,	 run	 through	ethanol	and	xylene,	and	covered	 for	observation	by	 light	
microscopy.	 For	 every	 animal,	we	blindly	 scored	 the	amount	of	 damage	 to	 the	 SCN	and	
surrounding	hypothalamic	nuclei	involved	in	metabolism	(PVN	and	VMH).	
Indirect calorimetry and metabolic cages
Individual	measurements	by	 indirect	calorimetry	were	performed	for	a	period	of	at	 least	
4	 consecutive	 days	 (Comprehensive	 Laboratory	 Animal	 Monitoring	 System;	 Columbus	
Instruments,	 Columbus,	 OH).19	 A	 period	 of	 24	 hrs	 was	 included	 at	 the	 start	 of	 the	
experiment	to	allow	acclimatization	of	the	mice	to	the	cages.	Experimental	analysis	started	





Eight	 weeks	 after	 SCN	 lesioning,	 hyperinsulinemic–euglycemic	 clamp	 experiments	 were	
performed	 as	 previously	 described.20	Mice	 were	 fasted	 for	 16	 hrs	 with	 food	 withdrawn	
at	 17:00	 the	 day	 before	 the	 study.	 All	 mice	 ate	 within	 60	 min	 before	 the	 start	 of	 the	
fasting	period,	minimizing	differences	 in	 fasting	time.	During	 the	experiment,	mice	were	
anesthetized	 by	 intraperitoneal	 injection	 with	 a	 combination	 of	 acepromazin	 (6.25	mg/
kg;	 Sanofi	 Sant	 Nutrition	 Animale,	 Libourne	 Cedex,	 France),	 midazolam	 (6.25	 mg/kg;	
Roche,	 Mijdrecht,	 the	 Netherlands),	 and	 fentanyl	 (0.31	 mg/kg;	 Janssen-Cilag,	 Tilburg,	
the	 Netherlands).	 Anesthesia	 and	 body	 temperature	 were	 maintained	 throughout	 the	
procedure.	At	 the	end	of	 the	basal	 and	 the	hyperinsulinemic	periods,	hematocrit	 values	
were	determined	 to	ensure	 that	 the	mice	were	not	 anemic.	 First,	 basal	 rates	of	 glucose	
turnover	were	determined	by	administering	a	primed	 (0.8	mCi)	 constant	 (0.02	mCi/min)	














































steady-state	 circulating	 insulin	 levels	 of	 ~4	ng/mL	 together	with	3-3H-glucose.	A	 variable	
intravenous	 infusion	 of	 a	 12.5%	D-glucose	 solution	was	 used	 to	maintain	 euglycemia	 as	
determined	at	10-min	intervals	via	tail	bleeding	(<3	mL;	Accu-chek,	Sensor	Comfort;	Roche	
Diagnostics).	All	mice	were	clamped	at	their	respective	basal	glucose	levels,	because	it	has	
been	 shown	 that	 alterations	 in	 basal	 fasting	 glucose	 levels	 alone	 are	 sufficient	 to	 affect	
insulin	sensitivity.21	Seventy	minutes	after	the	start	of	the	hyperinsulinemic	period,	when	



















Behavioral and histological verification of SCN lesions.
Periodogram	 analysis	 of	 activity	 showed	 that	 all	 sham-operated	mice	 retained	 a	 strong	
circadian	rhythm	(Fig. 1A),	whereas	SCN	lesioned	mice	lost	their	circadian	rhythm	in	activity	
after	 the	 lesion	 procedures	 (Fig. 1B).	 Histological	 analysis	 revealed	 SCN	 lesions	 without	
















































vasopressin	 (immunohistochemical	staining,	Suppl. Fig. 1A),	vasoactive	 intestinal	peptide	





























































Suppl. Fig. 1. Representative histological sections of the hypothalamus, illustrating the histological verification of 
lesion position and size. 40 micrometer coronal sections were alternately stained for arginine vasopressin (AVP, 
immuno-histochemical staining, A), vasoactive intestinal peptide (VIP, immuno-histochemical staining, B) and 
cresyl violet (CV, cell-nuclei staining, C). For each animal, the location of lesion-induced damage was judged by 
independent researchers. Animals were classified based on (I) the presence of a bilateral ablation of the 
suprachiasmatic nucleus (SCN, top row of each panel) and for the presence of additional damage: (II) unilateral 
or bilateral ablation of the paraventricular nucleus (PVN, middle row in each panel) and (III) damage to the 
rostral part of the ventromedial hypothalamus (VMH, bottom row in each panel). For comparison, schematic 




C Suppl. Fig. 1. Representative	 histological	 sections	 of	 the	 hypothalamus,	 illustrating	 the	 histological	 verification	
of	 lesion	 p sition	 and	 size.	 40	 micrometer	 coronal	 sections	 were	 alternately	 st ined	 or	 argi ine	 vasopressin	
(AVP,	 immuno-histochemical	 staining,	A),	 vasoactive	 intestinal	 peptide	 (VIP,	 immuno-histochemical	 staining,	B)	
and	cresyl	violet	(CV,	cell-nuclei	staining,	C).	For	each	animal,	the	location	of	lesion-induced	damage	was	judged	
by	 independent	 researchers.	 Animals	 were	 classified	 based	 on	 (I)	 the	 presence	 of	 a	 bilateral	 ablation	 of	 the	











































































Fig. 2.	 Body	mass	 and	 composition	 of	 sham	
(white	 bars)	 and	 SCN	 lesioned	 (black	 bars)	
mice	 at	 the	 time	 of	 the	 hyperinsulinemic–
euglycemic	clamp.	Total	body	mass,	lean	body	




























































Fig. 3.	 Indirect	 calorimetry	 and	metabolic	 cage	
analysis	of	sham	and	SCN	lesioned	(SCNx)	mice:	
oxygen	consumption	(A),	activity	(B),	and	energy	
intake	 (C).	 White	 bars	 represent	 the	 average	
value	 during	 the	 day	 and	 black	 bars	 represent	
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Table 1.	 Body	mass	 and	hyperinsulinemic–euglycemic	 clamp	parameters	of	 sham	and	 suprachiasmatic	nucleus	
lesioned	(SCNx)	mice.
Sham SCNx
Basal Clamp Basal Clamp
Body mass (g) 24.9	±	1.2 29.2	±	1.9†
Insulin (ng/ml) 0.5	±	0.3 5.2	±	1.1‡ 1.0	±	0.3† 4.8	±	1.9‡
Glucose (mmol/l) 4.9	±	0.8 4.7	±	0.9 6.7	±	1.2† 6.8	±	1.2†
FFA (mmol/l) 0.9	±	0.2 0.6	±	0.3‡ 1.2	±	0.3* 0.8	±	0.2
Hematocrit (%) 41.6	±	4.7 38.5	±	2.3 41.7	±	2.7 40.5	±	0.7



















Sham 5.0	±	0.7 4.9	±	1.0 4.6	±	0.8 4.7	±	1.0 4.7	±	1.0
SCNx 6.6	±	1.1 6.8	±	1.4 7.4	±	1.3 6.7	±	1.1 6.8	±	1.1
SCNx	+	unilat	PVN	damage 6.7	±	0.6 7.3	±	2.0 7.0	±	1.1 7.1	±	1.2 7.1	±	1.2
SCNx	+	bilat	PVN	damage 7.2	±	0.9 7.4	±	1.5 7.2	±	0.7 7.2	±	0.9 7.2	±	1.3
SCNx	+	PVN/VMH	damage 7.6	±	1.7 7.6	±	1.9 6.8	±1.0 7.4	±	1.7 7.4	±	1.6
Basal 1 SA 
(DPM/µmol)
Basal 2 SA 
(DPM/µmol)
Hyper 1 SA 
(DPM/µmol)
Hyper 2 SA 
(DPM/µmol)
Hyper 3 SA 
(DPM/µmol)
Sham 12100	±	3966 12855	±	4176 7831	±	2283 7519	±	2587 7398	±	1990
SCNx 8849	±	1828 8891	±	1803 6066	±	283 5452	±	1044 6659	±	1241
SCNx	+	unilat	PVN	damage 9925	±	2274 9383	±	2606 6842	±	1804 7085±	1365 7109	±	2013
SCNx	+	bilat	PVN	damage 6450	±	1098 6887	±	1864 5775	±	1339 6031	±	1625 6755	±	2227
SCNx	+	PVN/VMH	damage 7532	±	4189 8174	±	5039 5302	±	1906 6068	±	2177 5920	±	2677
In	 the	basal	period,	EGP,	which	equals	Rd,	was	not	different	between	sham	and	SCN	
lesioned	mice	 (53.6	 ±	 16.6	 vs.	 65.0	 6	 8.6	mmol/min/kg,	 not	 significant;	 Fig. 5A).	 In	 the	
hyperinsulinemic–euglycemic	period,	Rd	was	increasedby	57%	in	the	sham	mice	compared	
with	the	basal	period	(83.9	±	23.8	vs.	53.6	±	16.6	mmol/min/kg;	P <	0.01)	and	by	27%	in	


















































SCN lesion with collateral hypothalamic damage
SCN	lesioned	mice	with	collateral	damage	to	hypothalamic	nuclei	 involved	in	metabolism	









Fig. 4.	 Hyperinsulinemic–euglycemic	 clamp	
analysis	 of	 sham	 (white)	 and	 SCN	 lesioned	
(SCNx,	 black)	 mice.	 Line	 graphs	 represent	
the	 plasma	 glucose	 levels	 (A)	 and	 GIR	 (B)	
during	 the	 hyperinsulinemic	 period	 of	 the	
clamp.	 Bar	 graph	 represents	 the	 clamped	









































































































Suppl. Table 2.	Indirect	calorimetry/metabolic	cage	(A),	hyperinsulinemic-euglycemic	clamp	(B)	and	plasma	insulin 
data	(C)	of	sham	and	SCN	lesioned	(SCNx)	mice	with	collateral	damage.	Data	are	represented	as	mean	±	SD,	*P < 




Sham 3386	±	173 195	±	67 3.20	±	0.53
SCNx	+	unilat	PVN	damage 3107	±	162* 74	±	22* 2.24	±	0.54*
SCNx	+	bilat	PVN	damage 2530	±	196* 61	±	23* 2.52	±	0.73*









Sham 76531	±	3831 273	±	123 4.73	±	0.50
SCNx	+	unilat	PVN	damage 74849	±	4302 166	±	62* 4.51	±	1.43
SCNx	+	bilat	PVN	damage 61561	±	4327* 154	±	55* 4.13	±	1.06






Sham 53.6	±	16.6 83.9	±	23.8 8.8	±	12.2
SCNx	+	unilat	PVN	damage 61.1	±	17.9 77.5	±	31.6 36.2	±	29.3*
SCNx	+	bilat	PVN	damage 61.0	±	9.5 61.7	±	21.1* 37.8	±	18.3*








This	 study	 addressed	 the	 effects	 of	 thermic,	 bilateral	 ablation	 of	 the	 SCN	 on	 energy	
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Anatomically,	 the	 SCN	 is	 connected	 with	 the	 VMH	 and	 the	 PVN	 through	 the	
subparaventricular	 zone	 of	 the	 hypothalamus.22	 In	 line	with	 previous	 studies,	mice	with	
collateral	damage	to	the	PVN	or	VMH	developed	severe	obesity	and	insulin	resistance.23-28 





(~20%)	 limits	 the	 potential	 of	 this	method	 to	 study	 the	 role	 of	 the	 SCN	 in	metabolism,	
increasing	the	value	of	the	current	study.	
The	mild	 increase	 in	 weight	 gain	 in	mice	 with	 exclusive	 SCN	 lesions	 compared	 with	





Previously,	 it	 has	 been	 shown	 that	 the	 SCN	 is	 involved	 in	 the	 regulation	 of	 energy	
homeostasis	 in	mice33 and	rats.34	 In	 the	current	study,	 indirect	calorimetry	and	metabolic	
cage	analysis	revealed	that	ablation	of	the	SCN	induced	a	loss	of	circadian	rhythm	in	oxygen	
consumption	and	activity	without	affecting	the	24	hr	average	levels.	This	loss	of	circadian	
rhythm	 in	homeostasis	 is	 in	 line	with	previous	findings,	 in	which	 SCN	 lesions	eliminated	
a	wide	range	of	rhythms,	 including	leptin.10	Although	total	food	intake	over	a	period	of	1	
day	and	1	night	was	reduced	by	26%,	SCN	lesioned	mice	consumed	more	during	the	light	
part	 of	 the	 day	 compared	with	 sham	mice	 (46%	vs.	 32%	of	 total	 food	 intake).	 Recently,	
it	 has	 been	 shown	 that	mice	 and	 rats	 fed	 only	 during	 the	 day	 gained	 significantly	more	
weight	than	mice	fed	only	at	night.35-37	In	these	studies,	obesity	resulted	from	dissociation	
between	the	timing	of	food	intake	and	the	intrinsic	rhythm	of	energy	expenditure	and,	thus,	







induced	arrhythmic	mice,	 total	activity	and	 food	 intake	 levels	did	not	differ	 from	that	of	
mice	 in	 light/dark.	Even	though	energy	balance	over	24	hrs	was	similar,	mice	exposed	to	























































fasting	FFA	 levels,	 suggesting	a	possible	 removal	of	 inhibitory	 input	 from	the	SCN	 to	 the	
adipose	tissue,	thereby	increasing	the	basal	rate	of	lipolysis.	Increased	circulating	levels	of	
FFA	have	been	 implicated	as	a	possible	pathway	for	development	of	 insulin	resistance	 in	




Severe	hepatic	 insulin	 resistance,	but	not	peripheral	 insulin	 resistance,	was	present	even	











rhythms	 in	energy	metabolism	and	food	 intake.	Although	ablation	of	the	SCN	resulted	 in	
only	mild	overweight	status,	SCN	lesioned	mice	were	severely	insulin	resistant	in	the	liver.	
Great	care	was	taken	to	distinguish	between	exclusive	SCN	lesioned	mice	from	mice	that	
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Environmental 24-hour cycles 





































































induced	a	 transient	pro-inflammatory	 state.	After	 the	mice	were	 returned	 to	 a	 standard	
light-dark	cycle,	 the	SCN	neurons	 rapidly	 recovered	their	normal	high-amplitude	 rhythm,	















































adapt	 to	 the	 environmental	 day-night	 cycle.	 In	 mammals,	 these	 circadian	 rhythms	 are	
orchestrated	 by	 neurons	 within	 the	 suprachiasmatic	 nucleus	 (SCN),	 which	 is	 located	 in	
the	 anterior	 hypothalamus.	 The	 SCN	 conveys	 temporal	 information	 to	 peripheral	 tissue	
oscillators,	 thus	 producing	 synchronized	 circadian	 rhythms	 in	 many	 bodily	 processes,	
including	 muscle	 function,	 bone	 metabolism,	 and	 immune	 system	 function.1-4	 Under	
evolutionary	pressure,	 the	circadian	system	evolved	as	a	 robust	mechanism	 for	adapting	
to	life	in	a	cyclic	environment.	Thus,	we	hypothesize	that	organisms	require	clear	external	
cycles	 in	 order	 to	 maintain	 a	 healthy	 state	 and	 that	 absence	 of	 external	 rhythmicity	 is	
detrimental	for	health.	
The	use	of	artificial	lighting	in	modern	society—particularly	during	the	night—disrupts	




epidemiological	 studies	of	 shift	workers	 revealed	 increased	prevalence	of	breast	 cancer,9 
metabolic	syndrome,10	osteoporosis,11	and	bone	fractures12	in	this	population.	In	addition,	
individuals	who	are	exposed	to	more	light	at	night	tend	to	have	decreased	sleep	quality,13 
increased	 body	 weight,14 and	 a	 higher	 prevalence	 of	 cardiovascular	 disease.15	 Although	
these	studies suggest	a	correlation	between	artificial	light	exposure	and	health,	they	cannot	
determine	whether	this	relationship	is	causal.	Animal	studies	have	shown	that	aberrant	light	
exposure	can	affect	both	the	 immune	system16-18	and	metabolic	 function.19-20	However,	 in	






rhythmicity	 in	 the	 central	 clock,	we	 performed	 in vivo electrophysiological	 recordings	 in	
the	SCN	of	freely	moving	mice	implanted	with	stationary	electrodes.	Although	short-term	































































































































hoc	LSD.	*P <	0.05,	**P <	0.01,	***P <	0.001.
Fig. 1. Continuous	exposure	to	light	





to	 light	 continuously	 from	weeks	
0-24	 (experimental	 phase),	 then	


















































Continuous light exposure attenuates neuronal rhythms in the central clock
At	t =	0	(i.e.,	baseline),	the	MUA	recordings	revealed	high-amplitude	rhythms,	with	higher	
levels	of	electrical	activity	during	the	subjective	day	than	during	the	subjective	night	(Fig. 
2A).	When	exposed	 to	 continuous	 light,	 this	 amplitude	decreased	 initially	 to	63%	of	 the	
baseline	amplitude	(Fig. 2A-B);	at	8	and	24	weeks,	the	amplitude	was	reduced	further	to	
34%	and	30%	of	baseline,	respectively.	The	strength	of	the	behavioral	rhythm	was	strongly	
correlated	with	MUA	amplitude	(R2 =	0.754,	P < 0.001,	Pearson	correlation),	and	fluctuations	
in	 the	 strength	 of	 the	 SCN	 rhythm	 within	 individual	 animals	 occurred	 in	 parallel	 with	




histologically	(Fig. 2C,	Suppl. Fig. 1).
Fig. 2. Continuous	exposure	to	light	attenuates	rhythmic	neuronal	activity	in	the	central	clock. In vivo	recording	





























































significantly	 different	 values	measured	 at	 8	weeks	 (Fig. 3A-C).	 The	 difference	 in	 skeletal	

























































biogenesis	 (PGC1α),	 or	fiber	 type	 (Myh7,	Myh2,	 and	Myh4,	which	are	expressed	 in	 type	
1	slow	fibers,	 type	2A	fibers,	and	fast	 type	2B	fibers,	 respectively)	markers	 in	quadriceps	
muscles	at	8	and	24	weeks.






(SMI),	and	BV/TV	began	 to	differ	between	 the	 two	groups	 (Suppl. Fig. 3A-E).	At	 the	end	
of	the	24-week	experimental	phase,	the	trabeculae	of	the	mice	in	the	LL	group	were	34%	
Fig. 3.	Exposure	to	continuous	light	causes	a	reversible	
decline	 in	muscle	 function	compared	 to	control	mice.	
(A-C)	 Forelimb	 grip	 strength,	 maximum	 wire	 hanging	
time,	and	maximum	grid	hanging	time	 in	both	 the	 LL	
and	 control	 (LD)	 groups	 (mean	 ±	 SD;	 n	 =	 8-10	 mice	
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smaller	in	volume	and	10%	thinner	(Fig. 4B-C, Suppl. Fig. 3A-B).	The	mice	in	the	LL	group	
also	had	28%	fewer	 trabeculae,	which	were	separated	more	 (by	16%).	The	 trabeculae	 in	
this	group	were	also	more	rod-like	in	shape	compared	to	the	control	group.	Together,	these	
findings	are	characteristic	of	the	early	stages	of	osteoporosis.	


































































Exposure to continuous light alters the immune system
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Suppl. Fig. 3: Continuous	exposure	to	light	induces	changes	in	several	bone-related	characteristics.	(A-E)	Trabecular	
bone	parameters,	 (F-I)	 cortical	bone	parameters,	 and	 (J-L)	 serum	 levels	were	measured	 in	both	 LL	and	control	
(LD)	mice	at	the	indicated	time	points	(mean	±	SEM;	n	=	8-9	mice	per	group).	The	data	were	analyzed	by	two-way	
ANOVA	followed	by	post-hoc	LSD.	*P < 0.05,	**P < 0.01.
Total	 cytokine	 secretion	 measured	 as	 the	 area	 under	 the	 curve	 (AUC)	 also	 differed	














































































































2 wks 8 wks 24 wks 26 wks
LD LL LD LL LD LL LD LL
Pro-inflammatory cytokines
IL-1β	(x104) 6.7	±	0.9 5.0	±	1.0** 4.7	±	1.0 6.2	±	1.6** 4.8	±	0.7 4.4	±	1.0 3.4	±	2.6 5.0	±	1.1
IL-6	(x105) 8.0	±	2.3 8.5	±	2.8 7.5	±	1.8 13.8	±	5.6** 6.4	±	2.2 7.3	±	2.3 4.7	±	3.6 6.5	±	2.3
TNF-α	(x105) 4.7	±	1.7 9.2	±	4.1* 9.1	±	3.5 14.1	±	3.7** 9.5	±	4.4 7.9	±	4.1.0 4.5	±	4.4 8.5	±	5.6
Anti-inflammatory cytokine













Exposure to continuous light decreases the strength of circadian rhythms 
Retinal	photoreceptors	receive	light	and	project	light-encoded	information	to	the	SCN	via	
melanopsin-containing	retinal	ganglion	cells	and	chemical	photoreceptors.25,26	Continuous	
exposure	 to	 light	 causes	 desynchronization	 of	 SCN	 neurons,22	 and	 in	 peripheral	 bodily	
tissues.27	The	long-term	effects	of	LL—as	well	as	the	system’s	capacity	to	restore	rhythmicity	
after	 returning	 to	 a	 standard	 light-dark	 cycle—had	 not	 been	 studied	 previously	 and	 are	
highly	 relevant,	 given	 that	 circadian	 rhythms	 can	be	disrupted	 for	 extended	periods,	 for	
example	 in	 shift	workers	 or	 elderly	 persons.	We	 confirm	 that	 short-term	exposure	 to	 LL	
decreases	 neuronal	 amplitude20	 and	 demonstrate	 that	 long-term	 LL	 exposure	 further	
attenuates	rhythmicity	by	approximately	two-thirds	throughout	the	24-weeks	of	exposure.	












































Continuous light exposure disrupts skeletal muscle function




















muscle	 function.1,31	 However,	 because	 clock	 gene	 mutants	 may	 have	 impaired	 muscle	
function	due	to	a	direct	effect	of	the	clock	gene	mutation	on	the	cell	cycle,32	these	models	
do	not	necessarily	 simulate	disruptions	 in	environmental	 rhythmicity.	Our	data	 therefore	
provide	first	evidence,	that	robust	external	circadian	rhythms	support	muscle	function.
Continuous exposure to light induces clinical features reminiscent of early osteoporosis 
Short-term	 (i.e.,	 up	 to	 8	 weeks)	 exposure	 to	 continuous	 light	 had	 no	 effect	 on	 bone	
microstructure.33 Indeed,	 the	 maturation	 of	 bone	 in	 both	 animal	 groups	 was	 similar	 to	


























































function,	 which	 was	 assessed	 by	 measuring	 creatinine	 levels,	 was	 also	 unaffected	 by	
continuous	light	exposure.




Circadian disruption and the immune system
Two	 weeks	 of	 LL	 exposure	 mildly	 affected	 LPS-induced	 cytokine	 secretion.	 Eight	 weeks	
of	 LL	 exposure	 induced	 a	 higher	 numbers	 of	 neutrophils,	 pro-inflammatory	 cells	 in	 the	







Previous	 studies	 have	 linked	 disruptions	 in	 environmental	 rhythms	 with	 impaired	
immune	function.	For	example,	shift	workers	have	an	increased	risk	of	cancer9	and	metabolic	
syndrome,36	both	of	which	are	related	to	 immune	system	dysfunction.37	Shift	workers	do	




irritant−induced	 colitis	 is	 more	 aggressive	 in	 mice	 that	 are	 chronically	 phase-shifted.39 













































Recovery of health vs. stability of health upon returning to a normal environmental cycle
After	 returning	 to	 a	 standard	 light-dark	 cycle	 (i.e.,	 the	 recovery	 phase),	 the	 mice	 in	
the	 LL	 group	no	 longer	had	 impaired	muscle	performance	or	deficits	 in	 trabecular	 bone	






















cycle	may	be	particularly	 relevant	 to	severely	 ill	patients,	as	 these	patients	could	benefit	
considerably	from	a	robust	immune	response.	Studies	have	shown	that	preterm	infants	in	































































increasing	diurnal	 light	levels	 in	such	settings.	For	example,	 in	addition	to	increasing	light	

































































Two	weeks	 prior	 to	 beginning	 the	 experiments,	 the	mice	were	 transferred	 to	 individual	














with	 the	 TREAT-NMD	 Network	 protocol	 (http://www.treat-nmd.eu/resources/research-
resources/dmd-sops.42	 Forelimb	grip	 strength	was	measured	using	a	grip	 strength	device	
(Columbus	 Instruments,	 Columbus,	 OH)	 in	 five	 trials	 consisting	 of	 three	 attempts,	 with	
a	 two-minute	 interval	between	each	 trial.	 The	 three	highest	values	were	 then	averaged.	
During	 the	wire	hanging	 test,	 the	mice	had	 three	attempts	 to	hang	 for	10	minutes	 from	
a	rigid	metal	wire.	For	the	grid	hanging	test,	the	mice	were	placed	on	an	inverted	grid	in	
order	to	assess	maximum	grid	hanging	time;	the	mice	had	three	attempts	to	hang	for	10	
minutes.	 The	mice	were	 allowed	 to	 rest	 for	 three	minutes	 between	 each	 attempt,	with	
45	minutes	between	each	test.	Before	the	muscle	 function	tests,	unfasted	glucose	 levels	
were	measured	from	a	drop	of	blood	obtained	via	a	small	tail	cut;	glucose	was	measured	
using	 glucose	 strips	 (Accu-Chek	 Aviva,	 Reeuwijk,	 Netherlands).	 Blood	was	 also	 collected	
in	0.3	ml	Microvette	CB300	 tubes	before	and	after	 the	 functional	 testing;	 the	blood	was	





















































Dissection and tissue processing
Mice	 were	 euthanized	 under	 deep	 anesthesia	 with	 50	 mg/kg	 ketamine	 and	 0.5	 mg/kg	
dexdomitor,	 and	 blood	 was	 collected	 by	 retro-orbital	 bleeding.	 Blood	 was	 collected	 in	
Microtainer	 tubes	 containing	K2EDTA	 (Becton	Dickinson	B.V.,	Breda,	 the	Netherlands)	 for	
whole	blood	analysis	and	in	uncoated	Eppendorf	tubes	for	serum	analysis.	The	quadriceps	
muscles	were	 dissected,	 snap-frozen	 in	 2-methylbutane	 (Sigma-Aldrich,	 Zwijndrecht,	 the	
Netherlands),	then	stored	in	liquid	nitrogen.	Femurs	were	fixed	in	4%	paraformaldehyde	for	
48	hours	and	then	stored	in	70%	ethanol	at	4°C.	


















The	 quadriceps	 muscle	 was	 obtained	 at	 8-week	 and	 24-week	 time	 points	 as	 described	



















































a	 1-mm	Al	 filter	 (to	 reduce	beam	hardening	 artifacts)	 and	 a	 step	 size	of	 0.8°	 covering	 a	
trajectory	of	180°.	Images	were	reconstructed	at	9.12-μm	isotropic	voxel	size	using	NRecon	
software	 (V1.6.2.0,	 Skyscan)	 with	 ring	 artifact	 correction	 set	 to	 5	 and	 beam	 hardening	
correction	 set	 to	 20%.	 Femurs	 were	 reoriented	 with	 the	 mid-diaphysis	 parallel	 to	 the	
z-axis,	and	15-mm	long	regions	were	selected	 in	the	diaphysis	and	distal	metaphysis	 (0.3	
mm	 under	 the	 epiphysis).	 Reconstructed	 grayscale	 images	 were	 segmented	 using	 an	







blood	cell	 counter	 (Sysmex	Cooperation,	Kobe,	 Japan).	Total	and	differential	white	blood	
cell	(WBC)	counts	were	determined	using	flow	cytometry	with	forward-scatter,	side-scatter,	
and	lateral	fluorescent	light.64	Hemoglobin	and	hematocrit	values	were	measured	using	the	
sodium	 lauryl	 sulfate-hemoglobin	and	RBC	pulse-height	detection	methods,	 respectively.	
The	results	were	confirmed	by	performing	a	light-microscopy	examination	of	hematoxylin	
and	eosin−stained	blood	smears	from	ten	mice.	
LPS challenge and cytokine analysis






using	 the	Bio-Plex	Protein	Array	System	and	a	mouse	cytokine	panel	 (Bio-Rad).	 IL-1β,	 IL-
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In vivo SCN electrophysiology 
At	an	age	of	12	to	15	weeks	,	a	separate	group	of	mice	was	anesthetized	with	100	mg/kg	
ketamine,	20	mg/kg	xylazine,	and	1	mg/kg	atropine,	and	a	tripolar	stainless	steel	electrode	
(PlasticsOne,	 Roanoke,	 VA)	 was	 implanted	 using	 a	 stereotaxic	 setup	 (Stoelting	 Europe,	
Dublin,	Ireland).	Two	polyimide-insulated	electrodes	were	aimed	at	the	SCN	(0.61	mm	lateral	
of	 Bregma,	 5.38	mm	below	 the	dura,	 at	 a	 5°	 angle)	 for	 differential	 neuronal	 recordings,	
and	a	reference	electrode	was	placed	in	the	cortex.	Following	a	one-week	recovery	period,	




activity	 (MUA)	was	 recorded	 for	3	days	 in	a	 standard	LD	cycle	and	 for	 the	first	7	days	 in	
LL.	Mice	were	then	recorded	at	8	and	24	weeks	in	LL,	and	upon	returning	to	a	regular	LD	
cycle.	 The	mice	 in	 the	 control	 group	were	 not	 subjected	 to	 continuous	 light.	 Behavioral	
activity	was	recorded	simultaneously	using	a	PIR	sensor.	Mice	were	disconnected	from	the	













Q-Q	plots.	Two-way	ANOVAs	were	performed	and,	 in	 case	of	 significance	 (P < 0.05),	 the	
Fisher’s	Least	Significant	Difference	(LSD)	procedure	was	used	to	compare	the	LL	and	control	
groups	 at	 each	 time	 point.	 Analyses	 were	 performed	 separately	 for	 the	 exposure	 and	
recovery	phases	of	 the	experiment.	 Repeated-measures	ANOVA	with	post-hoc	 LSD	were	
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Evening chronotype is associated with 
changes in eating behavior, more sleep 
apnea, and increased stress hormones in 



























































Background:	 Short	 sleep	 duration	 and	 decreased	 sleep	 quality	 are	 emerging	 risk	 factors	
for	obesity	and	its	associated	morbidities.	Chronotype,	an	attribute	that	reflects	individual	
preferences	in	the	timing	of	sleep	and	other	behaviors,	is	a	continuum	from	morningness	
to	eveningness.	The	 importance	of	chronotype	 in	 relation	 to	obesity	 is	mostly	unknown.	
Evening	types	tend	to	have	unhealthy	eating	habits	and	suffer	from	psychological	problems	
more	 frequently	 than	Morning	 types,	 thus	we	hypothesized	 that	eveningness	may	affect	
health	parameters	in	a	cohort	of	obese	individuals	reporting	sleeping	less	than	6.5	hrs	per	
night.	
Methodology and Principal Findings:	 Baseline	 data	 from	 obese	 (BMI:	 38.5	 ±	 6.4	 kg/
m2)	 and	 short	 sleeping	 (5.8	 ±	 0.8	 hrs/night	 by	 actigraphy)	 participants	 (n	 =	 119)	 of	 the	
Sleep	 Extension	 Study	 were	 analyzed	 (www.ClinicalTrials.gov,	 identifier	 NCT00261898).	
Assessments	 included	 the	Horne	and	Ostberg	Morningness-Eveningness	questionnaire,	a	
three-day	dietary	intake	diary,	a	14-day	sleep	diary,	14	days	of	actigraphy,	and	measurements	
of	 sleep	apnea.	 Twenty-four	hrs	urinary	 free	 cortisol,	 24	hrs	urinary	norepinephrine	and	
epinephrine	levels,	morning	plasma	ACTH	and	serum	cortisol,	fasting	glucose	and	insulin,	
and	 lipid	 parameters	were	 determined.	 Eveningness	was	 associated	with	 eating	 later	 in	
the	 day	 on	 both	 working	 and	 non-working	 days.	 Progression	 towards	 eveningness	 was	
associated	with	an	 increase	 in	BMI,	 resting	heart	 rate,	 food	portion	size,	and	a	decrease	
in	the	number	of	eating	occasions	and	HDL-cholesterol.	Evening	types	had	overtly	higher	
24	hrs	urinary	epinephrine	and	morning	plasma	ACTH	levels,	and	higher	morning	resting	
heart	 rate	 than	Morning	 types.	 In	 addition,	 Evening	 types	more	 often	 had	 sleep	 apnea,	
independent	of	BMI	or	neck	circumference.	
Conclusions:	Eveningness	was	associated	with	eating	later	and	a	tendency	towards	fewer	
and	 larger	meals	 and	 lower	HDL	 cholesterol	 levels.	 In	 addition,	 Evening	 types	had	more	























































Individual	 preference	 for	 sleep	timing	 and	timing	of	 other	behaviors	 is	 a	 stable	 trait,	
referred	to	as	one’s	chronotype.	A	large	twin	study	demonstrated	that	approximately	50%	




women.5,6	 In	 1976,	 Horne	 and	Ostberg	 developed	 a	 questionnaire	 to	 classify	 individuals	
based	on	their	preferences	for	sleep	timing.7 





























































Study design and participants 
This	 analysis	 is	 part	 of	 the	 Sleep	 Extension	 Study,	 a	 prospective,	 randomized,	 controlled	
study	 of	 obese	 (BMI	 30–55	 kg/m2)	 men	 and	 premenopausal	 women,	 18	 to	 50	 yrs	 old,	


















(A) Chronotype questionnaire. 
The	 Horne	 and	 Ostberg	 questionnaire	 inquires	 about	 preferred	 sleep	 time	 and	 daily	
performance	(score	range:	16–86).7	It	contains	19	questions,	such	as:	“at	what	time	would	
you	like	to	get	up?”,	“at	what	time	do	you	feel	tired?”,	and	“what	would	be	the	best	time	
to	 perform	hard	 physical	work?”.	 Based	 on	 their	 scores,	 individuals	were	 categorized	 as	
being	either	Morning	(score:	50–86)	or	Evening	types	(score:	16–49).	Chronotype	was	also	
analyzed	as	a	continuous	variable.20
(B) Sleep measurements. 
Sleep	 duration	was	 assessed	 by	 a	wrist	 actigraphy	monitors	 (Actiwatch-64,	Mini	Mitter/
Respironics/	 Philips,	 Bend,	OR)	 that	 participants	 (n	 =	 115)	wore	 constantly	 for	 recording	
gross	 locomotor	 activity	 in	 one-minute	 epochs.21 Eighty-nine	 participants	 provided	
information	on	whether	the	days	were	working	or	non-working.	Bedtime	and	risetime	were	














































time	 sleeping	out	of	 total	time	 in	bed.	Mid	 sleep	time	was	 the	 clock	time	of	 the	 center	
of	 the	 sleep	duration	period,	which	was	 calculated	by	 adding	half	 the	 sleep	duration	 to	
the	 bedtime.	 The	 Pittsburgh	 Sleep	 Quality	 Index	 and	 the	 Epworth	 Sleepiness	 Scale	 are	




per	 hr	 of	 sleep.18,19	 An	 RDI	 greater	 than	 5	 episodes	 per	 hr	 is	 considered	 abnormal.	 The	
information	on	RDI	score	was	available	in	100	participants.	
(C) Anthropometric parameters. 
Height	was	measured	to	the	nearest	centimeter	using	a	wall-mounted	stadiometer	(SECA	
242,	SECA	North	America	East,	Hanover,	MD)	and	weight	was	measured	using	a	stand-on-
scale	 in	a	hospital	gown	to	the	nearest	1/10th	of	a	kg	 (SR555	SR	Scales,	SR	 Instruments,	
INC,	Tonawanda,	NY).	Neck	and	waist	circumference	measurements	were	done	using	a	non-
stretch	measuring	tape	in	triplicate	to	the	nearest	mm.	Neck	circumference	was	measured	
at	 the	minimal	 circumference	with	 the	head	 in	 the	Frankfort	Horizontal	Plane	and	waist	
circumference	was	measured	at	the	uppermost	border	of	the	iliac	crest.
(D) Clinical laboratory analysis.
Glucose,	 total	 cholesterol,	 and	 triglycerides	 were	 determined	 with	 enzymatic	 methods	
highdensity	lipoprotein	cholesterol	(HDL-C)	and	low-density	lipoprotein	cholesterol	(LDL-C)	
with	direct	homogeneous	methods	in	fasting	serum	specimens	on	an	automated	analyzer	
(Dimension	 Vista	 1500,	 Siemens	 Health	 Diagnostics,	 Deerfield,	 IL).	 Plasma	 ACTH,	 serum	
cortisol,	and	insulin	levels	were	assessed	with	chemiluminescence	immunoassays	(Immulite	
2500,	 Siemens).	 Urinary	 free	 cortisol	 and	 catecholamines	 were	 measured	 in	 24	 hrs	
collections	with	liquid	chromatography-tandem	mass	spectrometry,	and	high-performance	
liquid	chromatography,	respectively.	
(E) Dietary assessment. 
Participants	recorded	food	intake	for	three	consecutive	days,	preferably	two	weekdays	and	
one	weekend	day.	At	the	Screening	Visit,	they	received	written	and	verbal	instructions	on	



















































(F) Statistical analysis. 
Normality	of	variables	was	examined	by	Q-Q	normality	plots.	Mean	and	standard	deviation	













were	 not	 included	 because	 they	 are	 surrogates	 for	 chronotype	 score).	 This	multivariate	
model	was	corrected	for	age	and	gender.	We	tested	for	the	presence	of	interactions	among	
chronotype	score,	gender	and	age.	Since	we	found	no	interactions,	we	did	not	include	their	
product	 in	 the	model.	Analyses	were	performed	using	SPSS	 (version	19,	 IBM	SPSS	North	
America,	Chicago,	IL).	
Results


















































Morning chronotype  
(score 50 - 86)  
n = 80
Evening chronotype  




Chronotype	score	(range	16	–	86) 59.1	±	6.8 42.7	±	5.0 <0.001
Age	(yrs) 41.7	±	5.9 38.6	±	7.8 0.019
Female	 76% 80% 0.692
African-American/White/Other	races	(n) 54/38/9 72/28/0 0.054* 
0.219**
BMI	(kg/m2) 38.2	±	6.3 39.1	±	6.6 0.470
Waist	circumference	(cm) 113.0	±	13.6 114.7	±	11.5 0.510
Neck	circumference	(cm) 38.8	±	3.8 39.6	±	3.8 0.340





As	 expected	 for	 short	 sleepers,	 29%	 of	 the	 participants	 experienced	 excessive	 daytime	
























































Morning chronotype  
(score 50 - 86)  
n = 80
Evening chronotype  




Pittsburgh	Sleep	Quality	Index	score 8.0	±	2.7 8.6	±	2.9 0.263
Epworth	Sleepiness	Scale	score 8.4	±	4.5 7.6	±	4.5 0.387
Self-reported sleep duration by diary (min)
Working	days 361	±	561 403	±	51 0.002
Non-working	days 420	±	631 421	±39 0.947
Sleep duration by actigraphy (min)
Working	days 339	±	521 346	±	64 0.576
Non-working	days 386	±	611 379	±	60 0.625
Sleep efficiency by actigraphy (%)
Working	days 81.5	±	5.7 81.3	±	8.2 0.914
Non-working	days 81.1	±	7.5 81.0	±	7.8 0.964
Sleep apnea measurements
RDI	(events/hrs)# 5	(2	–	12) 10	(7	–	16) 0.018
RDI	>	5	(events/hrs) 47% 81% 0.001*
Values	are	means	±	SD,	#median	and	interquartile	range	for	skewed	variables,	or	%.	Skewed	variables	were	log-
transformed	prior	to	analysis.	p	values	for	t-tests	or	*Fisher	exact-test	are	depicted	and	significant	p	values	(<0.05)	
are	 bolded.	 *Fisher	 exact-test	 including	 all	 races;	 **Fisher	 exact-test	 excluding	 ”Other	 races”.	 1Sleep	 duration	
differed	on	working	vs.	non-working	days	in	Morning	(diary	and	actigraphy:	P <	0.001)	and	in	Evening	chronotypes	
(diary:	P =	0.053;	actigraphy:	P =	0.005).	


























































between	chronotypes	 in	 the	 total	 amount	of	 fat	 (P =	 0.14);	 carbohydrates	 (P =	 0.84);	or	
protein	(P =	0.89)	consumed	before	and	after	20:00.	
Table 3.	Food	intake	parameters	of	study	participants	divided	by	chronotype	on	working	vs.	non-working	days.
Working day Non-working day
Morning type Evening type p value Morning type Evening type p value
Total	food	intake	(kcal) 2129	±	631 2276	±	815 0.373 2383	±	928 2378	±	883 0.922	
Portion	size	(kcal) 461	±	177 545 ±	219 0.065 599	±	273 622	±	380 0.751	
Eating	occasions	per	day	(n) 4.9	±	1.5 4.4 ±	1.5 0.175 4.2	±	1.2 4.3	±	1.6 0.568	
First	eating	occasion	(h:min) 7:17	±	1:31 8:38 ±	1:52 <0.001 8:56	±2:30 9:59	±	2:32 0.075	
Food	intake	after	20:00	(kcal) 299	±	354 677	±	460 <0.001 327	±	354 537	±	480 0.028 
Food	intake	after	20:00	(%	of	
total	caloric	intake)
14	±	15 30	±	18 <0.001 14	±	15 24	±	20 0.009 
Values	are	means	±	SD.	Intake	parameters	of	chronotypes	were	compared	with	t-tests	on	working	and	non-working	
days	separately.	Significant	p	values	(<	0.05)	are	bolded.	
Relationship between chronotype and anthropometric and lipid parameters 
Moving	 from	morningness	 towards	 eveningness	 scores	was	 associated	with	 an	 increase	
in	 BMI,	 larger	 neck	 circumference,	 and	 lower	 HDL-C	 levels	 (Fig. 3).	 The	 effect	 size	 was	














































Fig. 2.	 Pattern	 and	 timing	 of	 food	 intake	
vs.	 chronotype	 score.	 Plot	 of	 chronotype	
scores	vs.	 the	number	of	eating	occasions	
(A),	the	portion	size	(B),	and	the	amount	of	




from	 gender-corrected	 models.	 Closed	


















































Fig. 3.	 Anthropometrics	 and	 HDL-C	 vs. 
chronotype	score.	Plot	of	Chronotype	scores	
vs.	 BMI	 (A),	 neck	 circumference	 (B),	 and	
HDL-C	 (C)	 with	 a	 trend	 line,	 respectively.	
n	 =	119	 for	all.	R2	 slope,	and	pvalue	 for	 the	
prediction	of	 chronotype	 score	on	 variables	
in	 each	 plot	 are	 calculated	 from	 gender-
















































plasma	ACTH	 levels,	 higher	24	hrs-urinary	epinephrine	and	norepinephrine	 levels,	 and	a	
higher	heart	rate	(Fig. 4).	
Fig. 4.	 Stress	 hormones	 and	 heart	 rate	 vs.	 chronotype	 score.	 Chronotype	 scores	 on	 the	 horizontal	 axis	 are	
regressed	against	plasma	ACTH	(n	=	118;	A),	24	hrs	urinary	epinephrine	(n	=	110;	B)	and	norepinephrine	(n	=	114;	
C),	and	resting	heart	rate	(n	=	113;	D).	R2	for	the	gender-corrected	model	is	reported,	and	slope	and	p	value	for	















































Morning chronotype  
(score 50 - 86)  
n = 80
Evening chronotype  





Morning	plasma	ACTH	(pg/ml)#,$ 17	(12	–	24) 21	(16	–	32) 0.019
Morning	serum	cortisol	(μg/dL)#,$ 9	(6	–	12) 10	(6	–	14) 0.530
Urinary	free	cortisol	(μg/24hrs)# 17	(12	–	24) 19	(10	–	28) 0.885
Urinary	norepinephrine	(μg/24hrs)# 39	(28	–	56) 45	(37	–	61) 0.052
Urinary	epinephrine	(μg/24hrs)# 3	(2	–	5) 4	(3	–	7) 0.039
Metabolic features
Insulin	(mU/l)#,$ 9	(7	–	14) 10	(6	–	16) 0.674
Glucose	(mg/dL)$ 88.6	±	10.5 90.1	±	9.6 0.465
Total	cholesterol	(mg/dL)$ 178.9	±	36.7 177.1	±	35.5 0.806
Triglycerides	(mg/dL)#,$ 91	(62	–	133) 75	(55	–	106) 0.214
HDL-C	(mg/dL)#,$ 48	(42	-	58) 49	(41	–	52) 0.513
LDL-C	(mg/dL)#,$ 106	(91	–	125) 116	(89	–	134) 0.532





to	 chronotype	 score	 after	 correction	 for	 BMI	 (coefficient	 =	 20.011,	P =	 0.018)	 and	 neck	
circumference	(coefficient	=20.009,	P =	0.037).	After	correction	for	BMI,	chronotype	score	
remained	 inversely	 related	 to	 the	 first	 eating	 occasion	 (coefficient	 =20.059,	 P <	 0.001),	
caloric	intake	after	20:00	(coefficient=210.687,	P =	0.001),	percent	caloric	intake	after	20:00	
(coefficient	=20.445,	P =	0.001),	and	HDL-C	concentrations	(coefficient	=20.002,	P =	0.035),	
portion	size	(coefficient	=	0.025,	P =	0.052),	and	eating	occasions	(coefficient	=23.554,	P = 
0.079).	
A	 gender-	 and	 age-corrected	 multivariate	 forward	 stepwise	 model	 was	 fitted	 with	
predictors	 that	 related	 to	 chronotype	 score	 at	 P <	 0.10	 in	 gender-corrected	 univariate	
regressions:	sleep	duration	by	diary	on	working	days,	RDI,	BMI,	neck	circumference,	number	
of	eating	occasions,	portion	size,	heart	rate,	HDL-C,	plasma	ACTH,	24	hrs-urinary	epinephrine	


























































levels	of	 stress	hormones,	and	had	a	higher	 resting	heart	 rate.	 In	addition,	moving	 from	







evening	 types	consumed	 twice	as	many	calories	after	20:00,	and	had	a	higher	BMI	 than	
control	subjects,	while	not	differing	in	total	food	dietary.26	In	a	cross-over,	nonrandomized	
study	of	weight	loss,	obese	women	lost	more	weight	and	had	greater	fat	oxidation	when	
they	 were	 assigned	 to	 consume	 two-thirds	 of	 their	 total	 caloric	 intake	 in	 the	 morning	
vs.	 the	evening.	However	the	evening	pattern	was	associated	with	a	 larger	 loss	of	 fat	vs. 
fat	 free	mass	 and	 there	was	 an	 order	 effect	 that	may	 have	 influenced	 the	 conclusion.27 
A	dietary	 intake	 study	 reported	 that	 food	 intake	 in	 the	 late	 night	was	 less	 satiating	 and	























































polysomnography	 study	 of	 12	Morning	 types	 and	 12	 Evening	 types,	 tested	 in	 the	 sleep	
laboratory	according	to	their	habitual	sleep	schedule	 in	which	there	were	no	differences	
in	subjective	sleep	quality,	as	well	as	 in	total	sleep	time	by	EEG.8	We	report	here	for	the	







In	our	 study	 sleep	duration	by	actigraphy	did	not	differ	between	 chronotypes	either,	
but	 Evening	 types	 reported	 sleeping	 approximately	 40	min	 longer	 during	 working	 days.	
Further,	self-reported	sleep	duration	in	both	chronotypes	was	longer	than	sleep	duration	






weight	 relied	 on	 self-reported	measures.3	 It	 has	 been	 recognized	 in	 this	 field	 that	 self-
reported	sleep	and	sleep	by	actigraphy	do	not	correspond	closely	to	each	other.	
The	 longer	sleep	 latency	period	observed	 in	our	 study	 for	 the	Evening	 type	may	also	
be	due	to	another	related	contributory	factor,	the	quality	of	light.	During	the	waking	hours	
Evening	 types	 are	 less	 exposed	 to	 light,	 especially	 in	 the	 100	 to	 500	 lux	 range,	which	 is	









reported	a	 somewhat	better	 sleep	efficiency	 in	Morning	 types	 (88%)	 than	Evening	 types	













































This	has	been	proposed	 in	 a	 report	of	 a	positive	 relationship	 in	 a	German	 sample	of	 84	
couples.36	Assortative	mating,	whether	positive	or	not,	has	been	recently	 listed	as	one	of	
the	10	putative	 factors	contributing	to	 the	obesity	epidemic	 .37	As	Evening	 types	 tend	to	
be	heavier	 and	 this	 is	 often	already	evident	 at	 reproductive	age,	 future	 research	 should	
determine	whether	assortative	mating	for	either	factor	has	additive	vs.	synergistic	effects	in	
the	etiology	of	obesity.	
Compared	 to	Morning	 types,	 Evening	 types	had	20–30%	higher	 24	hrs	 urinary	 levels	

















As	 indicated	 by	 twin	 studies,	 there	 is	 a	 clear	 genetic	 component	 to	 morningness-
eveningness,	which	accounts	for	more	than	50%	of	its	total	variance.46 Albeit	subjects	tend	
to	become	more	morning-oriented	with	age,	 the	age	component	of	 the	 total	variance	 is	
smaller	 than	 the	 genetic	 component.46 As	we	have	 recently	 reviewed,	 electrification	and	
exposure	 to	 artificial	 light	 have	 limited	 the	 opportunities	 of	 the	 natural,	 bright	 light	 to	
synchronize	our	internal	clock	to	the	24	hrs	day	cycle.47	The	magnitude	of	the	synchronizing	
effect	of	bright	light	is	dependent	on	the	internal	clock	as	well.48 
Some	study	 limitations	should	be	noted.	The	cross-sectional	nature	of	 this	 report	did	
not	allow	establishment	of	causality.	Hormone	determinations	at	a	single	time-point	may	
have	missed	endocrine	differences	between	chronotypes	in	circadian	rhythms.	Endocrine	


















































lower	 HDL-C	 levels,	 and	 a	 trend	 towards	 higher	 BMI.	 High	 BMI	 and	 low	 HDL-C	 levels	
predict	cardiovascular	morbidity.50	Our	findings	have	public	health	relevance	for	the	large	
number	of	obese	individuals	who	have	social	 jetlag	and	are	sleep-deprived.	We	advocate	
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Sleep extension improves neurocognitive 





































































Results:	 At	baseline,	 44%	of	 the	 individuals	 had	an	 impaired	global	 deficit	 score	 (t-score	




sleep	duration	 increased	by	11%	by	questionnaires	(P <	0.001)	and	by	4%	by	diaries	(P = 
0.04),	and	daytime	sleepiness	tended	to	improve	(P =	0.10).	Global	cognitive	function	and	
attention	improved	by	7%	and	10%,	respectively	(both	P =	0.001),	and	memory	and	executive	


























































Obese	 individuals	 exhibit	 deficits	 in	 executive	 functions,	 including	 mental	 flexibility,	
planning,	problem	solving,	and	display	impulsivity,5-9	and	tend	to	favor	immediate	reward	vs. 
long	term	gain.10	Possibly,	the	“higher	cortical	functions”	that	control	learning	and	executive	
function	 are	 no	 longer	 appropriately	 inhibiting	 feeding	 behavior	 in	 obese	 individuals.	 In	
turn,	altered	eating	behavior	in	obesity	may	cause	neurocognitive	dysfunction;	for	example	
a	high-fat	or	high-carbohydrate	meal	can	disrupt	hippocampal	function.11 







Interestingly,	 six	 days	of	 partial	 sleep	 restriction	 increased	 the	 activation	of	 food	 reward	
pathways	 –a	 putative	 pathway	 leading	 to	 weight	 gain	 in	 chronically	 sleepdeprived	
individuals.18 
Cognitive	performance	has	 never	 been	evaluated	 in	 a	 sample	of	 individuals	who	 are	

















































Study design and individuals 
The	 Sleep	 Extension	 Study	 was	 a	 randomized,	 controlled,	 prospective	 study	 of	 sleep	
extension	 in	 chronically	 sleep-deprived	 obese	 individuals.	 Details	 have	 been	 provided	
elsewhere.19	In	brief,	individuals	were	recruited	by	advertising	for	men	and	premenopausal	
women	aged	18	 to	50	yrs	with	a	body	mass	 index	 (BMI)	between	30	and	55	kg/m2	who	




Group	 were	 coached	 to	 increase	 sleep	 duration	 up	 to	 7.5	 hrs	 per	 night,	 following	 a	
personalized	 sleep	 plan.	 Strategies	 included	 implementation	 of	 consistent	 bedtime	
routine,	 avoiding	 caffeine,	 alcohol,	 heavy	meals	 and	 exercise	 prior	 to	 bedtime,	 creating	

















6)		 Trail	Making	 Test	 (TMT)	 parts	 A	 and	 B:	 tests	 visual	 attention	 and	 task	 switching	 that	
requires	visual	scanning,	sequencing,	and	visual	motor	speed.23
7)		 Verbal	 Fluency	 Test	 (FAS):	 assesses	 phonemic	 fluency	 associated	 with	 executive	
functioning.24 













































Recall,	 CVLT-II	 Short	 and	 Long	 Delay),	 b)	 Attention	 (Rey	 Immediate	 Recall,	 CVLT-II	 Sum,	
TMT-A),	c)	Motor	skills	(GPeg),	and	d)	Executive	function	(TMT-B,	WCST,	FAS,	IGT).	The	same	
battery	of	 tests	was	administered	at	baseline	and	at	 the	final	 follow	up	visit,	 except	 the	
WASI,	which	was	only	administered	at	baseline.	The	time	interval	between	administrations	
of	the	tests	would	not	be	likely	to	produce	practice	effects.26














(C) Subjective and objective sleep measures.
Sleep	duration	was	assessed	by	two-week	sleep	diaries	and	by	concomitant	usage	of	wrist	
actigraphy	 (Actiwatch-64,	 Mini	 Mitter/Respironics/Philips,	 Bend,	 OR,	 USA)	 via	 recording	
gross	locomotor	activity	in	one-minute	epochs.	Sleep	efficiency	was	the	sleep	time	divided	
by	 the	time	 spent	 in	bed.	 The	 respiratory	disturbance	 index	 (RDI;	 the	number	of	 (hypo)
apneas	per	hr	of	sleep)	was	documented	overnight	by	a	portable	validated	screening	device	
(Apnea	 Risk	 Evaluation	 System,	 Advanced	 Brain	 Monitoring	 Inc.,	 Carlsbad,	 CA,	 USA).28 
Daytime	sleepiness	was	assessed	by	the	Epworth	Sleepiness	Scale	(ESS),	a	validated	8-item	
questionnaire	with	 scores	 ranging	 from	0	 to	 24,	with	higher	 scores	 representing	 greater	












































(D) Clinical laboratory assessments. 
Plasma	 ACTH	 and	 serum	 cortisol	 were	 determined	 by	 immunochemiluminescence	
methods	(Immulite	2000	and	2500,	Siemens	Health	Diagnostics,	Deerfield,	 IL,	USA).	Total	
plasma	ghrelin	was	measured	with	a	 sandwich	ELISA	kit	measuring	both	 intact	 and	des-
octanoyl	forms	with	the	lowest	level	of	detection	at	50	pg/mL	for	total	ghrelin	(Millipore,	
Billerica,	 MA,	 USA).	 The	 intra-	 and	 inter-assay	 CV’s	 were	 1.96%	 and	 7.8%,	 respectively.	
























A	 multivariate	 mixed	 model	 using	 both	 baseline	 and	 follow-up	 data	 determined	
which	variables	were	associated	with	GDS,	after	accounting	for	 repeated	measurements.	
Additional	 mixed	 models	 were	 constructed	 with	 change	 in	 GDS	 between	 the	 baseline	















































Baseline neuropsychological, demographic, anthropometric, sleep, and hormonal 




6	 hrs	 and	 25	min	 (385	 ±	 48	min/night),	whereas	 sleep	 duration	 by	 actigraphy	monitors	
was	approximately	30	min	shorter	(356	±	49	min/night).	Seven	percent	of	the	individuals	
smoked,	13%	had	hypertension,	and	26%	had	metabolic	syndrome.







the	cognitive	domains	examined	are	also	shown	in	Table 1.  




were	 no	 differences	 in	 baseline	 characteristics	 level	 for	 participants	 with	 impaired	 vs. 
unimpaired	executive	functions.	
Changes between the baseline and final neuropsychological evaluations 
Of	the	121	original	individuals	with	baseline	neuropsychological	evaluation,	74	individuals	
(34	 from	 the	 Comparison	 Group	 and	 40	 from	 the	 Intervention	 Group;	 51F/23M)	 had	
another	 neuropsychological	 evaluation	 468	 ±	 88	 days	 later	 (median	 436,	 IQR	 412–496	
days)	(Table 2).	Group	allocation	and	GDS	category	were	similar	between	the	74	individuals	
who	completed	 the	 study	and	 the	47	 individuals	who	did	not	 (P =	 0.836	and	P =	 0.240,	
respectively).	Because	there	were	no	significant	differences	in	neuropsychological	functions	
between	the	Comparison	and	the	 Intervention	Groups	either	at	 the	 initial	or	at	 the	final	
evaluation,	results	from	the	two	groups	were	combined	together.	
The	following	changes	were	observed:	the	GDS	improved	by	approximately	7%;	attention	





















































Age	(yrs) 41.8	(6.3) 40.4	(7.5) 0.27
Sex	(%	female) 83 71 0.11
Race	(White/Black/Other	in	%) 62/36/2 57/35/7 0.38
Education	(yrs) 15.7	(2.3) 15.8	(2.7) 0.73
Smokers	(%) 8 6 0.75
Hypertension	(≥140/90mmHg)	(%) 16 13 0.62
Metabolic	syndrome	(%) 26 30 0.63
Anthropometric 
BMI	(kg/m2) 37.8	(6.0) 38.9	(6.6) 0.34
Waist	circumference	(cm) 113.2	(12.4) 115.6	(13.7) 0.88
Neck	circumference	(cm) 38.6	(4.0) 39.9	(4.3) 0.71
Abdominal	visceral	fat	(cm3) 319	(152) 357	(172) 0.98
Sleep
Sleep	duration	by	PSQI	(min) 334	(62) 338	(45) 0.73
Sleep	duration	by	diary	(min) 383	(43) 387	(52) 0.70
Sleep	duration	by	actigraphy	(min) 351	(47) 345	(50) 0.48
Percent	sleep	efficiency	 79.0	(7.3) 80.4	(5.7) 0.27
RDI	(events/hrs) 7	(2	–	18) 8	(3	–	13) 0.65
Daytime	sleepiness	(ESS	score)	 8.1	(4.8) 8.4	(4.4) 0.71
Subjective	sleep	quality	(PSQI	score)	 8.9	(2.9) 7.7	(2.7) 0.04
Abnormal	subjective	sleep	quality	(PSQI	score	>4)	(%) 93 76 0.02
Hormonal
Plasma	ACTH	(pg/mL) 18.2	(13.0	–	26.1) 18.9	(14.3	–	27.4) 0.48
Serum	cortisol	(µg/dL) 9.5	(3.8) 9.5	(4.3) 0.99
Urinary	dopamine	(μg/24h	urine) 239	(169	–	292) 276	(230	–	341) 0.001
Urinary	epinephrine	(μg/24h	urine) 3.4	(2.1	–	4.9) 4.5	(2.3	–	6.6) 0.24
Urinary	norepinephrine	(μg/24h	urine) 38.0	(28.0	–	53.0) 44.5	(35.0	–	59.0) 0.07
Urinary	free	cortisol	(μg/24h	urine) 17.3	(12.0	–	23.3) 19.5	(14.5	–	28.3) 0.07









Sleep	efficiency	(%)	 78.1	(6.7) 80.6	(6.2) 0.06
Urinary	dopamine	(μg/24h	urine) 228	(146	–	310) 269	(228	–	325) 0.006
Urinary	norepinephrine	(μg/24h	urine) 38.0	(26.0	–	52.0) 44.0	(35.0	–	35.0) 0.04








Sleep	efficiency	(%)	 78.0	(6.9) 80.8	(6.0) 0.02
Urinary	dopamine	(μg/24h	urine) 241	(183	–	294) 276	(223	–	338) 0.01
Urinary	norepinephrine	(μg/24h	urine) 37.5	(23.8	–	53.0) 45.0	(36.0	–	59.0)	 0.02
Urinary	free	cortisol	(μg/24h	urine) 16.0	(10.0	–	24.0) 19.0	(15.0	–	28.0) 0.02
Motor Skills  
t-score 0-39
(n = 51)




Sleep	efficiency	(%) 78.1	(7.4) 81.1	(5.4) 0.02



































































increased	 by	 approximately	 17%	 (Table 3).	 There	were	 no	 significant	 changes	 in	 urinary	
dopamine,	epinephrine	and	norepinephrine,	UFC,	and	plasma	total	ghrelin.	Of	note,	each	
















































 (n = 74)a
p value
GDS and DDS
GDS 43.5	(9.2) 46.6	(9.0) 0.001
Memory	DDS 47.7	(14.3) 50.9	(11.3) 0.07
Attention	DDS 47.6	(11.3) 52.5	(10.2) 0.001
Motor	Skills	DDS 45.6	(14.6) 47.5	(14.7) 0.26
Executive	function	DDS 42.8	(9.8) 45.1	(11.0) 0.06
Specific neurocognitive test t-scores
Rey Complex Figure Test
Copy	(n	=	73) 44.4	(9.0) 43.3	(8.8) 0.26
Immediate	Recallb	(n	=	49) 47.9	(12.7) 52.3	(12.4) 0.002
Delayed	Recallb	(n	=	49) 45.6	(14.1) 51.1	(12.2) <0.001
California Verbal Leaning Test
Long	Delay	(n	=	72) 52.1	(11.9) 53.5	(11.4)	 0.12
Short	Delay	(n	=	71) 51.5	(12.1) 53.1	(11.4)	 0.08
Sum	(n	=	72) 55.4	(11.3) 57.9	(12.6)	 0.01
Grooved Peg Board Test
Dominant	Hand	(n	=	69) 44.3	(11.8) 45.0	(11.9)	 0.68
Non-Dominant	Hand	(n	=	72) 44.8	(10.0) 46.1	(10.6) 0.17
Wisconsin	Card	Sort-test	(Perseverative	Errors;	n	=	72) 37.6	(9.1)	 38.4	(7.7) 0.38
Trail	Making	Test	part	A	(n	=	73) 50.1	(12.0)	 52.5	(12.7)	 0.15
Trail	Making	Test	part	B	(n	=	72) 52.2	(11.6) 53.9	(11.8)	 0.30
Verbal	Fluency	Test	(n	=	73) 52.4	(10.8) 52.9	(10.7)	 0.60
Iowa	Gambling	Task	(n	=	48) 47.0	(11.2)	 50.8	(11.5)	 0.04
Values	are	means	(SD).	aNumber	of	individuals	per	time	point	unless	otherwise.	bScores	for	Immediate	and	Delayed	













































Parameters Baseline Final follow-up p value
Sleep parameters
Sleep	duration	by	actiwatch	(min;	n	=	40) 356	(49)	 360	(51) 0.51
Sleep	duration	by	diary	(min;	n	=	40) 388	(53)	 405	(49)	 0.04
Subjective	sleep	quality	(PSQI	score;	n	=	64)	 8.0	(2.8) 6.1	(2.4) <0.001
Sleep	duration	by	PSQI	(min;	n	=	64)	 336	(60)	 372	(72)	 <0.001
Daytime	sleepiness	(ESS	score;	n	=	63) 8.8	(4.8) 8.0	(4.5) 0.10
Anthropometrics
BMI	(kg/m2;	n	=	74) 38.2	(6.7) 38.2	(6.9) 0.98
Waist	circumference	(cm;	n	=	74) 114	(14) 114	(15)	 0.77
Neck	circumference	(cm;	n	=	73) 39.3	(4.3) 39.0	(4.2) 0.10
Total	visceral	fat	(cm3;	n	=	70) 352	(167) 351	(175) 0.95
Hormonal parameters
Serum	cortisol	(µg/dL;	n	=	67) 8.7	(3.8) 10.2	(4.8)	 0.02
Urinary	dopamine	(μg/24h	urine;	n	=	69) 256	(199	–	317) 241	(188	–	331) 0.53
Urinary	epinephrine	(μg/24h	urine;	n	=	69) 3.3	(2.0	–	4.8)	 3.8	(2.3	–	5.5)	 0.11
Urinary	norepinephrine	(μg/24h	urine;	n	=	69) 38.5	(28.5	–	56.5)	 40.0	(33.0	–	55.5)	 0.35
UFC	(μg/24h	urine;	n	=	69) 15.0	(10.0	–	21.0)	 16.0	(10.0	–	26.0)	 0.76
Plasma	total	ghrelin	(pg/mL;	n	=	67) 268.8	(148.8) 292.1	(204.6) 0.32







Relationships between neurocognitive function by domain deficit score, obesity, sleep and 
urinary stress hormones 
Five	 variables	 were	 included	 in	 the	 model,	 sleep	 quality	 by	 PSQI	 and	 sleep	 efficiency,	
and	UFC,	urinary	dopamine	and	plasma	 total	ghrelin,	 together	accounting	 for	1/5	of	 the	
variability	in	global	cognitive	functions	(Table 4).	The	effect	size	was	of	clinical	significance;	
as	an	example,	an	improvement	in	sleep	quality	of	1	unit	would	improve	the	GDS	by	0.64	















































Dependent Variable: GDS Model A: unadjusted Model B: adjusted by age
Intercept 22.5	(8.3) (P = 0.008) 12.4	(9.2)	(P =	0.18)
Goodness of fit R2	=	0.224	(P < 0.001) R2	=	0.280 (P < 0.001)
Subjective	sleep	quality	(PSQI	score) −0.64	(0.24) (P = 0.01) −0.70	(0.24) (P = 0.005)
Sleep	efficiency	(%) 0.25	(0.10) (P = 0.01) 0.23	(0.10) (P = 0.02)
UFC	(μg/24h	urine) 0.09	(0.05)	(P =	0.09) 0.10	(0.05)	(P =	0.06)
Urinary	dopamine	(μg/24h	urine) 0.02	(0.01) (P = 0.001) 0.03	(0.01) (P < 0.001)
Plasma	total	ghrelin	(pg/mL) −0.01	(0.01)	(P =	0.07) −0.01	(0.04) (P = 0.02)
Group	(0=Comparison,	1=Intervention) −0.41	(1.56)	(P =	0.79) −0.66	(1.51)	(P =	0.66)
Follow-up	time	(days) 0.0020	(0.0024)	(P =	0.41) 0.0020	(0.0025)	(P =	0.42)








Questionnaire	 Index,	UFC	=	Urinary	Free	Cortisol.	 SI	 conversion	 factors:	To	convert	 cortisol	 to	nmol/L,	multiply	
values	by	27.588;	to	convert	dopamine	to	nmol/d,	multiply	values	by	6.528;	to	convert	total	ghrelin	to	pmol/L,	
multiply	values	by	0.2
Influence of sleep and anthropometric characteristics on change between baseline and final 
neuropsychological evaluations 
Mixed	models	were	contructed	 to	evaluate	 the	modulation	of	 sleep	and	anthropometric	
characteristics	on	the	change	in	GDS.	In	unadjusted	models,	sleep	duration	by	diary	and	by	
actiwatch,	and	sleep	efficiency	associated	significantly	with	a	change	in	GDS	in	a	positive	
manner	 (Table 5).	 These	 associations	 remained	 significant	 when	 corrected	 for	 baseline	
characteristics	 and	 change	 in	 BMI	 between	 the	 baseline	 and	 final	 evaluation	 (Table 5).	




waist	and	neck	circumference	and	 total	 visceral	 fat	were	also	constructed	without	other	













































Dependent Variable:	improvement	in	GDS Unadjusted models Models adjusted by BMI, change in 
BMI, yrs of education, gender, race
Sleep parameters
Sleep	duration	by	diary 0.022	(0.009)	(P = 0.02) 0.023	(0.010)	(P = 0.03)
Sleep	duration	by	actiwatch 0.022	(0.010)	(P = 0.01) 0.026	(0.009)	(P = 0.006)
Sleep	efficiency 0.124	(0.062) (P = 0.05) 0.147	(0.070)	(P = 0.04)
Subjective	sleep	quality	(PSQI	score) 0.014	(0.166)	(P =	0.93) 0.017	(0.173)	(P =	0.92)
Daytime	sleepiness	(ESS	score) 0.039	(0.103)	(P =	0.70) 0.044	(0.106)	(P =	0.68)
Antropometrics
BMI 0.038	(0.067)	(P =	0.57) 0.052	(0.069)	(P =	0.45)
Waist	circumference 0.063	(0.032)	(P =	0.05) 0.097	(0.060)	(P =	0.11)
Neck	circumference 0.193	(0.107)	(P =	0.07) 0.103	(0.218)	(P =	0.64)
Total	visceral	fat	 0.005	(0.003)	(P =	0.06) 0.004	(0.004)	(P =	0.27)







few	 smokers	 and	 few	 individuals	with	hypertension.	 Furthermore,	 individuals	with	more	
accentuated	deficits	had	worse	sleep	quality	and	sleep	efficiency,	and	a	distinct	hormonal	









or	 direction,33	which	would	 confound	 the	 results.	 Improvement	 in	GDS	 score	 associated	
with	several	sleep	parameters,	but	not	with	anthropometric	parameters.	Therefore,	these	
findings	are	strongly	suggestive	of	a	contributory	role	of	sleep	deprivation	for	the	cognitive	
deficits	 observed.	 More	 importantly,	 they	 indicate	 that	 some	 of	 these	 deficits	 may	 be	
ameliorated	by	sleep	improvement.		
Sleep	 duration	 as	 assessed	 by	 actigraphy	 monitors	 and	 sleep	 duration	 by	 diaries	










































approximately	 30	 min	 shorter	 than	 sleep	 duration	 by	 diaries.	 Sleep	 duration	 usually	 is	
estimated	 by	 self-reported	 sleep	 in	 epidemiological	 studies,	 by	 actigraphy	 in	 smaller	
studies,	and	by	polysomnography	(PSG)	in	clinical	studies.	No	method	is	without	limitations	
in	 determining	 sleep	 duration;	 even	 PSG,	 which	 is	 considered	 the	 “gold	 standard”,	may	






Obese	 subjects	 often	 have	 impairments	 in	 the	 executive	 domain,5,8,10,11	 while	 sleep	
deprivation	decreases	attention	and	 impairs	processing	speed.12,14,16,36	Compared	to	other	
studies	of	obese	adults,	our	participants	had	worse	scores	on	the	TMT-B	(all	 tests	of	 the	
executive	 domain),35	but	 similar	 scores	 at	 the	 IGT	 or	 the	WCST.8,10,37,38	Medical	 residents	
that	habitually	sleep	less	than	six	hrs	were	quicker	on	the	TMT-A	and	TMT-B	(attention	and	
executive	 function,	 respectively),	 and	 scored	 better	 on	 the	 CVLT-LD	 (memory)	 than	 our	
participants.38	As	in	these	studies	scores	were	not	corrected	for	demographic	characteristics,	
differences	with	our	findings	should	be	interpreted	with	caution.	
Sleep	 quality	 was	 worst	 in	 participants	 with	 memory,	 attention	 and	motor	 domains	
impairments.	This	is	likely	independent	of	sleep	apnea,	since	the	RDI	was	similar	between	
participants	with	impaired	vs.	normal	cognitive	function.	Deficits	in	memory	and	executive	
functions	 have	 been	 reported	 in	 men	 with	 sleep	 apnea.39	 Another	 comparison	 to	 our	
participants	 is	patients	with	chronic	non-restorative	sleep,	 in	which	memory	 function	on	
the	Rey	test	was	correlated	with	sleep	efficiency.40	Patients	with	restless	leg	syndrome	who	
experience	decreased	sleep	efficiency	also	have	impairments	in	executive	functions.41 
Sleep	 loss	 affects	 attention	 span.	 Because	 executive	 functions	 are	 impaired	 in	 obese	
individuals,	we	hypothesize	that	the	compensatory	ability	of	brain	areas	devoted	to	attention	
may	 be	 limited	 in	 obese,	 sleep-deprived	 individuals,	 resulting	 in	 a	 larger	 impairment	
compared	to	non-obese,	sleep-deprived	individuals.	In	our	cohort,	we	found	no	relationship	






















































Plasma	 levels	 of	 the	 appetite	 stimulant	 ghrelin	were	 inversely	 related	 to	 the	 GDS	 in	




Study	 merits	 included	 the	 prospective,	 long-term	 characterization	 of	 a	 large	 cohort	
















functions.	 Prospective	 studies	 of	 obese	 individuals	 undergoing	 bariatric	 surgery	may	 be	
warranted. 
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The association between sleep and 
musculoskeletal parameters in middle-aged 




































































After	 adjustment	 for	 confounding	 factors,	 one	point	 increase	 in	 total	 PSQI	 score	 (OR 
and 95% CI, 1.09, 1.03-1.14),	declined	self-rated	sleep	quality	(1.76, 1.03-3.01),	and	sleep	
latency	(1.18, 1.06-1.31),	and	a	one	hour	later	sleep	timing	(1.51, 1.08-2.11),	but	not	sleep	
duration	(1.05, 0.90-1.23),	were	associated	with	osteopenia.	Total	PSQI	score	(1.10, 1.02-
1.19)	 was	 also	 associated	with	 sarcopenia	 and	 sleep	 latency	 (1.14, 0.99-1.31)	 and	 later	
mid-sleep	time	 (1.54, 0.91-2.61)	 tended	 to	 associate	with	 sarcopenia.	Associations	were	
somewhat	stronger	in	women	and	varied	per	menopausal	status.	The	association	of	sleep	
parameters	and	osteopenia	was	 independent	of	RASM,	and	 the	association	of	 sleep	and	
sarcopenia	was	independent	of	BMD.
These	results	imply	that	decreased	sleep	quality	and	a	later	sleep	timing	are	risk	factors	
















































diabetes,	 and	 obesity,	 which	 may	 be	 caused	 by	 alterations	 in	 sympatho-vagal	 balance,	
increased	 evening	 cortisol	 levels,	 pro-inflammatory	 changes,	 and/or	 decreased	 levels	
of	 growth	hormone.2	 These	effects	 are	 also	observed	 in	 studies	 that	 selectively	 reduced	
sleep	quality	without	affecting	total	sleep	duration.3,4	Additionally,	sleep	timing	may	impact	
health,	as	evening	types	generally	have	higher	levels	of	catecholamines	and	cortisol.5,6 
These	 endocrine,	 neural	 and	 inflammatory	 alterations	 mentioned	 above	 have	 the	
potential	 to	 negatively	 affect	 the	 musculoskeletal	 system.	 Recent	 studies	 suggest	 that	
insufficient	 sleep	 is	 associated	 with	 a	 decline	 in	 musculoskeletal	 parameters,	 although	
outcomes	 have	 been	 inconsistent.7,8	 Studies	 have	 reported	 positive,9,10	 negative,11,12	 or	
U-shaped13	 associations	 between	 sleep	 duration	 and	 bone	 mineral	 density	 (BMD),	 or	
observed	no	association.7	One	small	study	observed	a	negative	association	between	sleep	
duration	and	skeletal	muscle	mass.8	Self-reported	sleep	quality	has	been	associated	with	

















Study design and study population 
The	Netherlands	Epidemiology	of	Obesity	 (NEO)	 study	 is	a	population-based	prospective	
cohort	 study	 that	 included	 6,671	 participants	 between	 September	 2008	 and	 September	











































BMI	 of	 27	 kg/m2	 or	 higher	 from	 the	 city	 of	 Leiden	 and	 its	 surrounding	 municipalities	
(the	 Netherlands)	 were	 eligible	 to	 participate	 and	 were	 recruited	 via	 registries,	 general	
practitioners,	and	advertisements.	In	addition,	all	inhabitants	aged	between	45	and	65	years	




to	 this	 visit,	 all	 participants	 completed	 questionnaires	 with	 demographic,	 lifestyle,	 and	
clinical	information,	in	addition	to	a	questionnaire	on	sleep	behaviour.	At	the	baseline	visit,	
anthropometric	measurements	and	 fasting	blood	samples	were	obtained	 in	 the	morning	
after	participants	 fasted	 for	at	 least	10	hours.	Furthermore,	a	 random	subsample	of	915	
participants	underwent	dual	energy	X-ray	absorptiometry	 (DXA)	measurements	between	
10:00	and	12:30,	assessing	bone	mineral	densitometry	(BMD),	body	fat	mass	and	lean	body	






Ethnicity,	 education,	 menopausal	 status,	 medication	 use,	 and	 past	 fractures	 were	 self-
reported.	 Education	 was	 considered	 high	 if	 participants	 highest	 level	 of	 education	 was	
higher	 vocational	 school,	 university,	 or	 post-graduate	 education.	Menopausal	 status	was	
divided	 into	 three	categories	 (pre-,	peri-,	and	postmenopausal)	based	on	 information	on	
oopho-	 or	 hysterectomy	 and/or	 self-reported	menopausal	 status.	Women	who	 reported	
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11
Participants	 reported	 the	 frequency	 and	 duration	 of	 their	 usual	 physical	 activity	 in	
the	past	4	weeks	on	the	Short	Questionnaire	to	Assess	Health-enhancing	physical	activity	
(SQUASH),	a	method	previously	validated	 in	 the	Dutch	population.29,30	We	calculated	 the	














DXA bone and muscle measurements
Absolute	BMD	values	were	obtained	for	the	lumbar	spine	(L1-L4)	and	the	proximal	femur	











































































































































































































































1high	 education:	 higher	 vocational	 school,	 university,	 or	 post-graduate	 education.	 BMI,	 body	mass	 index;	MET,	
metabolic	 equivalents;	 PSQI,	 Pittsburgh	 Sleep	Quality	 Index;	 C1,	 Component	 1;	 C2,	 Component	 2,	 BMD,	 bone	








Associations of sleep parameters with BMD and muscle mass
Table 2	shows	the	mean	differences	in	BMD	in	the	spine	and	hip	and	muscle	mass	(RASM)	
associated	with	one	unit	 change	 in	 the	 sleep	parameters.	After	adjustment	 for	potential	






































































								Fairly	good -0.025 -0.039 -0.922 
(-0.049 - -0.001)*** (-0.059 – -0.019)* (-1.620 - -0.225)*
							Fairly	or					 -0.029 -0.023	 -1.202
							very	bad (-0.063	-	-0.004) (-0.055	–	0.010) (-2.180 - -0.225)*
Sleep	latency	score
-0.012 -0.013 -0.627
(-0.019 - -0.006)** (-0.019 - -0.013)** (-0.810 - -0.444)**
Mid-sleep	time	(hrs)
-0.036 -0.049 -0.644








Age-, sex-, and whole body fat mass-adjusted models
PSQI	score
-0.004 -0.003 -0.011





								Fairly	good -0.011 -0.018 -0.112
(-0.034	–	0.012) (-0.036	–	0.001) (-0.397	–	0.173)
								Fairly	or -0.022 -0.022	 -0.081
								very	bad (-0.053	–	0.009) (-0.034	–	0.021) (-0.479	–	0.317)
Sleep	latency	score
-0.007 -0.002 -0.070
(-0.013 - -0.001)* (-0.008	-	0.003) (-0.155	-	0.014)
Mid-sleep	time	(hrs)
-0.014 -0.012 -0.139
















								Fairly	good -0.017 0.012 -0.165
(-0.035	–	0.001) (-0.035	–	0.011) (-0.442	–	0.112)
								Fairly	or -0.006 -0.020 -0.002	










































Sleep measure BMD spine (g/cm2) BMD hip (g/cm2) RASM (% of total body weight)
Sleep	latency	score
-0.007 -0.003 -0.061









education,	 alcohol	 intake,	 physical	 activity,	 vitamin	D	 levels	 and	 season,	 usage	 of	 systemic	 corticosteroids	 and	
bisphosphonates)	models	are	 shown.	PSQI,	Pittsburgh	Sleep	Quality	 Index;	BMD,	bone	mineral	density;	RASM,	
relative	appendicular	skeletal	muscle	mass.	Results	were	based	on	analyses	weighted	towards	the	BMI	distribution	
of	the	general	population	(n	=	915).	Significant	associations	are	bolded.	*P < 0.05,	**P < 0.01,	***P < 0.001.	
Suppl. Table 1: Difference	(95%	CI)	in	BMD	spine,	BMD	hip	and	RASM	per	unit	change	of	sleep	parameter	stratified	
by	sex.
Sleep measure
BMD spine (g/cm2) BMD hip (g/cm2) RASM (% of total body weight)
men women men women men women
Crude models
PSQI	score
0.000 -0.005 0.001 -0.005 -0.089 -0.106




				(reference)		 - - - - - -
				Fairly	good 0.004 -0.039 0.004 -0.054 -0.056 -0.050
(-0.029	–	0.036) (-0.073 - -0.005)* (-0.029	-0.036) (-0.081 - -0.027)*** (-0.623	–	0.510) (-0.734	–	0.635)
				Fairly	or 0.003 -0.045 0.022	 -0.034	 -0.140 -0.362
				very	bad (-0.045	–	0.051) (0.089 - -0.011)* (-0.023	–	0.066) (-0.075	–	0.007) (-0.978	–	0.697) (-1.302	–	0.579)
Sleep	latency	
score
-0.002 -0.011 0.004 -0.008 -0.154 -0.073
(-0.013	-	0.009) (-0.019 - -0.003)** (-0.006	-	0.015) (-0.015 - -0.002)* (-0.344	-	0.037) (-0.257	-	0.112)
Mid-sleep	time	
(hrs)
-0.005 -0.037 -0.014 -0.033 0.018 0.022















Age & whole body fat mass-adjusted models
PSQI	score
-0.001 -0.005 0.000 -0.004 -0.035 -0.039




				(reference)		 - - - - - -
				Fairly	good 0.003 -0.022 0.004 -0.038 -0.001 -0.202
(-0.028	–	0.035) (-0.054	–	0.011) (-0.022	-0.030) (-0.063 - -0.013)** (-0.366	–	0.364) (-0.640	–	0.235)
				Fairly	or 0.004 -0.038 0.017 -0.028 -0.232	 -0.042
				very	bad (-0.043	–	0.050) (-0.081	–	0.004) (-0.024	–	0.058) (-0.066	–	0.010) (-0.724	–	0.259) (-0.638	–	0.554)
Sleep	latency	
score
-0.003 -0.006 0.003 -0.004 -0.111 -0.055













































BMD spine (g/cm2) BMD hip (g/cm2) RASM (% of total body weight)
men women men women men women
Mid-sleep	time	
(hrs)
-0.004 -0.023 -0.003 -0.019 -0.035 -0.101

















0.001 -0.004 0.001 -0.006 -0.007 -0.043




				(reference)		 - - - - - -
				Fairly	good 0.000 -0.023 0.002	 -0.040 -0.015	 -0.379	
(-0.031	–	0.032) (-0.055	–	0.009) (-0.024	–	0.028) (-0.064 – 0.159)** (-0.371	–	0.341) (-0.800	–	0.041)
				Fairly	or 0.001 -0.042 0.025 -0.035	 -0.020 0.073
				very	bad (-0.043	–	0.057) -(0.082 – -0.002)* (-0.020	–	0.071) (-0.071	–	0.002) (-0.479	–	0.439) (-0.679	–	0.532)
Sleep	latency	
score
-0.002 -0.007 0.003 -0.005 -0.054 -0.063
(-0.013	-	0.009) (-0.015	-	0.001) (-0.008	-	0.013) (-0.011	-	0.002) (-0.176	-	0.067) (-0.178	-	0.051)
Mid-sleep	time	
(hrs)
-0.004 -0.025 -0.001 -0.019 0.035 -0.181
(-0.036	-	0.027) (-0.052	-	0.002) (-0.025	-	0.028) (-0.040	-	0.002) (-0.332	-	0.402) (-0.505	-	0.144)
Sleep	duration	
(hrs)
-0.017 -0.005 -0.008 -0.003 -0.003 0.055
(-0.032 - -0.001)* (-0.017	-	0.008) (-0.022	-	0.005) (-0.014	-	0.008) (-0.174	-	0.168) (-0.127	-	0.238)
Crude,	 age	 &	 whole	 body	 fat	 mass	 adjusted,	 and	 maximally	 adjusted	 (age,	 whole	 body	 fat	 mass	 ethnicity,	
education,	 alcohol	 intake,	 physical	 activity,	 vitamin	D	 levels	 and	 season,	 usage	 of	 systemic	 corticosteroids	 and	
bisphosphonates,	and	menopause)	models	are	shown.	 1age,	whole	body	 fat	mass,	ethnicity,	education,	alcohol	
intake,	 physical	 activity,	menopause.	 PSQI,	 Pittsburgh	 Sleep	Quality	 Index;	 BMD,	 bone	mineral	 density;	 RASM,	
relative	appendicular	skeletal	muscle	mass.	Results	were	based	on	analyses	weighted	towards	the	BMI	distribution	

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































and	 27%	of	women).	 Prevalence	of	 osteopenia	 and	 sarcopenia	 differed	per	menopausal	
status.	Of	pre-,	peri-	and	postmenopausal	women,	26%,	28%	and	50%	had	osteopenia,	and	
18%,	24%,	and	31%	had	sarcopenia,	respectively.
Fig. 1: OR	 (95%	CI)	 for	osteopenia	and	 sarcopenia	per	unit	 change	of	 sleep	parameter.	Crude;	age,	 sex,	whole	










































































PSQI	score 1.09 1.08 1.06 1.09





- - - -
				Fairly	good 2.03 1.95 1.78 2.38
 (1.38-2.99)*** (1.34 - 2.85)** (1.18 - 2.69)** (1.39 - 4.10)**
								Fairly	or	 1.85 1.73 1.86 1.69
								very	bad	 (1.11-3.08)* (1.04 - 2.87)* (1.08 - 3.20)* (0.82	–	3.50)
Sleep	latency 1.19 1.18 1.12 1.22
score (1.08 - 1.30)** (1.07 - 1.29)** (1.01 - 1.23)* (1.10 - 1.36)**
Mid	sleep	 1.67 1.62 1.16 2.01
time	(hrs) (1.23 - 2.28)** (1.19 - 2.19)** (0.86	-	1.58) (1.35 - 2.97)**
Sleep	 1.07 1.07 1.00 1.11
duration	(hrs) (0.92	-	1.25) (0.92	-	1.24) (0.85	-	1.18) (0.91	-	1.36)
Age, sex, whole body fat mass corrected
PSQI	score 1.09 1.09 1.07 1.09





- - - -
				Fairly	good 1.98 1.92 1.75 2.36
 (1.33 - 2.95)** (1.30 - 2.83)** (1.16 - 2.66)* (1.35 – 4.14)*
								Fairly	or	 1.93 1.82 1.92 1.80
								very	bad	 (1.15 - 3.24)* (1.09 – 3.04)* (1.11 - 3.32)* (0.86	-	3.78)
Sleep	latency 1.17 1.17 1.13 1.15
score (1.06 - 1.30)** (1.06 - 1.30)** (1.02 - 1.26)* (1.01 - 1.31)*
Mid	sleep	 1.49 1.44 1.12 1.62


















































Sleep	 1.03 1.03 0.98 1.05
duration	(hrs) (0.88	-	1.21) (0.88	-	1.20) (0.83	-	1.16) (0.84	-	1.32)
Maximally adjusted
PSQI	score 1.09 1.08 1.07 1.10





- - - -
				Fairly	good 1.97 1.90 1.75 2.42
 (1.31 - 2.97)** (1.27 - 2.84)** (1.14 - 2.68)* (1.36 - 4.30)**
								Fairly	or	 1.97 1.76 1.88 1.99
								very	bad	 (1.10 - 3.20)* (1.03 – 2.98)* (1.07 - 3.31)* (0.93	–	4.26)
Sleep	latency 1.18 1.18 1.13 1.17
score (1.06 - 1.31)** (1.06 - 1.31)** (1.02 - 1.25)* (1.02 - 1.33)**
Mid	sleep	 1.51 1.47 1.11 1.58
time	(hrs) (1.08 - 2.11)* (1.05 - 2.05)* (0.80	-	1.54) (1.00	-	2.51)
Sleep	 1.05 1.05 0.99 1.02
duration	(hrs) (0.90	-	1.23) (0.90	-	1.23) (0.85	-	1.17) (0.81	-	1.28)
Crude;	age,	sex,	and	whole	body	fat	mass	adjusted;	and	maximally	adjusted	(age,	whole	body	fat	mass,	ethnicity,	
education,	 alcohol	 intake,	 physical	 activity,	 vitamin	D	 levels	 and	 season,	 usage	 of	 systemic	 corticosteroids	 and	
bisphosphonates)	 models	 are	 shown.	 PSQI,	 Pittsburgh	 Sleep	 Quality	 Index.	 Results	 were	 based	 on	 analyses	
weighted	towards	the	BMI	distribution	of	the	general	population	(n	=	915).	Significant	associations	are	bolded.	*P 
< 0.05,	**P < 0.01,	***P < 0.001.
Odds ratios of osteopenia and sarcopenia stratified by sex and menopausal status
In	sex-stratified	analyses	most	associations	were	stronger	in	women	(Fig. 2).	For	PSQI	and	
sleep	 latency,	 associations	 between	men	 and	women	were	 only	marginally	 different	 for	
osteopenia.	For	example,	a	point	increase	PSQI	score	associated	with	a	7%	and	8%	higher	
risk	 for	 osteopenia	 in	men	 and	women,	 respectively.	 Correspondingly,	men	 and	women	
with	a	one-point	worse	sleep	latency	score,	had	a	14%	and	15%	higher	risk	for	osteopenia.	
For	 sarcopenia	 however,	 one	 point	 higher	 PSQI	 score	 associated	 with	 a	 14%	 increased	
risk	 in	women	a	 longer	sleep	 latency	with	a	19%	higher	risk,	but	these	sleep	parameters	
were	 not	 associated	with	 sarcopenia	 in	men.	 For	 self-rated	 sleep	 quality	 and	mid-sleep	
time,	associations	were	 larger	 in	women	than	 in	men	for	osteopenia	and	for	sarcopenia.	

























































Sleep parameters and risk of osteopenia adjusted for muscle mass and of sarcopenia 
adjusted for BMD
After	additional	adjustment	of	the	models	for	osteopenia	and	sarcopenia	for	muscle	mass	
and	BMD,	 respectively	 (Suppl. Fig. 2).	The	effect	sizes	of	 the	associations	between	sleep	





























































































models	 are	 shown	 for	 reference	 (age,	 sex,	 whole	 body	 fat	mass,	 ethnicity,	 education,	 alcohol	 intake,	 physical	





In	 this	 population-based	 study,	 we	 extensively	 examined	 associations	 of	 sleep	 duration,	
sleep	timing	 and	 sleep	quality	with	 osteopenia	 and	 sarcopenia	 in	middle-aged	men	and	
women.	In	our	cohort,	a	decline	in	sleep	quality	measures	was	associated	with	an	increased	
risk	 of	 osteopenia	 and	 sarcopenia.	 All	 measures	 of	 sleep	 quality	 (total	 PSQI	 score,	 self-
reported	sleep	quality,	and	sleep	latency)	were	consistently	associated	with	musculoskeletal	
health,	which	adds	to	the	validity	of	their	relationship.	
Individuals	with	 a	 later	 sleep	timing	 also	 exhibited	 a	 higher	 risk	 of	 osteopenia	 and	 a	
similar	 trend	 was	 observed	 for	 risk	 of	 sarcopenia.	 The	 mid-sleep	 time	 is	 a	 marker	 for	
chronotype,	 which	 constitutes	 the	 individual	 timing	 of	 behavior	 caused	 by	 the	 internal	
circadian	phase	relative	to	the	light-dark	cycle.	The	evening	chronotype	has	been	associated	
with	 higher	 levels	 of	 cortisol	 and	 of	 catecholamines,2,6	 which	 could	 in	 turn	 negatively	
affect	 the	musculoskeletal	 system.	These	high	 levels	of	 cortisol	 and	 catecholamines	may	
be	 caused	 by	 the	 discrepancy	 between	 preferred	 and	 actual	 sleep	 timing	 that	 evening	











































induced	by	 constant	 light	worsened	bone	microstructure	 in	 young	mice	 resembling	age-
related	osteoporosis.40	Alternatively,	 effects	 of	 sleep	time	on	 the	musculoskeletal	 system	
may	be	partly	explained	by	behavioral	differences.	Individuals	exhibiting	later	sleep	times	
display	more	unhealthy	behaviors,	such	as	smoking,	increased	alcohol	usage,41	less	physical	














































































However,	 we	 did	 not	 observe	 an	 association	 between	 osteopenia	 and	 sarcopenia	 and	
our	 additional	 statistical	 analyses	 suggest	 that	 the	 associations	of	 sleep	with	osteopenia	
and	 sarcopenia	were	 not	mediated	 via	muscle	 and	BMD,	 respectively.	 This	 is	 somewhat	
surprising,	 since	 there	 is	 evidence	 that	 deterioration	 of	 the	 musculoskeletal	 system	 is	
characterized	by	bone	loss	and	muscle	wasting	in	parallel	and	that	these	processes	share	
common	 determinants,21,50	 but	 may	 be	 explained	 by	 the	 relatively	 young	 age	 of	 our	






sleep	and	musculoskeletal	 health.	One	mechanism	 is	via endocrine	 factors	 known	 to	be	
affected	by	 sleep	and	 influencing	musculoskeletal	 health.	A	decline	 in	 sleep	quality	may	
prevent	 individuals	 from	 reaching	 the	 deepest	 sleep	 stages,3	 which	 are	 thought	 to	 be	
the	most	“restorative”	and	these	are	the	times	at	which	most	GH	is	secreted.51	GH	exerts	










A	weakness	of	 this	 study	 is	 that	 it	 is	observational	and	cross-sectional,	 so	we	cannot	
exclude	residual	confounding	and	reverse	causation,	precluding	causal	inference.	Individuals	
with	 osteopenia	 and	 sarcopenia	 could	 suffer	 from	 inadequate	 sleep.	 Furthermore,	 likely	
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Our	 body	 clock	 resides	 in	 the	 suprachiasmatic	 nuclei	 (SCN),	 a	 pinhead-sized	 area	 in	 the	
anterior	hypothalamus	that	is	responsible	for	synchronizing	circadian	rhythms	to	the	external	
environment.	 It	 additionally	 coordinates	 temporal	 synchrony	 within	 the	 body,	 assures	
that	our	bodily	 physiology	 is	 optimally	 adjusted	 to	our	 sleep-wake	 rhythm	and	prepares	
the	body	for	states	fitting	the	time	of	day.	Disruption	of	this	complex	temporal	physiology	
affects	health.	A	deeper	understanding	of	the	functioning	of	the	circadian	system	will	help	
us	 understand	 these	 health	 effects	 and	 may	 provide	 opportunities	 to	 enhance	 fitness.	
Therefore,	 I	 will	 first	 describe	 how	 appropriate	 behavioral	 (Chapter 6)	 and	 photic	 input	
(Chapter 4)	and	strong	synchrony	amongst	SCN	neurons	(Chapter 4)	can	provide	robustness	
to	 the	 circadian	 system	 and	 how	 phase	 shifting	 capacity,	 important	 for	 entrainment,	 is	
influenced	 by	 sleep	 and	 caffeine	 (Chapter 5).	 Subsequently,	 I	 will	 discuss	 the	 rhythmic	
characteristics	of	animal	models	of	circadian	disruption	that	were	used	in	studies	described	
in Chapter 7 and Chapter 8,	 and	 of	 human	 variations	 in	 temporal	 preferences	 (Chapter 
9).	Furthermore,	I	will	examine	the	relationship	between	sleep	and	circadian	rhythms	and	
the	contribution	of	detrimental	sleep	in	models	for	circadian	disruption.	I	will	discuss	the	
results	 of	 animal	 studies	 of	Chapter 7 and Chapter 8	 of	 disrupted	 circadian	 rhythms	on	
metabolism	and	 frailty	parameters	and	discuss	 their	applicability	 to	humans.	Specifically,	
I	will	compare	the	circadian	states	seen	in	constant	light	(LL,	Chapter 8)	and	in	aging.	I	will	
discuss	 the	associations	between	chronotype	and	metabolic	parameters	 (Chapter 9)	and	
neurocognitive	 function	 (Chapter 10)	 in	 short	 sleeping	 obese	 individuals.	 I	 will	 discuss	
reversibility	of	adverse	health	parameters	(Chapter 8, Chapter 10)	and	end	with	the	clinical	
implications	of	findings	in	the	current	thesis.	
Vasoactive intestinal peptide is necessary for seasonal rhythmicity
Studies	 in Chapter 4	 examine	 the	 function	 of	 VIP,	 a	 neurotransmitter	 implicated	 as	 an	
important	coupling	factor	of	SCN	neurons.	We	demonstrate	that	the	neurotransmitter	VIP	
is	necessary	for	memory	of	the	environmental	day	length.	Behavioral	and	neuronal	activity	
patterns	 in	 VIP	 KO	 mice	 exposed	 to	 long	 and	 short	 photoperiods	 are	 indistinguishable	
















































VIP	 is	 also	 expressed	 in	 many	 tissues	 outside	 the	 SCN	 and	 the	 brain,	 including	 the	
gut,	 pancreas,	 and	 cardiopulmonary	 system.	 VIP	 KO	 mice	 therefore	 also	 exhibit	 other	









whether	 patients	with	 VIPoma	 exhibit	 circadian	 disturbances.	While	 the	 absence	 of	 VIP	
specifically	 might	 not	 be	 directly	 translational	 to	 humans,	 the	 examination	 of	 circadian	
properties	in	VIP	KO	mice	demonstrates	basic	functionalities	of	the	circadian	system.	
Appropriate input to the circadian system can compensate for deficient 
individual components and enhance rhythmicity
Although	VIP	is	needed	for	seasonal	encoding,	the	studies	in	Chapter 4	also	demonstrate	
that	 SCN	 function	 in	 light-dark	 conditions	 is	 relatively	well	maintained	 in	 the	absence	of	
VIP.	 On	 the	 other	 hand,	 many	 peripheral	 rhythms	 are	 disrupted	 in	 mice	 lacking	 VIP	 or	
its	 receptor,	 including	 rhythms	 of	 adrenocorticotropic	 hormone,	 cortisone,	 heart	 rate,	
behavior,	 and	 sleep-wake	 patterns.7-12 In vitro	 examination	 of	 the	 SCN	 also	 revealed	
disruption	of	 circadian	 rhythmicity13,14	and	weakened	synchrony	amongst	SCN	neurons	 in	
VIP	KO	mice.15,16	Additionally,	rhythmic	molecular	expression	of	clock	genes	in	their	SCN	is	
attenuated.17-19	Nevertheless,	VIP	KO	mice	display	MUA	rhythms	of	remarkable	quality	under	







in vivo while	VIP	 is	 so	 important	 for	neuronal	 coupling	demonstrates	 that	 compensation	















































mice,	 light	still	 suppresses	behavioral	activity,	while	darkness	enhances	active	behavior.10 
The	obvious	 lack	of	 light	 input	 in	 in vitro	experiments	may	account	 for	 the	severe	effect	
of	VIP	loss	in	these	experiments	vs. the	sustained	rhythmicity	under	light-dark	conditions	





Timing of behavioral activity strongly reflects SCN rhythmicity
In	wild	type	mice,	appropriate	timing	of	behavioral	activity	also	has	the	potential	to	enhance	
circadian	 rhythms	 (Chapter 6).	Using	simultaneous	 in vivo	behavioral	and	neuronal	MUA	
recordings	in	freely	moving	mice,	we	observed	that	MUA	was	acutely	suppressed	during	short	








proper	time	can	boost	clock	amplitude	(Chapter 6, Fig. 6).
The	 circadian	 rhythm	 of	 behavioral	 activity	 is	 strongly	 correlated	 with	 the	 amount	
of	 rhythmicity	of	 the	SCN.	For	 instance,	constant	 light	 (LL)	decreases	 the	strength	of	 the	
behavioral	as	well	as	the	neuronal	rhythm	(Chapter 8, Fig. 1, Fig. 2).	LL	decreases	rhythmicity	
more	in	some	than	in	other	mice	and	the	effect	of	LL	varies	over	time,	generally	with	rhythm	
disruptions	 becoming	 progressively	 outspoken	 with	 a	 longer	 duration	 of	 LL	 exposure.	
Interestingly,	 in	 mice	 recordings	 that	 displayed	 neuronal	 rhythms	 of	 higher	 amplitude,	
concomitant	 behavior	 also	 followed	 a	 more	 robust	 and	 circadian	 pattern	 (Chapter 8, 
Fig. 2).	 The	 association	 between	 time-scale	 behavior	 and	 acute	 neuronal	 suppressions	
remains	present	in	LL,	as	well	as	in	constant	darkness	(DD)	(Chapter 6).	Furthermore,	the	















































It	 has	 additionally	 been	 shown	 that	 mice	 fed	 a	 high	 fat	 diet	 display	 attenuated	
rhythmicity	 in	behavior	and	that	placing	a	running	wheel	 in	 their	cage,	allowing	them	to	







It	was	difficult	 to	distinguish	cause	and	effect	 in	our	 recordings,	as	we	recorded	on	a	
1-second	 bin	 timescale	 and	 behavioral	 activity	 and	 neuronal	 suppression	 appeared	 to	
occur	 simultaneously.	We	hypothesize	 that	 behavior	 causes	 the	 suppression	 in	 neuronal	
firing,	because	the	MUA	signal	remains	suppressed	after	termination	of	behavioral	activity.	
Furthermore,	 behavior	 elicited	 by	 an	 external	 stimulus	 had	 a	 direct	 effect	 on	 neuronal	
activity	 (Chapter 6, Fig. 5).	 Additionally,	 in vitro	 recordings	 of	 SCN	 slices	 do	 not	 exhibit	
suppression-like	patterns	in	neuronal	activity	rhythms.	Vice versa,	artificial	suppression	of	
MUA	by	infusion	of	tetrodotoxin	(TTX)	during	the	resting	phase	elicits	behavioral	activity,	





Differential effects of spontaneous vs. induced behavior on neuronal firing
Whereas	 spontaneous	 behavior	 is	 associated	 with	 a	 reduction	 in	 neuronal	 activity,	
increases	 in	MUA	are	observed	with	behavior	 that	 is	 induced	by	noise	production	or	by	
small	movements	of	the	cage	floor	(Chapter 6, Fig. 5).	The	kinetics	of	the	neuronal	response	
to	 induced	behavior	 shows	 clear	differences	 to	 that	 induced	by	 spontaneous	 activity.	At	
the	start	of	the	behavior,	neuronal	firing	is	acutely	diminished	and	remains	at	a	low	level	
throughout	 both	 types	 of	 behavioral	 activity.	 After	 termination	 of	 induced	 behavior,	
neuronal	firing	 levels	climb	back	up	more	slowly	to	their	original	 levels	 in	an	exponential	
function	in	comparison	to	spontaneous	behavior	(Chapter 6, Fig. 2, Fig. 5).37	These	findings	
may	be	 caused	by	usage	of	 a	 different	 subset	 of	 neurons	or	 neurotransmitters	 in	 either	
situation.	In	our	experiment,	mice	froze	upon	disturbance,	an	activity	that	is	associated	by	
type	2	theta	activity	in	the	hippocampus	that	uses	acetylcholine.38	As	cholinergic	neurons	


















































of	 hypocretin	 demonstrates	 alteration	 of	 SCN	 activity	 with	 a	 similar	 characteristic	 slow	
recovery43	and	behavioral	activity	leads	to	increased	c-Fos	expression	in	hypocretin	cells	in	
the	lateral	hypothalamus.44 






Photic phase shifting capacity is influenced by behavioral aspects and 
caffeine
The	 circadian	 system	 must	 be	 responsive	 to	 phase	 shifts,	 in	 order	 to	 adapt	 to	 a	 new	
environment,	 but	 it	 should	 not	 be	 disrupted	 too	 easily	 to	 provide	 temporal	 stability.	
Behavior,	 light	 and	 sleep	 deprivation	 are	 examples	 of	 Zeitgebers	 that	 can	 induce	 phase	
shifting.	When	applied	at	 the	beginning	of	 the	 subjective	night	 (CT14),	phase	delay	 to	a	
light	pulse	is	of	maximal	magnitude	and	the	behavioral	rhythm	shifts	by	about	2	hrs	in	one	
day	(Chapter 5, Fig. 1).45	The	nonphotic	phase	response	curve	follows	a	different	pattern	
and	its	shape	is	similar	for	novelty-induced	wheel	running	and	sleep	deprivation.46,47	Sleep	
deprivation	at	CT14	induces	a	phase-delay	of	about	45	minutes	(Chapter 5, Fig. 1).	Photic	
and	nonphotic	effects	are	not	additive,	as	a	light	pulse	combined	with	sleep	deprivation	at	
CT14	resulted	in	a	phase	shift	of	about	an	hour	(Chapter 5, Fig. 1).48,49	Behavioral	activity	
also	 influences	phase	shifting	magnitude.	For	example,	phase	shifts	are	attenuated	when	
the	 running	 wheel	 is	 blocked,	 so	 active	 behavior	 accelerates	 re-entrainment	 to	 shifted	
environments.34,50,51	In	studies	described	in	Chapter 5,	we	show	that	the	light	response	of	
SCN	neurons	 is	attenuated	 in	sleep	deprived	mice,	which	may	reflect	the	reduced	photic	
phase-shifting	capacity	(Chapter 5, Fig. 2).	















































displayed	 light	 responses	 that	 were	 indistinguishable	 from	 well	 rested	 mice	 given	 light	
pulses.	Exposure	to	LL	input	lengthens	endogenous	period	(Chapter 8, Fig. 1, Chapter 5, Fig. 
4)	and	the	administration	of	caffeine	during	LL	exposure	leads	to	an	extreme	lengthening	
of	the	period	(Chapter 5, Fig. 4).	Mice	consuming	caffeine	in	DD	also	lengthen	their	period,	
but	to	a	much	lesser	extend	(Chapter 5, Fig. 4).	These	observations	support	the	hypothesis	
that	caffeine	enhances	light	sensitivity	of	the	circadian	system.	Caffeine	also	exerts	a	direct	
effect	on	SCN	function,	as	it	lengthened	the	endogenous	period	in	the	absence	of	light	input	
(Chapter 5, Fig. 4)	and	application	of	caffeine	induces	a	phase	delay	of	peripheral	clocks.52
Besides	adenosine	effects,	the	loss	of	sleep	results	in	increased	SCN	serotonergic	activity,	






phase	may	 already	 significantly	 affect	well-being.57	 Chronic	 sleep	 deprivation	 in	 humans	
affects	 light-induced	 phase	 shifting	 magnitude	 more	 severely.58,59	 Thus,	 in	 humans	 that	












7,	 SCN	 lesions	were	performed	 in	mice	which	 completely	 abolished	behavioral	 circadian	
rhythmicity	 (Chapter 7, Fig. 1, Fig. 2).	 Destruction	 of	 the	 central	 pacemaker	 results	 in	














































A	 less	 drastic	 method,	 used	 in	 Chapter 8,	 that	 also	 affects	 the	 SCN	 is	 exposure	 to	
constant	light,	which	removes	circadian	environmental	cues	and	decreases	the	amplitude	
of	 circadian	 rhythms.	 The	diminished	 rhythmicity	 in	 the	SCN	 in	 LL	 (Chapter 8, Fig. 2)62,63 
is	 caused	 by	 a	 desynchrony	 amongst	 SCN	 neurons.64	 The	weak	 remaining	 rhythms	 in	 LL	
may	be	generated	by	a	subpopulation	of	synchronous	cells.	As	a	consequence,	rhythms	in	
peripheral	tissues65	and	in	behavior	(Chapter 8, Fig. 1)62	are	also	attenuated.	The	amplitude	


















Therefore,	 the	 circadian	 consequences	 of	 SCN	 lesions	 and	 LL	 are	mainly	 a	 reduction	
in	 amplitude	 whereas	 chronotype	 mainly	 causes	 altered	 timing	 of	 certain	 behaviors	 in	
relationship	to	the	environment	and	the	internal	rhythm.	
Contribution of altered sleep in SCN lesions, LL, and chronotype on health 
effects
The	control	of	the	circadian	rhythm	of	sleep	lays	in	the	SCN.	Therefore,	rhythmicity	in	sleep	
is	 absent	 in	 SCN-lesioned	 animals73,74	and	 it	 is	 diminished	 in	 LL.75	 The	 SCN	may	 regulate	
additional	aspects	of	sleep	beyond	timing,	such	as	sleep	duration	and	homeostasis.	Besides	
abolishment	 of	 rhythmicity,	 SCN	 lesioning	 also	 lengthened	 total	 sleep	 time	 in	 squirrel	


















































types	 (Chapter 9, Fig. 1).77	Without	 social	 constraints,	both	 chronotypes	exhibit	 sleep	of	
similar	duration	and	quality.78,79	However,	in	everyday	life,	Evening	types	generally	accumulate	
sleep	debt	over	 the	work	week	 that	 they	 replenish	by	extending	 sleep	on	weekends.72,77	
Obese,	short	sleeping	Morning	and	Evening	types	do	not	differ	in	sleep	duration	on	work-	or	
weekend	days,	overall	sleep	quality	or	daytime	sleepiness	(Chapter 9, Table 2).	However,	





self-reported	 sleep	 diary	 and	 objectively	 measured	 actigraphy	 measurements	 (Chapter 
9, Table 2).	 The	 fact	 that	 these	Evening	 types	appear	 to	be	 less	 conscious	of	 their	 sleep	
debt	may	render	them	less	prone	to	ameliorate	their	sleep	length.	The	distribution	of	the	
chronotype	 score	 in	 a	population	 that	was	 selected	based	on	obesity	 and	 short	 sleep	 is	
slightly	 skewed	 towards	 eveningness	 in	 comparison	 to	 the	 normal	 population	 (Chapter 
9),79,80	indicating	that	the	Evening	chronotype	is	somewhat	more	likely	to	be	obese	and	short-
sleeping.	The	separate	contribution	of	obesity	and	short	sleep	in	skewing	scores	towards	
eveningness	 cannot	 be	 distinguished.	 Thus,	 the	 effects	 of	 chronotype	 on	 metabolism	
presented	in	Chapter 9	are	caused	by	differences	in	sleep	and	behavioral	timing	relative	to	
the	environment,	but	only	apply	to	a	short-sleeping	obese	population.	
Lesions of the central clock in the SCN lead to metabolic alterations
SCN-lesioned	mice	lack	the	physiological	nocturnal	increase	in	oxygen	consumption,	energy	
intake,	 behavioral	 activity,	 and	 respiratory	 ratio	 (Chapter 7, Fig. 3).	 Their	 total	 oxygen	
consumption	and	behavioral	activity	 levels	are	similar	to	sham-lesioned	mice,	while	total	
energy	 intake	 is	 reduced	 by	 26%.	 Despite	 their	 lower	 food	 intake,	 SCN-lesioned	 mice	
are	17%	heavier,	due	to	an	increased	fat	mass	(Chapter 7, Fig. 2).	The	respiratory	ratio	is	
lower	 during	 the	 day	 and	 night	 in	 SCN-lesioned	mice,	 so	 the	 response	 to	 food	 intake	 is	
directed	more	 toward	 fat	oxidation	 instead	of	 carbohydrates.	The	 inability	 to	upregulate	
carbohydrate	oxidation	appears	to	be	caused	by	a	deficient	tissue	glucose	uptake	due	to	
















































by	 SCN-lesioning	 (Chapter 7, Fig. 5).	 Thus,	while	 total	 levels	 of	metabolic	measures	 are	
similar,	SCN-lesions	induce	obesity	and	severe	hepatic	insulin	resistance.	Therefore,	these	
metabolic	defects	appear	 to	be	caused	by	either	 the	 lack	of	 rhythmicity	 in	SCN-lesioned	
animals	or	due	to	a	shift	in	homeostatic	set	point.	For	instance,	the	mild	weight	gain	in	SCN-
lesioned	mice	may	be	caused	by	reduced	brown	adipose	tissue	activity,	because	the	SCN	
exerts	an	excitatory	 influence	on	 the	VMH	neurons	 involved	 in	activating	brown	adipose	
tissue.82	Possibly,	SCN	lesions	remove	the	physiological	inhibitory	SCN	input	to	the	adipose	
tissue,	 thereby	 increasing	 the	basal	 rate	 of	 lipolysis.	 Indeed,	 levels	 of	 free	 fatty	 acid	 are	
increased	in	SCN-lesioned	mice	(Chapter 7,	Table 1),	which	is	an	additional	risk	factor	for	
developing	insulin	resistance.83
By	 abolishing	 rhythmicity	 due	 to	 SCN	 lesioning,	 the	 timing	 of	 food	 intake	 and	 of	
energy	expenditure	may	not	be	optimally	adjusted	to	one	another.	Physiological	circadian	
rhythmicity	in	hormones	regulating	metabolism	(Chapter 2),	such	as	leptin,	is	absent	in	mice	
with	 SCN-lesions.86 Additionally,	 neither	 basal	 glucose	 and	 insulin	 levels	 nor	 glucose	 and	
insulin	responses	to	meals87and	glucose	utilization	inhibitors88 display	a	circadian	variation	in	
SCN-lesioned	animals.	An	imbalance	between	energy	intake	and	expenditure	is	detrimental	
for	 glucose	 homeostasis.	 The	 importance	 of	 well-timed	 eating	 rhythms	 is	 supported	 by	
studies	in	rats:	these	nocturnal	animals	gain	more	weight	when	fed	only	during	the	day.89-
91	 These	 protocols	 are	 different	 from	 SCN	 lesioning,	 because	 these	 animals	 eat	 “against	
their	clock”	instead	of	having	an	absent	central	clock.	A	similar	phenomenon	is	observed	
in	mice	 exposed	 to	 LL	 (Chapter 8).62,92	 LL	 quickly	 induces	 a	mildly	 increased	weight	 that	
remains	stable	over	time	and	increased	unfasted	glucose	levels	at	CT0	(Chapter 8, Fig. 1).	
When	environmental	 rhythmicity	 is	 restored	 in	mice	previously	exposed	to	 long	term	LL,	
weight	and	glucose	levels	quickly	normalize	(Chapter 8, Fig. 1).	These	findings	 imply	that	
the	mechanisms	responsible	for	the	LL-induced	weight	increase	are	fast-acting	and	induce	
stable	changes.	
Damage to the PVN and VMH increases metabolic alterations in SCN-
lesioned mice
The	 SCN	 partly	 controls	 hepatic	 glucose	 homeostasis	 through	 time-dependent	 GABA-











































insulin	resistance	compared	to	mice	with	exclusive	SCN-lesions	(Chapter 7, Fig. 6).	Unlike	
mice	with	selective	SCN	lesions,	mice	with	extended	lesions	also	exhibit	peripheral	insulin	
resistance,	probably	resulting	from	their	increased	fat	mass.	Unilateral	damage	to	the	PVN	
does	 not	 additionally	 affect	weight	 in	 SCN-lesioned	mice	 (Chapter 7, Fig. 6),	 suggesting	
the	PVN	needs	 to	be	bilaterally	 damaged	 in	order	 to	 influence	weight.	 The	proximity	of	
the	anatomical	location	of	SCN	and	surrounding	metabolic	regulatory	areas	underlines	the	
importance	 of	 careful	 positioning	 of	 hypothalamic	 site-specific	 lesions	 and	 subsequent	
histological	verification.	
Diminished circadian rhythm amplitude induces a frail state
Studies	in	Chapter 8	describe	that	mice	exposed	to	LL	display	a	diminished	muscle	function,	





makes	 the	bone	more	brittle	and	easier	 to	break.	Effects	on	 the	 immune	system	change	
over	time	of	LL	exposure.	Two	wks	of	LL	 induce	some	changes	 in	 the	responsivity	of	 the	
immune	system.	Eight	wks	in	LL	results	in	a	pro-inflammatory	state,	characterised	by	higher	
circulating	levels	of	neutrophils	and	increased	pro-inflammatory	cytokine	responses	to	an	



























































of	 several	 peripheral	 rhythms	 is	 attenuated	 in	 all	 three	 conditions	 (Table 1).67,100-103	 The	
SCN	degenerates	and	 loses	VIP	neurons	 in	 the	process	of	human104	 and	murine105	 aging.	
Short	 term	 LL	 does	 not	 affect	 SCN	 volume,	 but	 reduces	 the	 number	 of	 glial	 cells	 in	 the	
circadian	system.106	More	importantly,	the	rhythmicity	of	the	SCN	neuronal	and	clock	genes	






























Thus,	 in	all	 three	conditions	(LL	and	aging	 in	mice,	and	aging	 in	human)	the	circadian	










































desynchronization	of	 individual	 neurons.	 Likewise,	behavioral	 activity	 is	 diminished	 in	 all	
conditions.	LL	and	aging	also	exert	comparable	effects	on	period	and	sleep	in	mice,	but	aging	
effects	these	parameters	differently	in	humans.	Thus,	there	are	some	differences	between	
species	 in	 age-induced	 effects	 on	 period	 and	 sleep,	 but	 the	 resemblance	 of	 circadian	
parameters	between	aging	and	LL	in	the	mouse	is	remarkable	and	provides	an	opportunity	
for	examining	effects	of	an	“old	clock”	in	otherwise	young	animals.	
Table 1: Comparison	 of	 circadian	 parameters	 in	 constant	 light	 and	 in	 aging	 in	mice	 (unless	 other	 animals	 are	
mentioned	specifically),	and	translation	to	aged	humans.
  LL (mice) Aging (mice) Aging (humans)
Circadian rhythm amplitude:

































Activity less62 less98,107 less99
Association between circadian rhythms and metabolic alterations in 
humans
In	 humans,	 disrupted	 circadian	 rhythms	 have	 been	 linked	 to	metabolic	 alterations.	 Shift	
workers	 are	 at	 increased	 risk	 for	 developing	obesity	 and	 type	2	 diabetes.	 This	 has	 been	
reported	consistently	in	large	cross-sectional120	and	prospective	studies,121,122	in	men121and 





outcomes.	Allelic	 variation	 in	 circadian	 related	 genes	Clock126,127 and Rev-erb alpha128 has 











































Cry2,131 and MTNR1B132-134 relate	to	higher	fasting	blood	glucose	levels	and	increased	risk	for	
type	2	diabetes.	Furthermore,	Clock,136,137	Cry2,137 and MTNR1B137 gene	variants	determine	
the	magnitude	of	improvement	of	metabolic	parameters	in	response	to	certain	diets.	Per1 












In	 studies	 in	Chapter 9,	 the	 association	 between	 chronotype	 and	metabolic	 parameters	
is	 examined	 in	 short	 sleeping	 obese	 individuals.	 In	 these	 individuals,	 chronotype	 scores	
towards	eveningness	also	relate	to	 increased	BMI	and	neck	circumference,	while	relating	
to	 lower	 circulating	 levels	 of	 HDL	 (Chapter 9, Fig. 3).	 Additionally,	 Evening	 types	 in	 this	
cohort	have	higher	values	of	ACTH,	24h	urinary	levels	of	norepinephrine	and	epinephrine	
and	a	higher	resting	heartbeat	(Chapter 9, Fig. 4, Table 4),	 indicating	an	activation	of	the	





have	a	 later	sleep	timing	and	a	 later	food	intake.	Overall,	they	eat	 less	often	and	tend	to	
eat	larger	portions	(Chapter 9, Fig. 2, Table 3).	These	altered	patterns146-148 and	timing149,150	
of	food	intake	have	been	associated	independently	with	a	higher	BMI	and	increased	risk	of	
weight	gain.	Additionally,	meal	composition	depends	on	the	time	of	day,	as	meals	consumed	












































Combined effect of short sleep and obesity on neurocognitive function
In	Chapter 10,	we	describe	studies	examining	the	neurocognitive	deficits	 in	a	population	
of	 short	 sleeping	 obese	 individuals.	 As	 expected,	 many	 of	 these	 individuals	 display	
neurocognitive	deficits:	the	mean	score	on	the	GDS	is	41.7,	which	is	below	average,	and	44%	
scores	in	the	impaired	range.	In	comparison,	10%	of	the	normal	population	has	impaired	
GDS	 scores.151	 Executive	 function	 is	most	 often	 impaired	 (51%),	 followed	by	motor	 skills	






short	sleeping	obese	individuals	(Chapter 10, Table 4).	Thus,	even	though	all	participants	
sleep	short,	a	decreased	sleep	quality	can	still	aggravate	cognitive	function.	The	absence	




Deficient	 neurocognitive	 functioning	 is	 associated	 with	 lower	 levels	 of	 circulating	
dopamine,	 urinary	 norepinephrine	 and	 free	 cortisol	 in	 short	 sleeping	 obese	 individuals	
(Chapter 10, Table 1, Table 4).	 Levels	 of	 these	 substances	 are	 only	 lower	 in	 individuals	
deficient	 in	memory-	and	attention-related	neurocognitive	 tasks,	while	a	deficient	motor	
or	 executive	 function	 did	 not	 affect	 levels.	 Dopamine,	 norepinephrine	 and	 cortisol	 are	
substances	that	are	widely	distributed	throughout	brain	areas	 involved	 in	neurocognitive	
function.	 The	 major	 site	 of	 memory	 processing	 and	 cognitive	 control,	 the	 prefrontal	
cortex,	 is	 highly	 sensitive	 to	 dopaminergic	 input.159	 Norepinephrine,	 a	 neurotransmitter	
that	 is	 synthesized	 from	 dopamine,160	 also	 acts	 in	 the	 prefrontal	 cortex161 as	well	 as	 the	
hippocampus,162	where	it	facilitates	long-term	potentiation	a	process	important	in	memory	
formation.	 Although	 peripheral	 levels	 of	 catecholamines	 and	 cortisol	 do	 not	 determine	
the	regional	distributions	of	these	levels	within	the	brain	and	therefore	do	not	necessarily	
reflect	central	neurotransmission	and	intracellular	processes,163 there	is	crosstalk	between	
the	 central	 and	 peripheral	 systems.164 In	 several	 psychiatric	 disorders,	 such	 as	 anxiety	
and	depression,	 central	 and	peripheral	 systems	 are	 affected164 and	 the	 administration	of	
medications	such	as	levodopa	and	antidepressents	influences	plasma,	urinary,	and	central	
levels.164,165	 High	 circulating	 levels	 of	 cortisol	 have	 been	 associated	 with	 hippocampal	
atrophy,	demonstrating	a	central	effect	of	peripheral	concentrations.166-168


















































mentioned	 above	 advocate	 a	 causative	 role	 of	 substance	 levels	 in	 decreased	 cognitive	






short	 sleep,	 obesity,	 and	 neurocognitive	 function	 may	 share	 common	 etiologies	 due	






Association of sleep with musculoskeletal parameters
Sleep	is	also	associated	with	musculoskeletal	health,	as	decribes	in	the	study	in	Chapter 11. 
In	this	study,	916	individuals	of	the	Netherlands	Epidemiology	of	Obesity	(NEO)	study	were	
enrolled.	 Participants	were	45-65	 yrs	 old,	 generally	 slept	 relatively	well	 (7	 hrs	 per	night,	
85%	reported	sleeping	fairly	or	very	good)	and	averagely	had	a	low	incidence	of	osteopenia	
in	 the	 spine	 or	 femoral	 neck	 (37%)	 and	 sarcopenia	 (19%).	We	 observed	 that	 decreased	
sleep	quality	and	 later	 sleep	timing	associates	with	an	 increased	 risk	 for	osteopenia	and	




individuals	experiencing	declined	 sleep	quality,188,189	while	 these	are	 the	times	of	 growth	













































of	catecholamines	(Chapter 9, Fig. 4).	Effects	may	also	be	explained	by	a	more	unhealthy	
lifestyle	that	 is	associated	with	 later	bed	times	(Chapter 9, Fig. 2),	although	we	adjusted	
analysis	for	smoking,	alcohol	intake	and	whole	body	fat	mass	and	results	remained	significant.	
Interestingly,	sleep	duration	did	not	associate	with	musculoskeletal	parameters,	consistent	
with	 a	 previous	 study	 in	 Caucasians.191	 Our	 participants	 slept	 relatively	 well,	 and	 more	
severe	sleep	deprivation	may	be	necessary	to	affect	musculoskeletal	health.	Alternatively,	
sleep	quality	and	timing	are	more	important	factors	in	musculoskeletal	health	than	sleep	
duration.	 The	 associations	 between	 sleep	 parameters	 and	 osteopenia/sarcopenia	 were	
independent	from	muscle	mass/BMD,	respectively,	indicating	that	these	associations	exist	
in	parallel	but	are	not	influenced	by	one	another.
Associations	 between	 sleep	 parameters	 and	musculoskeletal	 health	were	 stronger	 in	
women	than	in	men,	which	may	be	due	to	differences	in	sleep	and	musculoskeletal	health	
per se	 and	may	be	 influenced	by	 sex	hormones	 and	behavioral	 differences	 (Chapter 11, 
Fig. 2).	Small	differences	in	the	effect	sizes	of	the	associations	per	menopausal	status	were	
present	 (Chapter 11, Suppl. Fig. 1).	 In	 postmenopausal	 women,	 osteopenia	 associated	
somewhat	 weaker	 with	 sleep	 quality	 and	 timing	 while	 sarcopenia	 displayed	 a	 stronger	
association	compared	to	pre-	and	perimenopausal	women,	which	could	be	due	mediated	
by	differences	in	estrogen	levels.	
Recovery of functions by strong rhythms and improvement of sleep 
The	 study	 presented	 in Chapter 8 describes	 that	 LL	 exposure	 negatively	 effects	 muscle	
function	and	bone	microstructure.	These	adverse	effects	are	alleviated	by	the	reintroduction	
of	 a	 light-dark	 regime.	 The	neuronal	 rhythm	 in	 the	 SCN	 recovers	 immediately	upon	first	
dark	exposure	after	long	term	LL	as	well	as	the	rhythm	strength	of	the	behavioral	rhythm	
(Chapter 8, Fig. 1, Fig. 2).	At	the	first	time	point	after	LD12:12	exposure	(t	=	2	wks),	muscle	
function	 of	mice	 previously	 kept	 in	 LL	 is	 already	 indistinguishable	 from	mice	 that	 were	
on	LD12:12	 throughout	 the	experiment	 (Chapter 8, Fig. 3).	 Similarly,	while	all	 trabecular	
parameters	indicate	a	more	brittle	bone	structure	at	24	wks	of	LL	exposure,	no	differences	
in	bone	structure	are	observed	at	8	wks	after	recovery	of	the	light	regime	(Chapter 8, Fig. 
4, Suppl. Fig. 3).	Therefore,	recovery	of	environmental	rhythmicity	in	light	exposure	has	a	
fast-acting	beneficial	effect	on	health.	
An	advantageous	effect	of	exposure	 to	strong	environmental	 lighting	cycles	has	been	
demonstrated	 in	 humans.	 Enhancing	 the	 diurnal	 variability	 of	 lighting	 in	 nursing	 homes	
improved	 sleep,	 attenuated	 cognitive	 deterioration,	 and	 increased	 social	 and	 physically	
active	behavior	 in	residents.192,193	Likewise,	preterm	infants	at	the	neonatal	 intensive	care	

























































A	 robust	 and	 high	 amplitude	 circadian	 rhythm	 is	 beneficial	 for	 sleep.	 In	Chapter 10,	
we	describe	that	short	sleeping	obese	 individuals	were	coached	to	extend	their	sleep	by	
implementing	 sleep	 hygiene	methods.	Many	 of	 these	methods	 are	 aimed	 at	 improving	
circadian	amplitude,	such	as	avoiding	of	 light	at	night,	 increasing	daytime	light	exposure,	
abstinence	 from	 daytime	 naps	 and	 increasing	 daytime	 exercise.	When	 these	 individuals	
were	 evaluated	 averagely	 1.3	 yrs	 later,	 individuals	 had	 successfully	 extended	 their	 sleep	
by	average	17	minutes	by	diary	and	by	36	minutes	by	a	sleep	questionnaire	and	their	sleep	
quality	improved	by	23%	(Chapter 10, Table 3).	Individuals	also	improved	in	neurocognitive	
function:	mean	GDS	scores	improved	by	7%,	attention	by	10%,	and	memory	and	executive	
functions	by	7%	and	5%	with	a	borderline	significance,	respectively	(Chapter 10, Table 2).	It	
is	unlikely	that	the	improvement	in	neurocognitive	performance	is	caused	by	practice	effects	
because	 the	 time	 interval	 between	 testing	was	 sufficiently	 large.202	 Additionally,	 cortisol	
levels	increased	by	17%	(Chapter 10, Table 2).	The	amelioration	in	GDS	scores	associated	































































In	 the	 last	 parts,	 we	 demonstrated	 the	 detrimental	 effects	 of	 altered	 rhythmicity	
induced	by	SCN	lesions	(Chapter 7),	constant	light	(Chapter 8)	and	chronotype	(Chapter 9)	
on	body	weight	and	insulin	resistance	(Chapter 7, Chapter 8, Chapter 9),	bones	and	muscles	
(Chapter 8),	immune	system	(Chapter 8),	and	stress	hormones	(Chapter 9).	Additionally,	we	
show	an	association	between	sleep	loss	and	bones	and	muscles	(Chapter 11)	and	a	decline	







Insulin	 resistance	 also	 poses	 a	 risk	 factor	 for	 non-cardiovascular	 diseases,	 like	 cancer	 or	
impaired	kidney	function.206	Declined	bone	mass	 increases	the	risk	for	fractures,207	which	
increases	risk	for	mortality208	and	a	reduced	quality	of	life.209	Muscle	function	is	a	predictor	
of	 functional	 decline	 that	 may	 occur	 during	 aging.210	 Adequate	 immune	 responses	 are	
essential	to	battle	infection	and	to	protect	against	cancer,	neurodegenerative	disease,	and	
auto-immune	disease.	A	pro-inflammatory	state	has	been	associated	with	morbidity	and	
mortality.211 Likewise,	 high	 urinary	 catecholamine	 excretion	 is	 a	 risk	 factor	 for	 functional	
decline	and	mortality.212	Declined	cognitive	function	may	predispose	individuals	to	errors,	














































Results	are	at	particular	 importance	for	 individuals	experiencing	 internal	desynchrony	
and	 those	 at	 risk	 for	 sleep	 deprivation,	 such	 as	 shift	 workers,	 elderly	 individuals,	
those	 experiencing	 frequent	 (social)	 jet	 lag,	 and	 patients	 suffering	 from	 sepsis,213 
neurodegenerative	 diseases	 such	 as	 Alzheimer,214,215	 and	 individuals	who	 are	 exposed	 to	
diminished	environmental	rhythms	such	as	intensive	care	or	nursing	homes	settings.193
Studies	described	in	Chapter 8 and Chapter 10 demonstrate	that	the	effects	of	circadian	
disruption	 and	 sleep	 loss	 are	 reversible.	 This	 thesis	 thus	 provides	 new	 prevention	 and	
treatment	 opportunities	 for	 patients	 suffering	 from	 the	 above	 mentioned	 disorders	
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To	 be	 optimally	 adjusted	 to	 life	 on	 earth,	 nearly	 all	 bodily	 processes	 display	 a	 circadian	
rhythm.	 These	 rhythms	 of	 about	 24	 hours	 (circa	 =	 around,	 dies	 =	 a	 day)	 result	 from	 a	
molecular	 clockwork	 and	 are	 orchestrated	 by	 the	 suprachiasmatic	 nuclei	 (SCN)	 in	 the	
anterior	hypothalamus.	The	SCN	are	endogenous	pacemakers	that	are	synchronized	to	the	
environment	mainly	by	light.	Light	reaches	the	SCN	via	the	retinohypothalamic	tract	(RHT)	






timing	 is	 additionally	 influenced	by	 sleep	pressure,	 a	 homeostatic	drive	 for	 sleep,	which	
increases	 during	 wakefulness	 and	 decreases	 during	 sleep	 mainly	 because	 of	 rising	 and	
declining	levels	of	adenosine,	respectively.	Sleep	normally	consists	of	cycles	of	sleep	stages	
that	 can	be	 roughly	divided	 in	 rapid	eye	movement	 (REM)	and	nonrapid	eye	movement	
(NREM)	sleep.	The	individual	preference	for	sleep	timing	is	referred	to	as	“chronotype”	and	
generally	distinguishes	morning	and	evening	types.	
In	 modern	 society,	 irregular	 timing	 of	 behavior	 and	 light	 exposure	 is	 progressively	
common,	which	can	be	disruptive	for	circadian	rhythms.	Sleep	deprivation	is	also	frequently	
observed.	 Insufficient	 sleep	 and	 disrupted	 circadian	 rhythms	 have	 been	 related	 to	 a	







constant	 darkness,	 VIP	 KO	differed	 considerably	 from	wildtype	mice.	 For	 instance,	while	
wildtype	mice	had	encoded	the	preceding	day	length,	VIP	KO	mice	failed	to	adapt	to	short	
and	 long	 days.	 This	 indicates	 that	 VIP-mediated	 intercellular	 coupling	 is	 needed	 for	 the	
neuronal	 reorganisation	 of	 the	 SCN	 network	 necessary	 for	 seasonal	 adaptation.	 It	 also	
shows	that	 the	circadian	system	 lacking	VIP	can	be	“rescued”	by	receiving	proper	photic	
input,	possibly	regulated	via	the	RHT	or	through	behavioral	feedback	effects.	
In	 Chapter 5,	 effects	 of	 the	 widely	 used	 psychostimulant	 caffeine,	 an	 antagonist	 of	
the	 adenosine	 receptor,	 on	 sleep	 and	 the	 circadian	 system	were	 examined	 in	mice.	 The	











































adenosine	 is	 involved	 in	modulating	 the	 light	 sensitivity	of	 the	 circadian	 system.	Further	
evidence	for	this	was	provided	by	the	observation	that	exposure	to	constant	light	lengthened	
the	circadian	period	in	mice	and	that	this	effect	was	enhanced	by	chronic	caffeine	treatment.	
Importantly,	 in	 constant	 dark,	 caffeine	 treatment	 did	 not	 significantly	 alter	 the	 period	
duration.	Extrapolating	these	results	to	humans,	light	exposure	in	combination	with	caffeine	

















was	 similar	 in	 lesioned	mice	 and	 sham-lesioned	mice	 8	weeks	 after	 the	 lesion,	 lesioned	





circadian	 rhythms	 in	 behavior	 and	 in	 the	 SCN.	 Over	 time,	 constant	 light-exposed	 mice	
became	heavier,	had	a	worse	performance	on	a	functional	muscle	test	regime	and	displayed	




which	 normalized	 after	 longer	 constant	 light	 exposure.	 Taken	 together,	 these	 findings	











































In	 Chapter 9,	 the	 relationship	 between	 chronotype	 and	 cardiovascular	 predictors	 is	
examined	in	short	sleeping	obese	individuals.	With	the	Horne	and	Ostberg	Morningness-
Eveningness	 questionnaire,	 119	 individuals	were	 divided	 into	morning	 or	 evening	 types.	
Eveningness	 was	 associated	 with	 eating	 later	 in	 the	 day,	 having	 less	 eating	 occasions	
and	 eating	 larger	 portion	 sizes,	 which	 is	 considered	 a	 more	 unhealthy	 eating	 pattern.	
Furthermore,	eveningness	associated	with	a	higher	BMI,	a	higher	resting	health	rate,	higher	




In	 Chapter 10,	 we	 investigated	 the	 effect	 of	 sleep	 extension	 on	 neurocognitive	
function	 in	 the	 same	population	of	 short	 sleeping	obese	 individuals.	At	baseline,	a	 large	
proportion	of	these	individuals	had	an	impaired	global	deficit	score.	Sleep	was	improved	in	
a	nonpharmalogical	manner	for	about	one	year	and	individuals	visited	the	clinic	regularly.	





In	Chapter 11,	we	associated	sleep	with	musculoskeletal	parameters	 in	 the	cohort	of	
the	 Netherlands	 Epidemiology	 of	 Obesity	 Study	 (NEO).	 A	 lower	 subjective	 sleep	 quality	
and	a	later	sleep	timing	associated	with	an	increased	risk	for	osteopenia	(low	bone	mass)	
and	 sarcopenia	 (low	muscle	mass;	 association	 sleep	 timing	 -	 sarcopenia	was	 borderline	





























































































Bijna	 alle	 lichaamsprocessen	 vertonen	 een	 circadiaan	 ritme,	 waardoor	 we	 optimaal	
aangepast	zijn	aan	het	leven	op	aarde.	Deze	ritmes	van	ongeveer	24	uur	(circa	=	rondom,	
dies	=	een	dag)	worden	aangedreven	door	een	moleculair	klokwerk	en	worden	aangestuurd	
door	 de	 suprachiasmatische	 kernen	 (SCN)	 in	 de	 anteriore	 hypothalamus.	 De	 SCN	 zijn	
endogene	pacemakers	die	vooral	door	 licht	met	de	omgeving	worden	gesynchroniseerd.	
Licht	 bereikt	 de	 SCN	 via	 de	 tractus	 retinohypothalamicus	 (RHT)	 en	 kan	 de	 fase	 van	 het	
endogene	 circadiane	 ritme	 verschuiven	 afhankelijk	 van	 het	 tijdstip	 van	 blootstelling.	 De	
SCN	bevatten	ongeveer	20.000	neuronen	die	gekoppeld	zijn	en	samen	een	robuust	multi-
unit	 outputsignaal	 produceren.	De	duur	 van	de	daglengte	wordt	 gereflecteerd	door	 een	
verbreding	of	versmalling	van	de	golfvorm	van	het	outputritme	van	de	SCN.	De	SCN	sturen	
hun	 output	 naar	 meerdere	 systemen	 en	 beïnvloeden	 zo	 de	 timing	 van	 verschillende	
fysiologische	processen	en	van	gedrag,	bijvoorbeeld	van	slaap.	De	timing	van	slaap	wordt	
ook	beïnvloed	door	slaapdruk,	de	homeostatische	regulatie	van	slaap,	die	toeneemt	tijdens	
wakker	 zijn	 en	 afneemt	 tijdens	 slaap,	 door	 toedoen	 van	 respectievelijk	 toenemende	 en	
afnemende	niveaus	van	adenosine.	Slaap	bestaat	normaliter	uit	 cycli	 van	slaapstadia	die	
ruwweg	kunnen	worden	verdeeld	in	rapid eye movement	(REM)	en	nonrapid eye movement 
(NREM)	slaap.	De	individuele	voorkeur	voor	de	timing	van	slaap	wordt	ook	wel	“chronotype” 
genoemd	waarbij	een	onderscheid	kan	worden	gemaakt	tussen	ochtend-	en	avondmensen.	
In	 de	moderne	maatschappij	 komt	 onregelmatige timing	 van	 gedrag	 en	 blootstelling	
aan	 licht	 steeds	 vaker	 voor.	 Ook	 slaapdeprivatie	 komt	 vaker	 voor.	 Insufficiënte	 slaap	 en	
verstoorde	circadiane	ritmiek	zijn	gerelateerd	aan	een	spectrum	van	gezondheidseffecten,	die	




die	 normaliter	 onder	 andere	 in	 de	 SCN	 aanwezig	 is.	 In	 licht-donker	 omstandigheden	
vertoonden	deze	VIP	KO	muizen	normaal	gedrag	en	een	normale	neuronale	SCN	ritmiek	in 
vivo.	Wanneer	zij	echter	 in	een	constant	donkere	omgeving	werden	geplaatst	verschillen	
zij	 sterk	 van	 wildtype	 muizen.	 Wildtype	 muizen	 sloegen	 bijvoorbeeld	 de	 voorafgaande	
daglengte	 op	 in	 de	 SCN,	 maar	 VIP	 KO	 muizen	 niet.	 Dit	 geeft	 aan	 dat	 VIP-gemedieerde	

















































Dit	 impliceert	 dat	 adenosine	 betrokken	 is	 bij	 het	 moduleren	 van	 de	 lichtgevoeligheid	
van	 het	 circadiane	 systeem.	 Verder	 bewijs	 hiervoor	 werd	 geleverd	 door	 de	 observatie	
dat	 blootstelling	 aan	 constant	 licht	 de	 circadiane	 periode	 verlengde	 en	 dat	 dit	 effect	
versterkt	werd	door	chronische	behandeling	met	cafeïne.	Nota	bene,	 in	constant	donker	

























In	Hoofdstuk 8	werd	 het	 effect	 van	 verminderde	 circadiane	 ritmiek	 op	 verscheidene	
gezondheidsparameters	 in	 muizen	 onderzocht.	 Muizen	 werden	 gedurende	 24	 weken	
blootgesteld	aan	constant	licht,	waardoor	de	circadiane	ritmiek	in	hun	gedrag	en	in	de	SCN	
sterk	werden	verminderd.	Muizen	die	aan	constant	licht	waren	blootgesteld	werden	zwaarder,	
hadden	een	 slechter	 resultaat	op	 functionele	 spiertesten	en	hadden	osteoporoseachtige	
















































In	 Hoofdstuk 9	 onderzochten	 we	 de	 relatie	 tussen	 chronotype	 en	 cardiovasculaire	
voorspellers	 in	 kort	 slapende	 obese	 personen.	 Met	 behulp	 van	 de	 Horne	 en	 Ostberg	
Morningness-Eveningness	 vragenlijst	 werden	 119	 personen	 verdeeld	 in	 ochtend-	 of	
avondmensen.	Personen	die	 lager	 scoorden	op	de	vragenlijst	 (meer	 richting	avondmens)	
hadden	 latere	 eetmomenten,	minder	 eetmomenten	en	 aten	 grotere	porties	 –	dit	 is	 een	






















ritmiek	 /	 insufficiënte	 slaap	 en	 ongewenste	 gezondheidsuitkomsten,	 van	 obesitas,	
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